Cinemark Usa 10-Q 5 Nov 19 2019 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2019	Nov. 04, 2019
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q3
Trading Symbol	ck885975
Entity Registrant Name	CINEMARK USA INC /TX
Entity Central Index Key	0000885975
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Shell Company	false
Entity Small Business	false
Entity Emerging Growth Company	false
Entity File Number	33-47040
Entity Tax Identification Number	75-2206284
Entity Address, Address Line One	3900 Dallas Parkway
Entity Address, City or Town	Plano
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75093
City Area Code	972
Local Phone Number	665-1000
Entity Incorporation, State or Country Code	TX
Document Quarterly Report	true
Document Transition Report	false
Class A common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		1,500
Class B common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		182,648

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Sep. 30, 2019	Dec. 31, 2018
Current assets
Cash and cash equivalents		$ 482,688	$ 426,216
Inventories		19,346	19,319
Accounts receivable		66,942	95,076
Current income tax receivable		4,844	3,288
Prepaid expenses and other		20,859	15,114
Accounts receivable from parent		23,812	19,530
Total current assets		618,491	578,543
Theatre properties and equipment		3,262,990	3,404,150
Less: accumulated depreciation and amortization		1,580,589	1,571,017
Theatre properties and equipment – net	[1]	1,682,401	1,833,133
Operating lease right-of-use assets	[2]	1,384,019
Other assets
Goodwill	[3]	1,281,354	1,276,324
Intangible assets – net		322,671	330,910
Investments in and advances to affiliates		166,033	156,766
Long-term deferred tax asset		8,499	9,028
Deferred charges and other assets – net		39,102	41,055
Total other assets		2,090,415	2,089,675
Total assets		5,775,326	4,501,351
Current liabilities
Current portion of long-term debt		7,984	7,984
Current portion of operating lease obligations	[2]	215,015
Current portion of finance and capital lease obligations		15,501	27,065
Current income tax payable		12,656	12,179
Current liability for uncertain tax positions			573
Accounts payable and accrued expenses		388,033	426,252
Total current liabilities		639,189	474,053
Long-term liabilities
Long-term debt, less current portion		1,771,663	1,772,627
Operating lease obligations, less current portion	[2]	1,230,152
Finance and capital lease obligations, less current portion		126,344	232,467
Long-term deferred tax liability		152,494	155,626
Long-term liability for uncertain tax positions		13,884	13,380
Deferred lease expenses			39,235
Other long-term liabilities		42,961	49,431
Total long-term liabilities		3,614,483	2,550,115
Commitments and contingencies (see Note 17)
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543	49,543
Treasury stock, 57,245 Class B shares at cost		(24,233)	(24,233)
Additional paid-in-capital		1,287,720	1,277,921
Retained earnings		545,257	480,580
Accumulated other comprehensive loss		(349,381)	(319,007)
Total Cinemark USA, Inc.'s stockholder's equity		1,508,906	1,464,804
Noncontrolling interests		12,748	12,379
Total equity		1,521,654	1,477,183
Total liabilities and equity		5,775,326	4,501,351
NCM
Other assets
Investment in NCM		272,756	275,592
Long-term liabilities
NCM screen advertising advances		276,985	287,349
Class A common stock
Cinemark USA, Inc.'s stockholder's equity:
Common stock		0	0
Class B common stock
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543	49,543
Total equity		$ 49,543	$ 49,543
[1]	See Note 3 for discussion of impact of ASC Topic 842 on capital lease assets.
[2]	The operating lease right-of-use assets and liabilities recorded on the Company’s condensed consolidated balance sheet generally do not include renewal options that have not yet been exercised.  The Company does not consider a lease renewal as reasonably certain until immediately before the necessary notification is provided to the landlord.
[3]	Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2019	Dec. 31, 2018
Treasury stock, shares	57,245	57,245
Class A common stock
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	10,000,000	10,000,000
Common stock, shares issued	1,500	1,500
Common stock, shares outstanding	1,500	1,500
Class B common stock
Common stock, shares authorized	1,000,000	1,000,000
Common stock, shares issued	239,893	239,893
Common stock, shares outstanding	182,648	182,648
Common stock, par value

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Revenues
Total revenues		$ 821,817	$ 754,235	$ 2,494,296	$ 2,423,259
Cost of operations
Film rentals and advertising		254,911	230,121	759,693	758,242
Concession supplies		51,573	42,720	157,361	134,577
Salaries and wages		103,270	92,495	308,316	285,997
Facility lease expense		87,436	80,592	262,529	243,873
Utilities and other		123,877	112,832	357,210	337,866
General and administrative expenses		44,113	37,745	125,054	121,769
Depreciation and amortization	[1]	67,760	64,971	196,795	193,656
Impairment of long-lived assets		27,304	1,641	45,382	5,020
Loss on disposal of assets and other		2,453	7,826	8,057	28,666
Total cost of operations		762,697	670,943	2,220,397	2,109,666
Operating income		59,120	83,292	273,899	313,593
Other income (expense)
Interest expense	[1],[2]	(24,967)	(27,144)	(75,037)	(82,725)
Loss on debt amendments and refinancing					(1,484)
Interest income		3,897	2,754	10,042	7,847
Foreign currency exchange loss		(4,406)	(3,126)	(4,785)	(6,947)
Equity in income of affiliates		15,139	14,158	33,982	29,208
Total other expense		(12,529)	(15,955)	(40,810)	(56,808)
Income before income taxes		46,591	67,337	233,089	256,785
Income taxes		14,193	16,301	64,615	60,056
Net income		32,398	51,036	168,474	196,729
Less: Net income attributable to noncontrolling interests		602	393	1,957	878
Net income attributable to Cinemark USA, Inc.		31,796	50,643	166,517	195,851
Admissions
Revenues
Total revenues		454,429	427,616	1,371,041	1,389,110
Concession
Revenues
Total revenues		289,477	264,165	886,083	831,243
Other
Revenues
Total revenues		77,911	62,454	237,172	202,906
NCM
Other income (expense)
Distributions from NCM		2,474	2,386	9,168	12,168
Interest expense - NCM		(4,666)	(4,983)	(14,180)	(14,875)
Equity in income of affiliates		$ 9,050	$ 6,830	$ 14,062	$ 11,341
[1]	Amounts for the three and nine months ended September 30, 2019 were impacted by the adoption of ASC Topic 842 and the resulting change in the classification of certain of the Company’s leases
[2]	Includes amortization of debt issue costs.

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 32,398	$ 102,434	$ 33,642	$ 51,036	$ 83,022	$ 62,671	$ 168,474	$ 196,729
Other comprehensive loss, net of tax
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $417, $0, $3,391 and $0, net of settlements	(1,291)	(5,902)	(3,311)	0			(10,504)	0
Other comprehensive loss in equity method investments	(49)	$ (22)	$ (71)	(63)	$ (116)	$ 136	(142)	(43)
Foreign currency translation adjustments	(25,408)			(10,797)			(19,728)	(66,841)
Total other comprehensive loss, net of tax	(26,748)			(10,860)			(30,374)	(66,884)
Total comprehensive income, net of tax	5,650			40,176			138,100	129,845
Comprehensive income attributable to noncontrolling interests	(602)			(393)			(1,957)	(878)
Comprehensive income attributable to Cinemark USA, Inc.	$ 5,048			$ 39,783			$ 136,143	$ 128,967

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Statement Of Income And Comprehensive Income [Abstract]
Unrealized loss due to fair value adjustments on interest rate swap agreements, taxes	$ 417	$ 0	$ 3,391	$ 0

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands		9 Months Ended
		Sep. 30, 2019	Sep. 30, 2018
Operating activities
Net income		$ 168,474	$ 196,729
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation		193,032	191,236
Amortization of intangible and other assets and favorable/unfavorable leases		3,763	2,420
Amortization of long-term prepaid rents	[1]		1,814
Amortization of debt issue costs		3,983	4,236
Loss on debt amendments and refinancing			1,484
Amortization of deferred revenues, deferred lease incentives and other		(12,203)	(16,264)
Impairment of long-lived assets		45,382	5,020
Share based awards compensation expense		9,799	9,676
Loss on disposal of assets and other		8,057	28,666
Non-cash rent expense	[2]	(3,252)
Deferred lease expenses	[1]		(952)
Equity in income of affiliates		(33,982)	(29,208)
Deferred income tax expenses		(5,314)	9,096
Distributions from equity investees		28,163	21,041
Changes in assets and liabilities and other		(9,392)	(75,375)
Net cash provided by operating activities		396,510	349,619
Investing activities
Additions to theatre properties and equipment		(186,512)	(245,962)
Acquisition of theatres in the U.S. and international markets, net of cash acquired		(10,170)	(11,289)
Proceeds from sale of theatre properties and equipment and other		377	3,557
Investment in joint ventures and other, net			(20,442)
Net cash used for investing activities		(196,305)	(352,529)
Financing activities
Dividends paid to parent		(118,825)	(111,550)
Payroll taxes paid as a result of stock withholdings		(2,247)	(2,905)
Repayments of long-term debt		(4,947)	(4,946)
Payment of debt issue costs			(5,103)
Fees paid related to debt amendments			(704)
Payments on finance and capital leases		(10,830)	(18,778)
Other		(1,588)
Net cash used for financing activities		(138,437)	(143,986)
Effect of exchange rate changes on cash and cash equivalents		(5,296)	(8,732)
Increase (decrease) in cash and cash equivalents		56,472	(155,628)
Cash and cash equivalents:
Beginning of period		426,216	522,415
End of period		482,688	366,787
NCM
Adjustments to reconcile net income to cash provided by operating activities:
Equity in income of affiliates		$ (14,062)	(11,341)
Investing activities
Acquisition of NCM common units			$ 78,393
[1]	Amounts for the three and nine months ended September 30, 2019 were impacted by the adoption of ASC Topic 842 and the resulting change in the classification of certain of the Company’s leases
[2]	The adoption of ASC Topic 842 impacted how the Company amortizes lease related assets and liabilities such as deferred lease expenses, favorable and unfavorable lease intangible assets, long-term prepaid rents and deferred lease incentives.  Beginning January 1, 2019, these items are amortized to facility lease expense for theatre operating leases and utilities and other for equipment operating leases.  See Note 3 for discussion of the impact of ASC Topic 842

The Company and Basis of Presen

The Company and Basis of Presentation	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
The Company and Basis of Presentation	1. The Company and Basis of Presentation Cinemark USA, Inc. and subsidiaries (the “Company”), a wholly-owned subsidiary of Cinemark Holdings, Inc., operates in the motion picture exhibition industry, with theatres in the United States (“U.S.”), Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. The accompanying condensed consolidated balance sheet as of December 31, 2018, which was derived from audited financial statements, and the unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete consolidated financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation have been included. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. Actual results could differ from these estimates. Majority-owned subsidiaries that the Company has control of are consolidated while those affiliates of which the Company owns between 20% and 50% and does not control are accounted for under the equity method. Those of which the Company owns less than 20% are generally accounted for under the cost method, unless the Company is deemed to have the ability to exercise significant influence over the affiliate, in which case the Company would account for its investment under the equity method. Th These condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and the notes thereto for the year ended December 31, 2018, included in the Annual Report on Form 10-K filed March 4, 2019 by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Operating results for the three and nine months ended September 30, 2019 are not necessarily indicative of the results to be achieved for the full year.

New Accounting Pronouncements

New Accounting Pronouncements	9 Months Ended
	Sep. 30, 2019
Accounting Changes And Error Corrections [Abstract]
New Accounting Pronouncements	2. New Accounting Pronouncements In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842)

Adoption of ASC Topic 842 - Lea

Adoption of ASC Topic 842 - Lease Accounting	9 Months Ended
	Sep. 30, 2019
Leases [Abstract]
Adoption of ASC Topic 842 - Lease Accounting	3. Adoption of ASC Topic 842 – Lease Accounting The Company adopted ASC Topic 842 as of January 1, 2019 under the modified retrospective approach that resulted in the recognition of a cumulative-effect adjustment to the opening balance of retained earnings with an option to elect certain practical expedients. The Company elected the following practical expedients, as allowed by ASC Topic 842: • The Company chose not to separate nonlease components from lease components, accounting for lease components and nonlease components associated with a lease as a single lease component. More specifically, for theatre leases, the Company elected not to separate fixed common area maintenance costs from lease costs when calculating lease liabilities and assets. • The Company also elected the following practical expedients: o The Company did not reassess whether existing contracts in effect as of the transition date of January 1, 2019 were, or contained, a lease. o The Company did not reassess the classification of existing leases as operating or finance as of the transition date. o The Company did not reassess whether any initial direct costs were incurred for any of its existing leases. o The Company did not elect to apply the recognition requirements of ASC 842 to short-term leases. The adoption of ASC Topic 842 included the following primary impacts: 1. The Company recorded a right-of-use asset and lease liability for all of its operating leases as required by the standard. The lease liability for each lease was determined based on the present value of future minimum lease payments. The right-of-use asset was based on the lease liability value, adjusted for offsets that existed as of adoption, including deferred rent liabilities of ($39,235), net favorable and unfavorable lease intangibles of ($5,780), deferred lease incentive liabilities of ($12,960) and long-term prepaid rents of $7,707. The Company recorded operating lease right-of-use assets of $1,491,245 and operating lease liabilities of $1,545,210 upon adoption. 2. Certain of the Company’s existing lease assets and liabilities, which were accounted for under prior sale-leaseback accounting guidance, were derecognized in accordance with ASC Topic 842 and reevaluated for classification per the new accounting guidance. Several of these leases have been reestablished as operating leases based on ASC Topic 842. a. For those leases that are now classified as operating leases in accordance with ASC Topic 842, approximately $110,442 and $126,376 of lease assets and liabilities, respectively, were recorded as an adjustment to beginning retained earnings. The related net deferred income tax asset for these accounts was also recorded as an adjustment to beginning retained earnings. See additional impact discussed in item 3 below. b. The Company recognized finance lease assets and liabilities in the amount of $57,440 as of January 1, 2019 for the remaining leases that were determined to be finance leases under ASC Topic 842. 3. For the leases noted in item 2a above, the Company will now record the related operating lease payments as facility lease expense, compared to prior periods in which the capitalized asset was depreciated and lease payments were recorded as a reduction of a lease liability and interest expense. Real Estate Leases - The Company conducts a significant part of its theatre operations in leased properties under noncancelable operating and finance leases with terms generally ranging from 10 to 25 years. In addition to fixed lease payments, some of the leases provide for variable lease payments and some require the payment of taxes, insurance and other costs applicable to the property. Variable lease payments include payments based on a percentage of retail sales over contractual levels or payments adjusted periodically for inflation or changes in attendance. The Company can renew, at its option, a substantial portion of the leases at defined or then market rental rates for various periods. Some leases also provide for escalating rent payments throughout the lease term. The Company also leases certain office and warehouse facilities in the U.S. and in international locations. The lease terms for these facilities generally only include fixed payments. The Company recognizes fixed lease expense for the operating leases on a straight-line basis over the lease term. The Company’s real estate lease agreements do not contain any residual value guarantees or restrictive covenants. Equipment Leases - The Company has certain equipment operating leases primarily including projectors, trash compactors and various other equipment used in the day-to-day operation of the business. Certain of the leases require fixed lease payments to be made over the duration of the lease term, while others are variable in nature based on usage or sales. Certain of these leases are month-to-month, while others are noncancelable with terms generally ranging from 5 to 12 years. The Company’s equipment lease agreements do not contain any residual value guarantees or restrictive covenants. The following table represents the operating and finance right-of-use assets and lease liabilities as of September 30, 2019. As of Leases Classification September 30, 2019 Assets (1) Operating lease assets Operating lease assets $ 1,384,019 Finance lease assets Theatre properties and equipment, net of accumulated depreciation and amortization (2) 103,059 Total lease assets $ 1,487,078 Liabilities (1) Current Operating Current portion of operating lease obligations $ 215,015 Finance Current portion of finance lease obligations 15,501 Noncurrent Operating Operating lease obligations, less current portion 1,230,152 Finance Finance lease obligations, less current portion 126,344 Total lease liabilities $ 1,587,012 (1) The operating lease right-of-use assets and liabilities recorded on the Company’s condensed consolidated balance sheet generally do not include renewal options that have not yet been exercised. The Company does not consider a lease renewal as reasonably certain until immediately before the necessary notification is provided to the landlord. (2) Finance lease assets are net of accumulated amortization of $57,506 as of September 30, 2019. As of September 30, 2019, the Company had signed lease agreements with total noncancelable lease payments of approximately $258,453 related to theatre leases that had not yet commenced. The timing of lease commencement is dependent on the completion of construction of the related theatre facility. Additionally, these amounts are based on estimated square footage and costs to construct each facility and may be subject to adjustment upon final completion of each construction project. In accordance with ASC Topic 842, fixed minimum lease payments related to these theatres are not included in the right-of-use assets and lease liabilities as of September 30, 2019. There were no significant noncancelable lease agreements signed, but not yet commenced, related to equipment leases. The following table represents the Company’s aggregate lease costs, by lease classification, for the three and nine months ended September 30, 2019. Three Months Ended Nine Months Ended Lease Cost Classification September 30, 2019 September 30, 2019 Operating lease costs Equipment (1) Utilities and other $ 1,569 $ 5,173 Real Estate (2)(3) Facility lease expense 88,149 262,783 Total operating lease costs $ 89,718 $ 267,956 Finance lease costs Amortization of leased assets Depreciation and amortization $ 3,703 $ 11,182 Interest on lease liabilities Interest expense 1,922 5,927 Total finance lease costs $ 5,625 $ 17,109 (1) Includes approximately $452 and $1,808 of short-term lease payments for the three and nine months ended September 30, 2019, respectively. (2) Includes approximately $18,591 and $54,209 of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenues or attendance and variable common area maintenance costs for the three and nine months ended September 30, 2019 (3) Approximately $400 and $1,184 of lease payments are included in general and administrative expenses primarily related to office leases for the three and nine months ended September 30, 2019, respectively. The following table represents the maturity of lease liabilities, by lease classification, as of September 30, 2019. Operating Finance Years Ending Leases Leases Total 2019 $ 70,137 $ 5,588 $ 75,725 2020 276,114 22,373 298,487 2021 258,827 18,661 277,488 2022 229,272 17,925 247,197 2023 198,799 17,236 216,035 After 2023 704,440 101,110 805,550 Total lease payments $ 1,737,589 $ 182,893 $ 1,920,482 Less: Interest 292,422 41,048 333,470 Present value of lease liabilities $ 1,445,167 $ 141,845 $ 1,587,012 The following table represents future minimum lease payments under noncancelable operating and capital leases at December 31, 2018 as presented in the Company’s Annual Report on Form 10-K filed March 4, 2019: Operating Capital Years Ending Leases Leases 2019 $ 253,323 $ 42,434 2020 242,336 41,502 2021 230,396 34,589 2022 204,628 32,462 2023 176,802 28,534 Thereafter 677,091 166,375 Total $ 1,784,576 345,896 Amounts representing interest payments (86,364 ) Present value of future minimum payments 259,532 Current portion of finance and capital lease obligations (27,065 ) Capital lease obligations, less current portion $ 232,467 The following table represents the weighted-average remaining lease term and discount rate, disaggregated by lease classification, as of September 30, 2019. As of Lease Term and Discount Rate September 30, 2019 Weighted-average remaining lease term (years) (1) Operating leases - equipment 4.1 Operating leases - real estate 7.9 Finance leases - equipment 5.9 Finance leases - real estate 10.6 Weighted-average discount rate (2) Operating leases - equipment 4.3 % Operating leases - real estate 4.8 % Finance leases - equipment 5.5 % Finance leases - real estate 5.2 % (1) The lease assets and liabilities recorded on the Company’s condensed consolidated balance sheet generally do not include renewal options that have not yet been executed. The Company does not consider a lease renewal exercise as reasonably certain until immediately before the necessary notification is provided to the landlord. (2) The discount rate for each lease represents the incremental borrowing rate at which the Company would borrow, on a collateralized basis, over a similar term and at an amount equal to the lease payments in a similar economic environment. The following table represents the minimum cash lease payments included in the measurement of lease liabilities and the non-cash addition of right-of-use assets for the nine months ended September 30, 2019. Nine Months Ended Other Information September 30, 2019 Cash paid for amounts included in the measurement of lease liabilities Cash outflows for operating leases $ 211,940 Cash outflows for finance leases - operating activities $ 5,756 Cash outflows for finance leases - financing activities $ 10,830 Non-cash amount of leased assets obtained in exchange for: Operating lease liabilities - real estate $ 53,526 Operating lease liabilities - equipment $ 668 Finance lease liabilities $ — Lessor Arrangements As noted above, the Company did not reassess whether existing contracts in effect as of the transition date of January 1, 2019 were, or contained, a lease. However, effective September 17, 2019, the Company amended its Exhibitor Services Agreement (“ESA”) with National CineMedia, LLC (“NCM”) and, as a result of this amendment, the Company reassessed the ESA under ASC Topic 842. The Company’s assessment resulted in the determination that the nonconsecutive periods of use of the theatre screens by NCM under the ESA qualify as a lease in accordance with ASC Topic 842. See further discussion in Note 7. The Company rents its theatre auditoriums for corporate meetings, screenings, education and training sessions and other private events. These rentals, which are not significant to the Company, are generally one-time events and the related revenue is reflected as other revenue on condensed consolidated statement of income.

Revenue Recognition

Revenue Recognition	9 Months Ended
	Sep. 30, 2019
Revenue From Contract With Customer [Abstract]
Revenue Recognition	4. Revenue Recognition The Company’s patrons have the option to purchase movie tickets well in advance of a movie showtime or right before the movie showtime, or at any point in between those two timeframes depending on seat availability. The Company recognizes such admissions revenues when the showtime for a purchased movie ticket has passed. Concession revenues are recognized when sales are made at the registers. Other revenues primarily consist of screen advertising, promotional income, studio trailer placements and transactional fees. The Company sells gift cards and discount ticket vouchers, the proceeds from which are recorded as current liabilities. Revenues for gift cards and discount ticket vouchers are recognized when they are redeemed for movie tickets or concession items. The Company offers a subscription program in the U.S. whereby patrons can pay a monthly fee to receive a monthly credit for use towards a future movie ticket purchase. The Company records the monthly subscription program fees as current liabilities and records admissions revenues when the showtime for a movie ticket purchased with a credit has passed. The Company also has loyalty programs in many of its locations that either have a prepaid annual membership fee or award points to customers as purchases are made. For those loyalty programs that have an annual membership fee, the Company recognizes the fee collected as other revenues on a straight-line basis over the term of the membership. For those loyalty programs that award points to customers based on their purchases, the Company records a portion of the original transaction proceeds as liabilities based on the number of reward points issued to customers and recognizes the deferred revenues when the customer redeems such points. Advances collected on concession and other contracts are deferred and recognized during the period in which the Company satisfies the related performance obligations, which may differ from the period in which the advances are collected. These advances are recognized on either a straight-line basis over the term of the contracts or as the Company has met its performance obligations in accordance with the terms of the contracts. Screen advertising revenues for the U.S. operating segment primarily relate to the ESA with NCM and the Company’s beverage concessionaire agreement. As discussed in Note 3 and Note 7, prior to September 17, 2019, such screen advertising was accounted for under ASC Topic 606, Revenue from Contracts with Customers Accounts receivable as of September 30, 2019 included approximately $29,719 of receivables related to contracts with customers. The Company did not record any assets related to the costs to obtain or fulfill a contract with customers during the nine months ended September 30, 2019. Disaggregation of Revenue The following table presents revenues for the three and nine months ended September 30, 2019 and 2018, disaggregated based on major type of good or service and by reportable operating segment. Three Months Ended Nine Months Ended September 30, 2019 September 30, 2019 U.S. International U.S. International Operating Operating Operating Operating Major Goods/Services Segment (1) Segment Consolidated Segment (1) Segment Consolidated Admissions revenues $ 351,122 $ 103,307 $ 454,429 $ 1,066,884 $ 304,157 $ 1,371,041 Concession revenues 230,415 59,062 289,477 704,727 181,356 886,083 Screen advertising, screen rental and promotional revenues 21,114 16,448 37,562 63,996 49,587 113,583 Other revenues 30,394 9,955 40,349 95,180 28,409 123,589 Total revenues $ 633,045 $ 188,772 $ 821,817 $ 1,930,787 $ 563,509 $ 2,494,296 Three Months Ended Nine Months Ended September 30, 2018 September 30, 2018 U.S. International U.S. International Operating Operating Operating Operating Major Goods/Services Segment (1) Segment Consolidated Segment (1) Segment Consolidated Admissions revenues $ 333,274 $ 94,342 $ 427,616 $ 1,091,489 $ 297,621 $ 1,389,110 Concession revenues 207,960 56,205 264,165 661,328 169,915 831,243 Screen advertising and promotional revenues 19,010 13,420 32,430 58,240 43,135 101,375 Other revenues 22,031 7,993 30,024 76,635 24,896 101,531 Total revenues $ 582,275 $ 171,960 $ 754,235 $ 1,887,692 $ 535,567 $ 2,423,259 (1) U.S. segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 16 for additional information on intercompany eliminations. The following table presents revenues for the three and nine months ended September 30, 2019 and 2018, disaggregated based on timing of revenue recognition. Three Months Ended Nine Months Ended September 30, 2019 September 30, 2019 U.S. International U.S. International Operating Operating Operating Operating Segment (1) Segment Consolidated Segment (1) Segment Consolidated Goods and services transferred at a point in time $ 610,063 $ 169,171 $ 779,234 $ 1,860,828 $ 504,702 $ 2,365,530 Goods and services transferred over time 22,982 19,601 42,583 69,959 58,807 128,766 Total $ 633,045 $ 188,772 $ 821,817 $ 1,930,787 $ 563,509 $ 2,494,296 Three Months Ended Nine Months Ended September 30, 2018 September 30, 2018 U.S. International U.S. International Operating Operating Operating Operating Segment (1) Segment Consolidated Segment (1) Segment Consolidated Goods and services transferred at a point in time $ 561,849 $ 155,291 $ 717,140 $ 1,824,138 $ 482,790 $ 2,306,928 Goods and services transferred over time 20,426 16,669 37,095 63,554 52,777 116,331 Total $ 582,275 $ 171,960 $ 754,235 $ 1,887,692 $ 535,567 $ 2,423,259 (1) U.S. segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 16 for additional information on intercompany eliminations. Deferred Revenues The following table presents changes in the Company’s advances and deferred revenues for the nine months ended September 30, 2019. NCM screen advertising advances (1) Other Deferred Revenues (2) Total Balance at January 1, 2019 $ 287,349 $ 106,075 $ 393,424 Amounts recognized as accounts receivable — 10,186 10,186 Cash received from customers in advance — 138,927 138,927 Common units received from NCM (see Note 7) 1,552 — 1,552 Revenue recognized during period (11,916 ) (141,684 ) (153,600 ) Foreign currency translation adjustments — (1,321 ) (1,321 ) Balance at September 30, 2019 $ 276,985 $ 112,183 $ 389,168 (1) See Note 7 for the maturity of balance as of September 30, 2019 (2) Includes liabilities associated with outstanding gift cards and SuperSavers, points or rebates outstanding under the Company’s loyalty and membership programs and revenues not yet recognized for screen advertising, screen rental and other promotional activities. Classified as accounts payable and accrued expenses or other long-term liabilities on the condensed consolidated balance sheet. The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of September 30, 2019 and when the Company expects to recognize this revenue. Twelve Months Ended September 30, Remaining Performance Obligations 2020 2021 2022 2023 2024 Thereafter Total Deferred revenue 102,449 9,488 200 46 — — 112,183

Long Term Debt Activity

Long Term Debt Activity	9 Months Ended
	Sep. 30, 2019
Debt Disclosure [Abstract]
Long Term Debt Activity	5. Long Term Debt Activity Senior Secured Credit Facility On March 29, 2018, the Company amended its senior secured credit facility to extend the maturity of the term loan to March 29, 2025, reduce the rate at which the term loan bears interest by 0.25% and to reduce the amount of real property required to be mortgaged to secure the loans. Under the amended facility, quarterly principal payments of $1,649 are due on the term loan through December 31, 2024, with a final principal payment of $613,351 due on March 29, 2025. The Company incurred debt issue costs of approximately $4,962 in connection with the amendment. As a result of the amendment, the Company wrote-off $780 of unamortized debt issue costs and incurred approximately $704 in legal and other fees, both of which are reflected as loss on debt amendments and refinancing on the condensed consolidated statements of income for the nine months ended September 30, 2018. Fair Value of Long-Term Debt The Company estimates the fair value of its long-term debt using the market approach, which utilizes quoted market prices that fall under Level 2 of the U.S. GAAP fair value hierarchy as defined by ASC 820, Fair Value Measurement . Interest Rate Swap Agreements The Company is currently a party to three interest rate swap agreements that are used to hedge a portion of the interest rate risk associated with the variable interest rates on the Company’s term loan debt and that qualify for cash flow hedge accounting. The fair values of the interest rate swaps are recorded on the Company’s condensed consolidated balance sheet as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive loss. The changes in fair value are reclassified from accumulated other comprehensive loss into earnings in the same period that the hedged items affect earnings. The valuation technique used to determine fair value is the income approach. Under this approach, the Company uses projected future interest rates as provided by counterparty to the interest rate swap agreement and the fixed rates that the Company is obligated to pay under the agreement. Therefore, the Company’s measurements use significant unobservable inputs, which fall in Level 3 of the U.S. GAAP hierarchy as defined by FASB ASC Topic 820-10-35. See Note 12 for a summary of unrealized gains or losses recorded in accumulated other comprehensive loss. Below is a summary of the Company’s interest rate swap agreements designated as cash flow hedges as of September 30, 2019: Estimated Fair Value at Notional September 30, Amount Effective Date Pay Rate Receive Rate Expiration Date 2019 (1) $ 137,500 December 31, 2018 2.75% 1-Month LIBOR December 31, 2022 $ 5,778 $ 175,000 December 31, 2018 2.75% 1-Month LIBOR December 31, 2022 7,346 $ 137,500 December 31, 2018 2.77% 1-Month LIBOR December 31, 2022 5,864 Total $ 18,988 (1) Approximately $3,746 of the total is included in accounts payable and accrued expenses and $15,242 is included in other long-term liabilities on the condensed consolidated balance sheet as of September 30, 2019.

Equity

Equity	9 Months Ended
	Sep. 30, 2019
Equity [Abstract]
Equity	6. Equity Below is a summary of changes in stockholder’s equity attributable to Cinemark USA, Inc., noncontrolling interests and total equity for the three and nine months ended September 30, 2019 and 2018: Class A Common Stock Class B Common Stock Treasury Stock Additional Paid-In-Capital Retained Earnings Accumulated Other Total Cinemark USA, Inc. Stockholder's Equity Noncontrolling Interests Total Equity Balance at January 1, 2019 $ — $ 49,543 $ (24,233 ) $ 1,277,921 $ 480,580 $ (319,007 ) $ 1,464,804 $ 12,379 $ 1,477,183 Cumulative effect of change in accounting principle, net of taxes of $6,054 (see Note 3) — — — — 16,985 — 16,985 — 16,985 Share based awards compensation expense — — — 2,743 — — 2,743 — 2,743 Dividends paid to parent — — — — (39,575 ) — (39,575 ) — (39,575 ) Dividends paid to noncontrolling interests — — — — — — — (1,000 ) (1,000 ) Net income — — — — 33,177 — 33,177 465 33,642 Other comprehensive loss in equity method investees — — — — — (71 ) (71 ) — (71 ) Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements — — — — — (3,311 ) (3,311 ) (3,311 ) Foreign currency translation adjustments — — — — — 755 755 — 755 Balance at March 31, 2019 $ — $ 49,543 $ (24,233 ) $ 1,280,664 $ 491,167 $ (321,634 ) $ 1,475,507 $ 11,844 $ 1,487,351 Share based awards compensation expense — — — 3,447 — — 3,447 — 3,447 Dividends paid to parent — — — — (39,600 ) — (39,600 ) — (39,600 ) Dividends paid to noncontrolling interests — — — — — — — (294 ) (294 ) Net income — — — — 101,544 — 101,544 890 102,434 Other comprehensive loss in equity method investees — — — — — (22 ) (22 ) — (22 ) Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements — — — — — (5,902 ) (5,902 ) (5,902 ) Foreign currency translation adjustments — — — — — 4,925 4,925 — 4,925 Balance at June 30, 2019 $ — $ 49,543 $ (24,233 ) $ 1,284,111 $ 553,111 $ (322,633 ) $ 1,539,899 $ 12,440 $ 1,552,339 Share based awards compensation expense — — — 3,609 — — 3,609 — 3,609 Dividends paid to parent — — — — (39,650 ) — (39,650 ) — (39,650 ) Dividends paid to noncontrolling interests — — — — — — — (294 ) (294 ) Net income — — — — 31,796 — 31,796 602 32,398 Other comprehensive loss in equity method investees — — — — — (49 ) (49 ) — (49 ) Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements — — — — — (1,291 ) (1,291 ) — (1,291 ) Foreign currency translation adjustments — — — — — (25,408 ) (25,408 ) — (25,408 ) Balance at September 30, 2019 $ — $ 49,543 $ (24,233 ) $ 1,287,720 $ 545,257 $ (349,381 ) $ 1,508,906 $ 12,748 $ 1,521,654 Class A Common Stock Class B Common Stock Treasury Stock Additional Paid-In-Capital Retained Earnings Accumulated Other Total Cinemark USA, Inc. Stockholder's Equity Noncontrolling Interests Total Equity Balance at January 1, 2018 $ — $ 49,543 $ (24,233 ) $ 1,264,505 $ 373,069 $ (253,282 ) $ 1,409,602 $ 11,893 $ 1,421,495 Cumulative effect of change in accounting principle, net of taxes of $13,079 — — — — 40,526 — 40,526 — 40,526 Share based awards compensation expense — — — 3,199 — — 3,199 — 3,199 Dividends paid to parent — — — — (37,150 ) — (37,150 ) — (37,150 ) Net income — — — — 62,515 — 62,515 156 62,671 Other comprehensive loss in equity method investees — — — — — 136 136 — 136 Foreign currency translation adjustments — — — — — 204 204 — 204 Balance at March 31, 2018 $ — $ 49,543 $ (24,233 ) $ 1,267,704 $ 438,960 $ (252,942 ) $ 1,479,032 $ 12,049 $ 1,491,081 Share based awards compensation expense — — — 3,223 — — 3,223 — 3,223 Dividends paid to parent — — — — (37,200 ) — (37,200 ) — (37,200 ) Net income — — — — 82,693 — 82,693 329 83,022 Other comprehensive loss in equity method investees — — — — — (116 ) (116 ) — (116 ) Foreign currency translation adjustments — — — — — (56,248 ) (56,248 ) — (56,248 ) Balance at June 30, 2018 $ — $ 49,543 $ (24,233 ) $ 1,270,927 $ 484,453 $ (309,306 ) $ 1,471,384 $ 12,378 $ 1,483,762 Share based awards compensation expense — — — 3,254 — — 3,254 3,254 Dividends paid to parent — — — — (37,200 ) — (37,200 ) (37,200 ) Net income — — — — 50,643 — 50,643 393 51,036 Other comprehensive loss in equity method investees — — — — — (63 ) (63 ) (63 ) Foreign currency translation adjustments — — — — — (10,797 ) (10,797 ) (10,797 ) Balance at September 30, 2018 $ — $ 49,543 $ (24,233 ) $ 1,274,181 $ 497,896 $ (320,166 ) $ 1,477,221 $ 12,771 $ 1,489,992

National CineMedia

National CineMedia	9 Months Ended
	Sep. 30, 2019
NCM
National CineMedia	7. National CineMedia Below is a summary of activity with NCM included in the Company’s condensed consolidated financial statements: Investment in NCM NCM Screen Advertising Advances Distributions from NCM Equity in Earnings Other Revenue Interest Expense - NCM (2) Cash Received Balance as of January 1, 2019 $ 275,592 $ (287,349 ) Receipt of common units due to annual common unit adjustment ("CUA") 1,552 (1,552 ) — — — — — Revenues earned under ESA (1) (2) — — — — (22,151 ) 13,392 8,759 Revenues earned under amendment to ESA (2)(3) — — — — (1,482 ) 788 694 Receipt of excess cash distributions (16,126 ) — (8,009 ) — — — 24,135 Receipt of cash under tax receivable agreement (2,324 ) — (1,159 ) — — — 3,483 Equity in earnings 14,062 — — (14,062 ) — — — Amortization of deferred revenue — 11,916 — — (11,916 ) — — Balance as of and for the nine months ended September 30, 2019 $ 272,756 $ (276,985 ) $ (9,168 ) $ (14,062 ) $ (35,549 ) $ 14,180 $ 37,071 (1) Amount includes the per patron and per digital screen theatre access fees due to the Company prior to the first amendment to the Amended and Restated ESA, net of amounts paid to NCM for on-screen advertising time provided to the Company’s beverage concessionaire of approximately $8,808. (2) Reflects impact of significant financing component related to amounts received in advance under the ESA and CUA agreements. See also Notes 3 and 4. (3) Reflects screen rental revenues earned after the amendment to the ESA. Investment in National CineMedia NCM operates a digital in-theatre network in the U.S. for providing cinema advertising. The Company entered into an Exhibitor Services Agreement with NCM (“ESA”), pursuant to which NCM primarily provides advertising to our theatres. recognizes cash distributions it receives from NCM on its Tranche 1 Investment as a component of earnings as Distributions from NCM. During the three months ended September 30, 2019 and 2018, the Company recorded equity in earnings of $9,050 and $6,830, respectively. During the nine months ended September 30, 2019 and 2018, the Company recorded equity in earnings of $14,062 and $11,341, respectively. Common Unit Adjustments In addition to the consideration received upon the NCMI IPO and ESA modification in 2007, the Company also periodically receives consideration in the form of common units from NCM. Pursuant to a Common Unit Adjustment Agreement dated as of February 13, 2007 between NCMI and the Company, annual adjustments to the common membership units are made primarily based on increases or decreases in the number of theatre screens operated and theatre attendance generated by each Founding Member. As discussed in Note 7 to the Company’s financial statements as included in its 2018 Annual Report on Form 10-K, the common units received (collectively referred to as the Company’s “Tranche 2 Investment”) are recorded at estimated fair value as an increase in the Company’s investment in NCM with an offset to deferred revenue or NCM screen advertising advances. The Company’s Tranche 2 Investment is accounted for following the equity method, with undistributed equity earnings related to its Tranche 2 Investment included as a component of earnings in equity in income of affiliates and distributions received related to its Tranche 2 Investment are recorded as a reduction of investment basis During March 2019, NCM performed its annual common unit adjustment calculation under the Common Unit Adjustment Agreement. As a result of the calculation, on March 29, 2019, the Company received an additional 219,056 common units of NCM, each of which is convertible into one share of NCMI common stock. The Company recorded the additional common units received at estimated fair value with a corresponding adjustment to deferred revenue of approximately $1,552. The fair value of the common units received was estimated based on the market price of NCMI common stock at the time the common units were determined, adjusted for volatility associated with the estimated time period it would take to convert the common units and register the respective shares. The deferred revenue is recognized on a straight-line basis over the remaining term of the first amendment to the Amended and Restated ESA. As of September 30, 2019, the Company owned a total of 39,737,700 common units of NCM, representing an ownership interest of approximately 25%. The estimated fair value of the Company’s investment in NCM was approximately $325,849 based on the price of NCMI common stock as of September 30, 2019 of $8.20 per share (Level 1 input as defined in FASB ASC Topic 820). Exhibitor Service Agreement As previously discussed, our domestic theatres are part of the in-theatre digital network operated by NCM under the ESA. NCM provides advertising to our theatres through its branded “ Noovie Revenue from Contracts with Customers. Since the agreement was amended, the Company was required to evaluate the revised contract under ASC Topic 842, Leases , and as a result, determined that the ESA met the definition of a lease. The Company leases nonconsecutive periods of use of its domestic theatre screens to NCM for purposes of showing third party advertising content. The lease, which is classified as an operating lease, generally requires variable lease payments based on the number of patrons attending the showtimes during which such advertising is shown. The lease agreement is considered short-term due to the fact that the nonconsecutive periods of use, or advertising time slots, are set on a weekly basis . The revenues earned under the ESA screen advertising revenues, both before and after the amendment, are reflected in other revenue on the condensed consolidated income statement. The recognition of revenue related to the deferred revenue or NCM screen advertising advances will continue to be recorded on a straight-line basis over the new term of the amended ESA or February 2041. Twelve Months Ended September 30, Remaining Maturity 2020 2021 2022 2023 2024 Thereafter Total NCM screen advertising advances 15,912 15,917 15,917 15,917 15,917 197,405 276,985 Significant Financing Component Prior to the September 17, 2019 amendment of the ESA, the Company applied a significant financing component, as required by ASC Topic 606, due to the significant length of time between receiving the NCM screen advertising advances (the $174 million received at the NCMI IPO and the periodic common unit adjustments) and completion of the performance obligation. Effective September 17, 2019, upon the Company’s evaluation and determination that ASC Topic 842 applies to the amended ESA, the Company determined it acceptable to retain the accounting for the significant financing component as the economic substance of the arrangement represents a financing, consistent with the guidance in ASC Topic 606. As a result of the significant financing component, the Company recognized incremental screen advertising revenue and an offsetting interest expense of $4,666 and $4,983 during the three months ended September 30, 2019 and 2018, respectively, and $14,180 and $14,875 for the nine months ended September 30, 2019 and 2018, respectively. The interest expense was calculated using the Company’s incremental borrowing rates at the time when the cash and each tranche of common units were received from NCM, which ranged from 4.4% to 8.0%. NCM Financial Information Below is summary financial information for NCM for the periods indicated (financial information as of and for the three months ended September 27, 2019 is not yet available). Three Six Months ended Three Nine Months Ended June 27, 2019 June 27, 2019 September 27, 2018 September 27, 2018 Gross revenues $ 110,200 $ 187,100 $ 110,100 $ 304,000 Operating income $ 37,700 $ 48,600 $ 42,300 $ 93,500 Net income $ 23,500 $ 20,600 $ 28,500 $ 50,500 As of As of June 27, 2019 December 27, 2018 Current assets $ 141,100 $ 172,700 Noncurrent assets $ 732,900 $ 726,800 Current liabilities $ 88,400 $ 115,200 Noncurrent liabilities $ 939,300 $ 924,900 Members deficit $ (153,700 ) $ (140,600 )

Other Investments

Other Investments	9 Months Ended
	Sep. 30, 2019
Financial Support For Nonconsolidated Legal Entity [Abstract]
Other Investments	8. Other Investments Below is a summary of activity for each of the Company’s other investments for the nine months ended September 30, 2019: DCIP AC JV, LLC DCDC FE Concepts Other Total Balance at January 1, 2019 $ 125,252 $ 5,266 $ 2,255 $ 19,918 $ 4,075 $ 156,766 Cash distributions received (7,912 ) (1,800 ) — — — (9,712 ) Equity in income 17,024 2,185 777 (66 ) — 19,920 Equity in other comprehensive loss (142 ) — — — — (142 ) Other — — — — (799 ) (799 ) Balance at September 30, 2019 $ 134,222 $ 5,651 $ 3,032 $ 19,852 $ 3,276 $ 166,033 Digital Cinema Implementation Partners LLC (“DCIP”) On February 12, 2007, the Company, AMC and Regal (the “Exhibitors”) entered into a joint venture known as DCIP to facilitate the implementation of digital cinema in the Company’s theatres and to establish agreements with major motion picture studios for the financing of digital cinema. On March 10, 2010, DCIP and its subsidiaries completed an initial financing transaction to enable the purchase, deployment and leasing of digital projection systems to the Exhibitors under equipment lease and installation agreements. On March 31, 2011, DCIP obtained incremental financing necessary to complete the deployment of digital projection systems. DCIP also entered into long-term Digital Cinema Deployment Agreements (“DCDAs”) with six major motion picture studios pursuant to which Kasima LLC, one of DCIP’s subsidiaries, receives a virtual print fee ("VPF") each time the studio books a film or certain other content on the leased digital projection systems. Other content distributors entered into similar DCDAs that provide for the payment of VPFs for bookings of the distributor's content on a leased digital projection system. The DCDAs end on the earlier to occur of (i) the tenth anniversary of the "mean deployment date" for all digital projection systems scheduled to be deployed over a period of up to five years, or (ii) the date DCIP achieves "cost recoupment", each as defined in the DCDAs. Cost recoupment occurs when revenues attributable to the digital projection systems exceed the financing, deployment, administration and other costs associated with the purchase of the digital projection systems. DCIP expects cost recoupment to occur during late 2020. Pursuant to the operating agreement between the Exhibitors and DCIP, DCIP began to distribute excess cash to the Exhibitors upon the payoff of its outstanding debt, which occurred during the three months ended September 30, 2019. As of September 30, 2019, the Company had a 33% voting interest in DCIP and a 24.3% economic interest in DCIP. The Company accounts for its investment in DCIP and its subsidiaries under the equity method of accounting. Below is summary financial information for DCIP for the periods indicated: Three Months Ended Nine Months Ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Gross revenues $ 40,200 $ 43,403 $ 125,869 $ 126,957 Operating income $ 22,617 $ 25,816 $ 73,396 $ 74,310 Net income $ 22,362 $ 24,311 $ 69,323 $ 68,014 As of September 30, 2019 December 31, 2018 Current assets $ 64,019 $ 57,907 Noncurrent assets $ 603,209 $ 684,545 Current liabilities $ 66,942 $ 67,408 Noncurrent liabilities $ 11,985 $ 125,596 Members' equity $ 588,301 $ 549,448 As of September 30, 2019, the Company had 3,866 digital projection systems being leased under the master equipment lease agreement with Kasima LLC, which is an indirect subsidiary of DCIP and a related party to the Company. See Note 3 for discussion of the weighted-average remaining lease term and discount rate of equipment operating leases, which includes digital projection systems leased from Kasima, LLC. The Company had the following transactions with DCIP, reflected in utilities and other costs on the condensed consolidated statements of income, during the three and nine months ended September 30, 2019 and 2018: Three Nine Months Ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Equipment lease payments $ 1,105 $ 1,229 $ 3,357 $ 3,689 Warranty reimbursements from DCIP $ (2,953 ) $ (2,791 ) $ (8,842 ) $ (7,909 ) Management service fees $ 128 $ 180 $ 438 $ 558 AC JV, LLC During December 2013, the Company, Regal, AMC (the “AC Founding Members”) and NCM entered into a series of agreements that resulted in the formation of AC JV, LLC (“AC”), a joint venture that owns “Fathom Events” formerly operated by NCM. The Fathom Events business focuses on the marketing and distribution of live and pre-recorded entertainment programming to various theatre operators, including concerts, opera and symphony, DVD product releases and marketing events, theatrical premieres, Broadway plays, live sporting events and other special events. The Company paid event fees to AC of $10,332 and $8,516 for the nine months ended September 30, 2019 and 2018, respectively, which are included in film rentals and advertising costs on the condensed consolidated statements of income. Additionally, the remaining outstanding balance of a note payable from the Company to NCM, related to the formation of AC, was $1,389 as of September 30, 2019. Digital Cinema Distribution Coalition Digital Cinema Distribution Coalition (“DCDC”) is a joint venture among the Company, Universal, Warner Bros., AMC and Regal. DCDC operates a satellite distribution network that distributes all digital content to U.S. theatres via satellite. The Company has an approximate 14.6% ownership in DCDC. The Company paid approximately $703 and $657 to DCDC during the nine months ended September 30, 2019 and 2018, respectively, related to content delivery services provided by DCDC. These fees are included in film rentals and advertising costs on the condensed consolidated statements of income. FE Concepts, LLC During April 2018, the Company, through its wholly-owned indirect subsidiary CNMK Texas Properties, LLC (“CNMK”), formed a joint venture, FE Concepts, LLC (“FE Concepts”) with AWSR Investments, LLC (“AWSR”), an entity owned by Lee Roy Mitchell and Tandy Mitchell. FE Concepts will develop and operate a family entertainment center that offers bowling, gaming, movies and other amenities. The Company and AWSR each invested approximately $20,000 and each have a 50% voting interest in FE Concepts. The Company accounts for its investment in FE Concepts under the equity method of accounting.

Share Based Awards

Share Based Awards	9 Months Ended
	Sep. 30, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Share Based Awards	9. Share Based Awards Restricted Stock – During the nine months ended September 30, 2019, Cinemark Holdings, Inc. granted 308,250 shares of restricted stock to its directors and employees of the Company. The fair value of the restricted stock granted was determined based on the market value of Cinemark Holdings, Inc.’s common stock on the dates of grant, which ranged from $36.70 to $41.61 per share. The Company assumed forfeiture rates for the restricted stock awards that ranged from 0% to 10%. The restricted stock awards vest over periods ranging from one to four years. The recipients of restricted stock are entitled to receive non-forfeitable dividends and to vote their respective shares, however, the sale and transfer of the restricted shares is prohibited during the restriction period. Below is a summary of restricted stock activity for the nine months ended September 30, 2019: Shares of Weighted Average Restricted Grant Date Stock Fair Value Outstanding at January 1, 2019 704,353 $ 38.68 Granted 308,250 $ 37.42 Vested (198,711 ) $ 41.38 Forfeited (19,351 ) $ 37.41 Outstanding at September 30, 2019 794,541 $ 37.55 Unvested restricted stock at September 30, 2019 794,541 $ 37.55 Nine Months Ended September 30, 2019 2018 Compensation expense recognized by the Company during the period $ 6,769 $ 4,342 Additional compensation expense recognized by Cinemark Holdings, Inc. during the period $ 687 $ 2,924 Fair value of restricted shares held by Company employees that vested during the period $ 6,650 $ 7,013 Fair value of restricted shares held by Cinemark Holdings, Inc.’s directors that vested during the period $ 980 $ 802 Income tax benefit recognized upon vesting of restricted stock awards held by Company employees $ 1,228 $ 1,550 Additional income tax benefit recognized upon vesting of restricted stock awards held by Cinemark Holdings, Inc.'s directors $ 245 $ 201 As of September 30, 2019, the estimated remaining unrecognized compensation expense related to unvested restricted stock awards was $17,998, of which $17,350 will be recognized by the Company and $648 will be recognized by Cinemark Holdings, Inc. The weighted average period over which this remaining compensation expense will be recognized is approximately two years. Restricted Stock Units – During the nine months ended September 30, 2019, Cinemark Holdings, Inc. granted restricted stock units representing 306,651 hypothetical shares of its common stock to employees of the Company. The restricted stock units vest based on a combination of financial performance factors and continued service. The financial performance factors are based on an implied equity value concept that determines an internal rate of return (“IRR”) during the two fiscal year periods ending December 31, 2020 based on a formula utilizing a multiple of Adjusted EBITDA subject to certain adjustments as specified by the Compensation Committee prior to the grant date. The financial performance factors for the restricted stock units have a threshold, target and maximum level of payment opportunity and vest on a prorata basis according to the IRR achieved by the Company during the performance period. If the IRR for the two-year period is at least 6%, which is the threshold, one-third of the maximum restricted stock units vest. If the IRR for the two-year period is at least 8%, which is the target, two-thirds of the maximum restricted stock units vest. If the IRR for the two-year period is at least 14%, which is the maximum, 100% of the maximum restricted stock units vest. Grantees are eligible to receive a ratable portion of the common stock issuable if the IRR is within the targets previously noted. Further, as an example, if the Company achieves an IRR equal to 11%, the number of restricted stock units that shall vest will be greater than the target but less than the maximum number that would have vested had the Company achieved the highest IRR. All restricted stock units granted during 2019 will vest subject to an additional two-year service requirement and will be paid in the form of common stock of Cinemark Holdings, Inc. if the participant continues to provide services through the fourth anniversary of the grant date. Restricted stock unit award participants are eligible to receive dividend equivalent payments from the grant date if, and at the time that, the restricted stock unit awards vest. Below is a table summarizing the potential number of shares that could vest under restricted stock unit awards granted during the nine months ended September 30, 2019 Number of Shares Value at Vesting Grant at IRR of at least 6% 136,285 $ 5,011 at IRR of at least 8% 204,427 $ 7,517 at IRR of at least 14% 306,651 $ 11,276 Due to the fact that the IRR for the two-year performance period could not be determined at the time of the 2019 grant, the Company estimated that the most likely outcome is the achievement of the target IRR level. The fair value of the restricted stock unit awards was determined based on the closing price of Cinemark Holdings, Inc.’s common stock on the date of grant, which was $36.77 per share. The Company assumed a forfeiture rate of 5% for the restricted stock unit awards. If during the service period, additional information becomes available to lead the Company to believe a different IRR level will be achieved for the two-year performance period, the Company will reassess the number of units that are expected to vest for the grant and adjust its compensation expense accordingly on a prospective basis over the remaining service period. Nine Months Ended September 30, 2019 2018 Number of restricted stock unit awards that vested during the period 88,074 127,084 Fair value of restricted stock unit awards that vested during the period $ 3,550 $ 4,846 Accumulated dividends paid upon vesting of restricted stock unit awards $ 375 $ 526 Compensation expense recognized during the period $ 3,030 $ 3,098 Income tax benefit recognized upon vesting of restricted stock unit awards $ 175 $ 740 During the nine months ended September 30, 2019, the Company modified the performance target levels for the restricted stock unit awards granted during February 2017 and February 2018 for all participants other than certain executive officers. The modification adjusted the threshold, target and maximum IRR levels from 7.0%, 9.5% and 13.0%, respectively, to 6.0%, 8.0% and 14.0%, respectively. The Company accounted for the change in performance measures as modifications of each award, and recorded a reduction to compensation expense of $132 during the three months ended March 31, 2019. Simultaneous with the modification of the restricted stock unit awards granted during February 2017, the Company determined that the final IRR reached for the respective measurement period was 9.3%, which resulted in a reduction in compensation expense of approximately $563. As of September 30, 2019, the estimated remaining unrecognized compensation expense related to the outstanding restricted stock unit awards was $11,128. The weighted average period over which this remaining compensation expense will be recognized is approximately two years. As of September 30, 2019, the Company had restricted stock units outstanding that represented a total of 554,529 hypothetical shares of Cinemark Holdings, Inc.’s common stock, net of forfeitures, assuming an IRR of 7.2% was achieved for the 2016 grants, an IRR of 9.3% was achieved for the 2017 grants, and the maximum IRR level is achieved for all other grants outstanding.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	9 Months Ended
	Sep. 30, 2019
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	10. Goodwill and Other Intangible Assets The Company’s goodwill was as follows: U.S. Operating Segment International Operating Segment Total Balance at January 1, 2019 (1) $ 1,174,041 $ 102,283 $ 1,276,324 Theatres acquired in the US and Brazil (2) 8,812 869 9,681 Foreign currency translation adjustments — (4,651 ) (4,651 ) Balance at September 30, 2019 (1) $ 1,182,853 $ 98,501 $ 1,281,354 (1) Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment. (2) Amount represents final purchase price allocation for two theatres acquired in the U.S. during 2019 and the final purchase price allocation adjustment for theatres acquired in Brazil during 2018. The Company evaluates goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable. The Company evaluates goodwill for impairment at the reporting unit level and has allocated goodwill to the reporting unit based on an estimate of its relative fair value. Management considers the reporting unit to be each of its nineteen regions in the U.S. and seven countries internationally with Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala considered one reporting unit (the Company does not have goodwill recorded for all of its international locations). For the year ended December 31, 2018, the Company performed a quantitative goodwill impairment assessment on all reporting units, in accordance with ASC Topic 350-20-35. No events or changes in circumstances occurred during the nine months ended September 30, 2019 that indicated the carrying value of goodwill might exceed its estimated fair value. Intangible assets consisted of the following: Balance at January 1, 2019 Impact of Adoption of ASC Topic 842 (1) Amortization Other (2) Balance at September 30, 2019 Intangible assets with finite lives: Gross carrying amount $ 105,256 $ (18,024 ) $ — $ (2,501 ) $ 84,731 Accumulated amortization (74,603 ) 13,597 (3,730 ) 2,130 (62,606 ) Total net intangible assets with finite lives $ 30,653 $ (4,427 ) $ (3,730 ) $ (371 ) $ 22,125 Intangible assets with indefinite lives: Tradename and other 300,257 ― ― 289 300,546 Total intangible assets — net $ 330,910 $ (4,427 ) $ (3,730 ) $ (82 ) $ 322,671 (1) See Note 3 for further discussion of the impact of adoption of ASC Topic 842. (2) Amount represents the write-off of fully amortized intangible assets related to non-compete agreements, the acquisition of tradeable liquor licenses, fair values allocated to intangible assets acquired as part of acquisitions of two theatres in the U.S. and foreign currency translation adjustments. For the year ended December 31, 2018, the Company performed a quantitative assessment for all definite and indefinite-lived tradename assets. No events or changes in circumstances occurred during the nine months ended September 30, 2019 that indicated the carrying value of its tradename assets might exceed their estimated fair values. Estimated aggregate future amortization expense for intangible assets is as follows: For the three months ended December 31, 2019 $ 1,254 For the twelve months ended December 31, 2020 4,986 For the twelve months ended December 31, 2021 3,150 For the twelve months ended December 31, 2022 3,116 For the twelve months ended December 31, 2023 3,083 Thereafter 6,536 Total $ 22,125

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets	9 Months Ended
	Sep. 30, 2019
Impairment Or Disposal Of Tangible Assets Disclosure [Abstract]
Impairment of Long-Lived Assets	11. Impairment of Long-Lived Assets The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. See discussion of the Company’s long-lived asset impairment evaluation process in Note 1 to the Company’s financial statements as included in its 2018 Annual Report on Form 10-K. As noted in the discussion, fair value is determined based on a multiple of cash flows, which was six and a half times for the evaluations performed during the nine months ended September 30, 2019 and 2018. As of September 30, 2019, the estimated aggregate fair value of the long-lived assets impaired during the nine months ended September 30, 2019 was $27,383. The long-lived asset impairment charges recorded during each of the periods presented are specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics or adverse changes in the development or the conditions of the areas surrounding the theatre. Below is a summary of impairment charges for the periods presented: Three Months Ended Nine Months Ended September 30, September 30, 2019 2018 2019 2018 U.S. theatre properties and equipment $ 24,502 $ 1,553 $ 26,754 $ 3,331 U.S. operating lease right-of-use assets 2,157 — 10,204 — International theatre properties and equipment 645 88 6,796 1,689 International operating lease right-of-use assets — — 1,628 — Total $ 27,304 $ 1,641 $ 45,382 $ 5,020

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2019
Fair Value Disclosures [Abstract]
Fair Value Measurements	12. Fair Value Measurements The Company determines fair value measurements in accordance with ASC Topic 820, which establishes a fair value hierarchy under which an asset or liability is categorized based on the lowest level of input significant to its fair value measurement. The levels of input defined by ASC Topic 820 are as follows: Level 1 – quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date; Level 2 – other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3 – unobservable and should be used to measure fair value to the extent that observable inputs are not available. Below is a summary of liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of September 30, 2019: Carry Fair Value Description Value Level 1 Level 2 Level 3 Interest rate swap liabilities (1) $ (18,988 ) $ — $ — $ (18,988 ) (1) See further discussion of interest rate swaps at Note 5. Below is a summary of liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of December 31, 2018: Carry Fair Value Description Value Level 1 Level 2 Level 3 Interest rate swap liabilities (1) $ (5,093 ) $ — $ — $ (5,093 ) (1) Below is a reconciliation of the beginning and ending balance for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3): Liabilities (1) 2019 Beginning balance - January 1 $ 5,093 Total loss included in accumulated other comprehensive loss 15,036 Settlements included in interest expense (1,141 ) Ending balance - September 30 $ 18,988 (1) The Company uses the market approach for fair value measurements on a nonrecurring basis in the impairment evaluations of its long-lived assets (see Note 10 and Note 11). See additional explanation of fair value measurement techniques used for long-lived assets, goodwill and intangible assets in “Critical Accounting Policies” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, filed March 4, 2019. There were no changes in valuation techniques and there were no transfers in or out of Level 1, Level 2 or Level 3 during the nine months ended September 30, 2019.

Foreign Currency Translation

Foreign Currency Translation	9 Months Ended
	Sep. 30, 2019
Foreign Currency [Abstract]
Foreign Currency Translation	13. Foreign Currency Translation The accumulated other comprehensive loss account in stockholder’s equity of $349,381 and $319,007 as of September 30, 2019 and December 31, 2018, respectively, primarily includes cumulative foreign currency adjustments of $335,028 and $315,300, respectively, from translating the financial statements of the Company’s international subsidiaries and the cumulative changes in fair value of the Company’s interest rate swap agreements that are designated as hedges. As of September 30, 2019, all foreign countries where the Company has operations, other than Argentina, are non-highly inflationary, and the local currency is the same as the functional currency in all of the locations. Thus, any fluctuation in the currency results in a cumulative foreign currency translation adjustment recorded to accumulated other comprehensive loss. The Company deemed Argentina to be highly inflationary beginning July 1, 2018. A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity. The financial information of the Company’s Argentina subsidiaries has been remeasured in U.S. dollars in accordance with ASC Topic 830, Foreign Currency Matters Below is a summary of the impact of translating the September 30, 2019 financial statements of the Company’s international subsidiaries: Other Comprehensive Loss for Exchange Rate as of Nine Months Ended Country September 30, 2019 December 31, 2018 September 30, 2019 September 30, 2018 Brazil 4.16 3.88 $ (14,492 ) $ (42,588 ) Argentina (1) 57.41 37.68 — (18,272 ) Chile 727.65 694.74 (4,017 ) (4,822 ) Colombia 3,462.00 3,249.75 (1,507 ) 70 Peru 3.40 3.39 (203 ) (891 ) All other 491 (338 ) $ (19,728 ) $ (66,841 ) (1)

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	9 Months Ended
	Sep. 30, 2019
Supplemental Cash Flow Elements [Abstract]
Supplemental Cash Flow Information	14. Supplemental Cash Flow Information The following is provided as supplemental information to the condensed consolidated statements of cash flows: Nine Months Ended September 30, 2019 2018 Cash paid for interest $ 56,326 $ 62,773 Cash paid for income taxes, net of refunds received $ 69,498 $ 42,631 Noncash investing and financing activities: Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (1) $ (13,642 ) $ 7,050 Theatre properties acquired under capital lease $ — $ 4,035 Interest expense - NCM (see Note 7) $ (14,180 ) $ (14,875 ) Investment in NCM – receipt of common units (see Note 7) $ 1,552 $ 5,012 (1) Additions to theatre properties and equipment included in accounts payable as of September 30, 2019 and December 31, 2018 were $23,362 and $37,004, respectively.

Segments

Segments	9 Months Ended
	Sep. 30, 2019
Segment Reporting [Abstract]
Segments	15. Segments The Company manages its international market and its U.S. market as separate reportable operating segments, with the international segment consisting of operations in Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. Each segment’s revenue is derived from admissions and concession sales and other ancillary revenues. The Company uses Adjusted EBITDA, as shown in the reconciliation table below, as the primary measure of segment profit and loss to evaluate performance and allocate its resources. The Company does not report total assets by segment because that information is not used to evaluate the performance of or allocate resources between segments. Below is a breakdown of selected financial information by reportable operating segment: Three Months Ended Nine Months Ended September 30, September 30, 2019 2018 2019 2018 Revenues U.S. $ 636,628 $ 585,536 $ 1,941,545 $ 1,897,664 International 188,772 171,960 563,509 535,567 Eliminations (3,583 ) (3,261 ) (10,758 ) (9,972 ) Total revenues $ 821,817 $ 754,235 $ 2,494,296 $ 2,423,259 Adjusted EBITDA U.S. $ 132,705 $ 132,974 $ 454,665 $ 478,164 International 37,411 35,740 113,346 106,518 Total Adjusted EBITDA $ 170,116 $ 168,714 $ 568,011 $ 584,682 Capital expenditures U.S. $ 50,679 $ 65,458 $ 148,609 $ 195,104 International 20,664 17,915 37,903 50,858 Total capital expenditures $ 71,343 $ 83,373 $ 186,512 $ 245,962 The following table sets forth a reconciliation of net income to Adjusted EBITDA: Three Months Ended Nine Months Ended September 30, September 30, 2019 2018 2019 2018 Net income $ 32,398 $ 51,036 $ 168,474 $ 196,729 Add (deduct): Income taxes 14,193 16,301 64,615 60,056 Interest expense (1) (2) 24,967 27,144 75,037 82,725 Other income, net (3) (9,964 ) (8,803 ) (25,059 ) (15,233 ) Loss on debt amendments and refinancing — — — 1,484 Distributions from DCIP (4) 2,694 — 7,912 5,201 Other cash distributions from equity investees (5) 5,804 4,786 20,251 15,840 Depreciation and amortization (2) 67,760 64,971 196,795 193,656 Impairment of long-lived assets 27,304 1,641 45,382 5,020 Loss on disposal of assets and other 2,453 7,826 8,057 28,666 Non-cash rent expense (6) (1,102 ) — (3,252 ) — Deferred lease expenses (2) — (20 ) — (952 ) Amortization of long-term prepaid rents (2) — 578 — 1,814 Share based awards compensation expense 3,609 3,254 9,799 9,676 Adjusted EBITDA (2) $ 170,116 $ 168,714 $ 568,011 $ 584,682 (1) Includes amortization of debt issue costs. (2) Amounts for the three and nine months ended September 30, 2019 were impacted by the adoption of ASC Topic 842 and the resulting change in the classification of certain of the Company’s leases. (3) Includes interest income, foreign currency exchange loss, equity in income of affiliates and interest expense - NCM and excludes distributions from NCM. (4) See discussion of cash distributions from DCIP, which were recorded as a reduction of the Company’s investment in DCIP, at Note 8. (5) Includes cash distributions received from equity investees, other than those from DCIP noted above, that were recorded as a reduction of the respective investment balances (see Notes 7 and 8). These distributions are reported entirely within the U.S. operating segment. (6) The adoption of ASC Topic 842 impacted how the Company amortizes lease related assets and liabilities such as deferred lease expenses, favorable and unfavorable lease intangible assets, long-term prepaid rents and deferred lease incentives. Beginning January 1, 2019, these items are amortized to facility lease expense for theatre operating leases and utilities and other for equipment operating leases. See Note 3 for discussion of the impact of ASC Topic 842. Financial Information About Geographic Areas Below is a breakdown of selected financial information by geographic area: Three Months Ended Nine Months Ended September 30, September 30, Revenues 2019 2018 2019 2018 U.S. $ 636,628 $ 585,536 $ 1,941,545 $ 1,897,664 Brazil 79,776 65,152 240,263 218,265 Other international countries 108,996 106,808 323,246 317,302 Eliminations (3,583 ) (3,261 ) (10,758 ) (9,972 ) Total $ 821,817 $ 754,235 $ 2,494,296 $ 2,423,259 As of As of Theatre Properties and Equipment-net (1) September 30, 2019 December 31, 2018 U.S. $ 1,408,052 $ 1,479,603 Brazil 111,297 140,570 Other international countries 163,052 212,960 Total $ 1,682,401 $ 1,833,133 (1) See Note 3 for discussion of impact of ASC Topic 842 on capital lease assets.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2019
Related Party Transactions [Abstract]
Related Party Transactions	16. Related Party Transactions The Company manages theatres for Laredo Theatre, Ltd. (“Laredo”). The Company is the sole general partner and owns 75% of the limited partnership interests of Laredo. Lone Star Theatres, Inc. owns the remaining 25% of the limited partnership interests in Laredo and is 100% owned by Mr. David Roberts, Lee Roy Mitchell’s son-in-law. Lee Roy Mitchell is Cinemark Holdings, Inc.’s Chairman of the Board of Directors and directly and indirectly owns approximately 8% of Cinemark Holdings, Inc.’s common stock. Under the agreement, management fees are paid by Laredo to the Company at a rate of 5% of annual theatre revenues up to $50,000 and 3% of annual theatre revenues in excess of $50,000. The Company recorded $539 and $488 of management fee revenues during the nine months ended September 30, 2019 and 2018, respectively. All such amounts are included in the Company’s condensed consolidated financial statements with the intercompany amounts eliminated in consolidation. The Company has an Aircraft Time Sharing Agreement with Copper Beech Capital, LLC (“Copper Beech”) to use, on occasion, a private aircraft owned by Copper Beech. Copper Beech is owned by Mr. Mitchell and his wife, Tandy Mitchell. The private aircraft is used by Mr. Mitchell and other executives who accompany Mr. Mitchell to business meetings for the Company. The Company reimburses Copper Beech for the actual costs of fuel usage and the expenses of the pilots, landing fees, storage fees and similar expenses incurred during the trip. For the nine months ended September 30, 2019 and 2018, the aggregate amounts paid to Copper Beech for the use of the aircraft was $111 and $51, respectively. The Company leases 14 theatres and one parking facility from Syufy Enterprises, LP (“Syufy”) or affiliates of Syufy. Raymond Syufy is one of Cinemark Holdings, Inc.’s directors and is an officer of the general partner of Syufy. Of these 15 leases, 14 have fixed minimum annual rent. The one lease without minimum annual rent has rent based upon a specified percentage of gross sales as defined in the lease. For the nine months ended September 30, 2019 and 2018, the Company paid total rent of approximately $20,006 and $19,465, respectively, to Syufy. During 2019, the Company began providing digital equipment support to drive-in theatres owned by Syufy. The Company billed approximately $36 related to these services during the nine months ended September 30, 2019. The Company has paid certain fees on behalf of its parent, Cinemark Holdings, Inc., and Cinemark Holdings, Inc. has paid income taxes and other items on behalf of the Company. The net receivable from Cinemark Holdings, Inc. as of September 30, 2019 and December 31, 2018 was $23,812 and $19,530, respectively. The Company paid Cinemark Holdings, Inc. cash dividends of $118,825 and $111,550 during the nine months ended September 30, 2019 and 2018, respectively. The Company has a 50% voting interest in FE Concepts, a joint venture with AWSR, an entity owned by Lee Roy Mitchell and Tandy Mitchell. FE Concepts will develop and operate a family entertainment center that offers bowling, gaming, movies and other amenities. See Note 8 for further discussion.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2019
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	17. Commitments and Contingencies From time to time, the Company is involved in various legal proceedings arising from the ordinary course of its business operations, such as personal injury claims, employment matters, landlord-tenant disputes, patent claims and contractual disputes, some of which are covered by insurance. The Company believes its potential liability with respect to proceedings currently pending is not material, individually or in the aggregate, to the Company’s financial position, results of operations and cash flows. Silken Brown v. Cinemark USA, Inc., Case No. 3:13cv05669, In the United States District Court for the Northern District of California, San Francisco Division. The case presents putative class action claims for penalties and attorney's fees arising from alleged violations of the California wage statement law. The claim is also asserted as a representative action under the California Private Attorney General Act (PAGA) for penalties. The Court granted class certification. The company denies the claims, denies that class certification is appropriate, denies that the plaintiff has standing to assert the claims alleged and is vigorously defending against the claims. The Company denies any violation of law; however, to avoid the cost and uncertainty associated with litigation the Company and the plaintiff entered into a Joint Stipulation of Class Action Settlement and Release of Claims (the “Settlement Agreement”) to fully and finally dismiss all claims that would be brought in the case. The Settlement Agreement was approved by the Court in September 2019. The Company funded the appropriate amounts required under the Settlement Agreement with the administrator of the class claims in October 2019. Flagship Theatres of Palm Desert, LLC d/b/a Cinemas Palme D’Or v. Century Theatres, Inc., and Cinemark USA, Inc.; Superior Court of the State of California, County of Los Angeles. Plaintiff in this case alleges that the Company violated California antitrust and unfair competition laws by engaging in “circuit dealing” with various motion picture distributors and tortiously interfered with Plaintiff’s business relationships. Plaintiff seeks compensatory damages, trebling of those damages under California law, punitive damages, injunctive relief, attorneys’ fees, costs and interest. Plaintiff also alleges that the Company’s conduct ultimately resulted in closure of its theatre in June 2016. The Company denied the allegations. In 2008, the Company moved for summary judgment on Plaintiff’s claims, arguing primarily that clearances between the theatres at issue were lawful and that Plaintiff lacked proof sufficient to support certain technical elements of its antitrust claims. The trial court granted that motion and dismissed Plaintiff’s claims. Plaintiff appealed and, in 2011, the Court of Appeal reversed, holding, among other things, that Plaintiff’s claims were not about the illegality of clearances but were focused, instead, on “circuit dealing.” Having re-framed the claims in that manner, the Court of Appeal held that the trial court’s decision to limit discovery to the market where the theatres at issue operated was an error, as “circuit dealing” necessarily involves activities in different markets. Upon return to the trial court, the parties engaged in additional, broadened discovery related to Plaintiff’s “circuit dealing” claim. Thereafter, the Company moved again for summary judgment on all of Plaintiff’s claims. That new motion for summary judgment was pending when, on or about April 11, 2014, the trial court granted the Company’s motion for terminating sanctions and entered a judgment dismissing the case with prejudice. Plaintiff then appealed that second dismissal, seeking to have the judgment reversed and the case remanded to the trial court. The Court of Appeal issued a ruling on May 24, 2016, reversing the granting of terminating sanctions and instead imposed a lesser evidentiary and damages preclusion sanction. The case returned to the trial court on October 6, 2016. On May 10, 2018, after a five-week jury trial, the jury found no liability on one circuit dealing claim and awarded Plaintiff damages on the other claim, which are tripled for antitrust damage awards. Plaintiff would also be entitled to certain court costs and to seek at least some portion of its attorney’s fees. During 2018, the Company recorded a litigation reserve based on the jury award, court costs and attorney’s fees. The trial court denied a motion for a judgment notwithstanding the verdict and a motion for a new trial. The Company has appealed the judgment. Although the Company denies that it engaged in any form of circuit dealing, it cannot predict the outcome of its pending motions or future appeals. Civil Investigative Demand. The Company received a Civil Investigative Demand (“CID”) from the Antitrust Division of the United States Department of Justice. The CID relates to an investigation under Sections 1 and 2 of the Sherman Act. The Company also received CIDs from the Antitrust Section of the Office of the Attorney General of the State of Ohio and later from other states regarding similar inquiries under state antitrust laws. The CIDs request the Company to answer interrogatories, and produce documents, or both, related to the investigation of matters including film clearances, potential coordination and/or communication with other major theatre circuits and related joint ventures. The Company intends to fully cooperate with all federal and state government agencies. Although the Company does not believe that it has violated any federal or state antitrust or competition laws, it cannot predict the ultimate scope, duration or outcome of these investigations.

Condensed Consolidating Financi

Condensed Consolidating Financial Information of Subsidiary Guarantors	9 Months Ended
	Sep. 30, 2019
Statement Of Financial Position [Abstract]
Condensed Consolidating Financial Information of Subsidiary Guarantors	18. Condensed Consolidating Financial Information of Subsidiary Guarantors As of September 30, 2019, the Company had outstanding $400,000 aggregate principal amount of 5.125% senior notes due 2022, or the 5.125% Senior Notes, and $755,000 aggregate principal amount of 4.875% senior notes due 2023, or the 4.875% Senior Notes, (collectively the “Notes”). These Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by the following subsidiaries of Cinemark USA, Inc.: Sunnymead Cinema Corp., Cinemark Properties, Inc., Greeley Holdings, Inc., Cinemark Partners I, Inc., CNMK Investments, Inc., CNMK Texas Properties, LLC., Cinemark Concessions LLC, Century Theatres, Inc., Marin Theatre Management, LLC, Century Theatres NG, LLC, Cinearts LLC, Cinearts Sacramento, LLC, Corte Madera Theatres, LLC, Novato Theatres, LLC, San Rafael Theatres, LLC, Northbay Theatres, LLC, Century Theatres Summit Sierra, LLC and Century Theatres Seattle, LLC. The following supplemental condensed consolidating financial information presents: a. Condensed consolidating balance sheet information as of December 31, 2018 and September 30, 2019, condensed consolidating statements of income information for the three and nine months ended September 30, 2018 and 2019, condensed consolidating statements of comprehensive income (loss) information for the three and nine months ended September 30, 2018 and 2019 and condensed consolidating statements of cash flows information for the nine months ended September 30, 2018 and 2019. b. Cinemark USA, Inc. (the “Parent” and “Issuer”), combined Guarantor Subsidiaries and combined Non-Guarantor Subsidiaries with their investments in subsidiaries accounted for using the equity method of accounting and therefore, the Parent column reflects the equity income of its Guarantor Subsidiaries and Non-Guarantor Subsidiaries, which are also separately reflected in the stand-alone Guarantor Subsidiaries and Non-Guarantor Subsidiaries column. Additionally, the Guarantor Subsidiaries column reflects the equity income (loss) of its Non-Guarantor Subsidiaries, which are also separately reflected in the stand-alone Non-Guarantor Subsidiaries column. c. Elimination entries necessary to consolidate the Parent and all of its Subsidiaries CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2018 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Assets Current assets Cash and cash equivalents $ 197,965 $ 10,886 $ 217,365 $ — $ 426,216 Other current assets 60,829 19,997 67,149 (15,178 ) 132,797 Accounts receivable from parent or subsidiaries — 284,893 — (265,363 ) 19,530 Total current assets 258,794 315,776 284,514 (280,541 ) 578,543 Theatre properties and equipment - net 664,759 789,536 378,838 - 1,833,133 Investment in subsidiaries 1,806,255 57,845 - (1,864,100 ) — Other assets 1,500,366 155,011 546,834 (112,536 ) 2,089,675 Total assets $ 4,230,174 $ 1,318,168 $ 1,210,186 $ (2,257,177 ) $ 4,501,351 Liabilities and equity Current liabilities Current portion of long-term debt $ 6,595 $ — $ 1,389 $ — $ 7,984 Current portion of capital lease obligations 11,918 9,406 5,741 — 27,065 Accounts payable and accrued expenses 297,302 58,544 96,780 (13,622 ) 439,004 Accounts payable to parent or subsidiaries 40,421 — 224,942 (265,363 ) — Total current liabilities 356,236 67,950 328,852 (278,985 ) 474,053 Long-term liabilities Long-term debt, less current portion 1,872,627 — 7,955 (107,955 ) 1,772,627 Capital lease obligations, less current portion 123,329 59,539 49,599 — 232,467 Other long-term liabilities and deferrals 413,177 60,137 77,844 (6,137 ) 545,021 Total long-term liabilities 2,409,133 119,676 135,398 (114,092 ) 2,550,115 Commitments and contingencies Equity Cinemark USA, Inc.'s stockholder's equity: Common stock 49,543 457,368 10,238 (467,606 ) 49,543 Other stockholder's equity 1,415,262 673,174 723,319 (1,396,494 ) 1,415,261 Total Cinemark USA, Inc. stockholder's equity 1,464,805 1,130,542 733,557 (1,864,100 ) 1,464,804 Noncontrolling interests — — 12,379 — 12,379 Total equity 1,464,805 1,130,542 745,936 (1,864,100 ) 1,477,183 Total liabilities and equity $ 4,230,174 $ 1,318,168 $ 1,210,186 $ (2,257,177 ) $ 4,501,351 CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION SEPTEMBER 30, 2019 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Assets Current assets Cash and cash equivalents $ 174,862 $ 7,429 $ 300,397 $ — $ 482,688 Other current assets 91,856 20,556 66,894 (67,315 ) 111,991 Accounts receivable from parent or subsidiaries — 393,807 — (369,995 ) 23,812 Total current assets 266,718 421,792 367,291 (437,310 ) 618,491 Theatre properties and equipment - net 634,359 749,560 298,482 — 1,682,401 Operating lease right-of-use assets 704,578 486,473 192,968 — 1,384,019 Investment in subsidiaries 1,928,328 20,255 — (1,948,583 ) — Other assets 1,494,644 157,449 549,007 (110,685 ) 2,090,415 Total assets $ 5,028,627 $ 1,835,529 $ 1,407,748 $ (2,496,578 ) $ 5,775,326 Liabilities and equity Current liabilities Current portion of long-term debt $ 6,595 $ — $ 1,389 $ — $ 7,984 Current portion of operating lease obligations 99,173 86,302 29,540 — 215,015 Current portion of finance lease obligations 11,227 4,206 68 — 15,501 Accounts payable and accrued expenses 329,163 45,120 92,166 (65,760 ) 400,689 Accounts payable to parent or subsidiaries 116,745 — 253,250 (369,995 ) — Total current liabilities 562,903 135,628 376,413 (435,755 ) 639,189 Long-term liabilities Long-term debt, less current portion 1,871,663 — 4,455 (104,455 ) 1,771,663 Operating lease obligations, less current portion 635,326 434,533 160,293 — 1,230,152 Finance lease obligations, less current portion 75,841 50,115 388 — 126,344 Other long-term liabilities and deferrals 373,988 43,064 77,057 (7,785 ) 486,324 Total long-term liabilities 2,956,818 527,712 242,193 (112,240 ) 3,614,483 Commitments and contingencies Equity Cinemark USA, Inc.'s stockholder's equity: Common stock 49,543 457,368 10,238 (467,606 ) 49,543 Other stockholder's equity 1,459,363 714,821 766,156 (1,480,977 ) 1,459,363 Total Cinemark USA, Inc. stockholder's equity 1,508,906 1,172,189 776,394 (1,948,583 ) 1,508,906 Noncontrolling interests — — 12,748 — 12,748 Total equity 1,508,906 1,172,189 789,142 (1,948,583 ) 1,521,654 Total liabilities and equity $ 5,028,627 $ 1,835,529 $ 1,407,748 $ (2,496,578 ) $ 5,775,326 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION THREE MONTHS ENDED SEPTEMBER 30, 2018 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Revenues $ 264,247 $ 314,542 $ 181,866 $ (6,420 ) $ 754,235 Cost of operations Theatre operating expenses 205,693 224,592 134,895 (6,420 ) 558,760 General and administrative expenses 2,344 23,451 11,950 — 37,745 Depreciation and amortization 22,678 24,969 17,324 — 64,971 Impairment of long-lived assets 745 519 377 — 1,641 Loss on disposal of assets and other 2,711 4,856 259 — 7,826 Total cost of operations 234,171 278,387 164,805 (6,420 ) 670,943 Operating income 30,076 36,155 17,061 — 83,292 Other income (expense) Interest expense (24,469 ) (1,684 ) (1,333 ) 342 (27,144 ) Distributions from NCM — — 2,386 — 2,386 Interest expense - NCM (4,983 ) — — — (4,983 ) Equity in income of affiliates 50,262 4,187 10,661 (50,952 ) 14,158 Other income (expense) 1,088 1 (1,119 ) (342 ) (372 ) Total other income (expense) 21,898 2,504 10,595 (50,952 ) (15,955 ) Income before income taxes 51,974 38,659 27,656 (50,952 ) 67,337 Income taxes 1,331 7,671 7,299 — 16,301 Net income 50,643 30,988 20,357 (50,952 ) 51,036 Less: Net income attributable to noncontrolling interests — — 393 — 393 Net income attributable to Cinemark USA, Inc. $ 50,643 $ 30,988 $ 19,964 $ (50,952 ) $ 50,643 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION THREE MONTHS ENDED SEPTEMBER Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Revenues $ 295,148 $ 342,221 $ 200,093 $ (15,645 ) $ 821,817 Cost of operations Theatre operating expenses 238,834 247,512 150,366 (15,645 ) 621,067 General and administrative expenses 2,985 28,570 12,558 — 44,113 Depreciation and amortization 22,909 25,875 18,976 — 67,760 Impairment of long-lived assets 2,494 24,165 645 — 27,304 Loss on disposal of assets and other 1,221 783 449 — 2,453 Total cost of operations 268,443 326,905 182,994 (15,645 ) 762,697 Operating income 26,705 15,316 17,099 — 59,120 Other income (expense) Interest expense (24,482 ) (603 ) (200 ) 318 (24,967 ) Distributions from NCM — — 2,474 — 2,474 Interest expense - NCM (4,666 ) — — — (4,666 ) Equity in income (loss) of affiliates 32,606 1,825 9,832 (29,124 ) 15,139 Other income (expense) 1,173 3,020 (1,378 ) (3,324 ) (509 ) Total other income (expense) 4,631 4,242 10,728 (32,130 ) (12,529 ) Income before income taxes 31,336 19,558 27,827 (32,130 ) 46,591 Income taxes (460 ) 4,745 9,908 — 14,193 Net income 31,796 14,813 17,919 (32,130 ) 32,398 Less: Net income attributable to noncontrolling interests — — 602 — 602 Net income attributable to Cinemark USA, Inc. $ 31,796 $ 14,813 $ 17,317 $ (32,130 ) $ 31,796 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION NINE MONTHS ENDED SEPTEMBER 30, 2018 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Revenues $ 879,552 $ 1,018,666 $ 566,087 $ (41,046 ) $ 2,423,259 Cost of operations Theatre operating expenses 680,182 699,065 422,354 (41,046 ) 1,760,555 General and administrative expenses 9,104 73,401 39,264 — 121,769 Depreciation and amortization 66,333 73,299 54,024 — 193,656 Impairment of long-lived assets 1,946 519 2,555 — 5,020 Loss on disposal of assets and other 7,479 20,265 922 — 28,666 Total cost of operations 765,044 866,549 519,119 (41,046 ) 2,109,666 Operating income 114,508 152,117 46,968 — 313,593 Other income (expense) Interest expense (72,853 ) (5,045 ) (5,862 ) 1,035 (82,725 ) Loss on debt amendments (1,484 ) — — — (1,484 ) Distributions from NCM — — 12,168 — 12,168 Interest expense - NCM (14,875 ) — — — (14,875 ) Equity in income of affiliates 179,170 11,150 24,580 (185,692 ) 29,208 Other income (expense) 3,292 (6 ) (1,351 ) (1,035 ) 900 Total other income (expense) 93,250 6,099 29,535 (185,692 ) (56,808 ) Income before income taxes 207,758 158,216 76,503 (185,692 ) 256,785 Income taxes 11,907 34,611 13,538 — 60,056 Net income 195,851 123,605 62,965 (185,692 ) 196,729 Less: Net income attributable to noncontrolling interests — — 878 — 878 Net income attributable to Cinemark USA, Inc. $ 195,851 $ 123,605 $ 62,087 $ (185,692 ) $ 195,851 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION NINE MONTHS ENDED SEPTEMBER Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Revenues $ 905,445 $ 1,034,084 $ 597,646 $ (42,879 ) $ 2,494,296 Cost of operations Theatre operating expenses 707,057 733,408 447,523 (42,879 ) 1,845,109 General and administrative expenses 8,992 78,623 37,439 — 125,054 Depreciation and amortization 68,813 76,858 51,124 — 196,795 Impairment of long-lived assets 3,659 33,299 8,424 — 45,382 Loss on disposal of assets and other 3,560 2,859 1,638 — 8,057 Total cost of operations 792,081 925,047 546,148 (42,879 ) 2,220,397 Operating income 113,364 109,037 51,498 — 273,899 Other income (expense) Interest expense (73,523 ) (1,846 ) (669 ) 1,001 (75,037 ) Distributions from NCM — — 9,168 — 9,168 Interest expense - NCM (14,180 ) — — — (14,180 ) Equity in income (loss) of affiliates 144,279 (9,940 ) 25,741 (126,098 ) 33,982 Other income (expense) 3,297 6 2,955 (1,001 ) 5,257 Total other income (expense) 59,873 (11,780 ) 37,195 (126,098 ) (40,810 ) Income before income taxes 173,237 97,257 88,693 (126,098 ) 233,089 Income taxes 6,720 31,285 26,610 — 64,615 Net income 166,517 65,972 62,083 (126,098 ) 168,474 Less: Net income attributable to noncontrolling interests — — 1,957 — 1,957 Net income attributable to Cinemark USA, Inc. $ 166,517 $ 65,972 $ 60,126 $ (126,098 ) $ 166,517 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION THREE MONTHS ENDED SEPTEMBER Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Net income $ 50,643 $ 30,988 $ 20,357 $ (50,952 ) $ 51,036 Other comprehensive loss, net of tax Other comprehensive loss of equity method investments (63 ) — (63 ) 63 (63 ) Foreign currency translation adjustments (10,797 ) — (10,797 ) 10,797 (10,797 ) Total other comprehensive loss, net of tax (10,860 ) — (10,860 ) 10,860 (10,860 ) Total comprehensive income, net of tax $ 39,783 $ 30,988 $ 9,497 $ (40,092 ) $ 40,176 Comprehensive income attributable to noncontrolling interests — — (393 ) — (393 ) Comprehensive income attributable to Cinemark USA, Inc. $ 39,783 $ 30,988 $ 9,104 $ (40,092 ) $ 39,783 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS) INFORMATION THREE MONTHS ENDED SEPTEMBER Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Net income $ 31,796 $ 14,813 $ 17,919 $ (32,130 ) $ 32,398 Other comprehensive loss, net of tax Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $417, net of settlements (1,291 ) — — — (1,291 ) Other comprehensive loss of equity method investments (49 ) — (49 ) 49 (49 ) Foreign currency translation adjustments (25,408 ) — (25,408 ) 25,408 (25,408 ) Total other comprehensive loss, net of tax (26,748 ) — (25,457 ) 25,457 (26,748 ) Total comprehensive income (loss), net of tax $ 5,048 $ 14,813 $ (7,538 ) $ (6,673 ) $ 5,650 Comprehensive income attributable to noncontrolling interests — — (602 ) — (602 ) Comprehensive income (loss) attributable to Cinemark USA, Inc. $ 5,048 $ 14,813 $ (8,140 ) $ (6,673 ) $ 5,048 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS) INFORMATION NINE MONTHS ENDED SEPTEMBER Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Net income $ 195,851 $ 123,605 $ 62,965 $ (185,692 ) $ 196,729 Other comprehensive loss, net of tax Other comprehensive loss of equity method investments (43 ) — (43 ) 43 (43 ) Foreign currency translation adjustments (66,841 ) — (66,841 ) 66,841 (66,841 ) Total other comprehensive loss, net of tax (66,884 ) — (66,884 ) 66,884 (66,884 ) Total comprehensive income (loss), net of tax $ 128,967 $ 123,605 $ (3,919 ) $ (118,808 ) $ 129,845 Comprehensive income attributable to noncontrolling interests — — (878 ) — (878 ) Comprehensive income (loss) attributable to Cinemark USA, Inc. $ 128,967 $ 123,605 $ (4,797 ) $ (118,808 ) $ 128,967 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION NINE MONTHS ENDED SEPTEMBER Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Net income $ 166,517 $ 65,972 $ 62,083 $ (126,098 ) $ 168,474 Other comprehensive loss, net of tax Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $3,391, net of settlements (10,504 ) — — — (10,504 ) Other comprehensive loss of equity method investments (142 ) — (142 ) 142 (142 ) Foreign currency translation adjustments (19,728 ) — (19,728 ) 19,728 (19,728 ) Total other comprehensive loss, net of tax (30,374 ) — (19,870 ) 19,870 (30,374 ) Total comprehensive income, net of tax $ 136,143 $ 65,972 $ 42,213 $ (106,228 ) $ 138,100 Comprehensive income attributable to noncontrolling interests — — (1,957 ) — (1,957 ) Comprehensive income attributable to Cinemark USA, Inc. $ 136,143 $ 65,972 $ 40,256 $ (106,228 ) $ 136,143 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION NINE MONTHS ENDED SEPTEMBER Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Operating activities Net income $ 195,851 $ 123,605 $ 62,965 $ (185,692 ) $ 196,729 Adjustments to reconcile net income to cash provided by (used for) operating activities (90,311 ) 91,492 41,392 185,692 228,265 Changes in assets and liabilities 201,287 (243,336 ) (33,326 ) — (75,375 ) Net cash provided by (used for) operating activities 306,827 (28,239 ) 71,031 — 349,619 Investing activities Additions to theatre properties and equipment (70,519 ) (118,468 ) (56,975 ) — (245,962 ) Acquisition of theatres in international markets, net of cash acquired — — (11,289 ) — (11,289 ) Proceeds from sale of theatre properties and equipment and other 1,244 1,740 573 — 3,557 Proceeds from intercompany note repayment 1,867 — — (1,867 ) — Acquisition of NCM common units (78,393 ) — — — (78,393 ) Investment in joint ventures and other — (19,896 ) (546 ) — (20,442 ) Net cash used for investing activities (145,801 ) (136,624 ) (68,237 ) (1,867 ) (352,529 ) Financing activities Dividends paid to parent (111,550 ) — — — (111,550 ) Repayments of long-term debt (4,946 ) — — — (4,946 ) Payment of debt issue costs (5,103 ) — — — (5,103 ) Repayment of intercompany note — — (1,867 ) 1,867 — Payments on capital leases (8,605 ) (6,669 ) (3,504 ) — (18,778 ) Other (704 ) (2,905 ) — — (3,609 ) Net cash used for financing activities (130,908 ) (9,574 ) (5,371 ) 1,867 (143,986 ) Effect of exchange rate changes on cash and cash equivalents — — (8,732 ) — (8,732 ) Increase (decrease) in cash and cash equivalents 30,118 (174,437 ) (11,309 ) — (155,628 ) Cash and cash equivalents: Beginning of year 130,590 180,623 211,202 — 522,415 End of year $ 160,708 $ 6,186 $ 199,893 $ — $ 366,787 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION NINE MONTHS ENDED SEPTEMBER Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Operating activities Net income $ 166,517 $ 65,972 $ 62,083 $ (126,098 ) $ 168,474 Adjustments to reconcile net income to cash provided by operating activities (71,652 ) 130,125 52,857 126,098 237,428 Changes in assets and liabilities 87,748 (113,891 ) 16,751 — (9,392 ) Net cash provided by operating activities 182,613 82,206 131,691 — 396,510 Investing activities Additions to theatre properties and equipment (64,264 ) (83,757 ) (38,491 ) — (186,512 ) Acquisition of theatres in U.S. and international markets, net of cash acquired (10,170 ) — — — (10,170 ) Proceeds from sale of theatre properties and equipment and other — — 377 — 377 Dividends received from subsidiary 600 3,012 — (3,612 ) — Net cash used for investing activities (73,834 ) (80,745 ) (38,114 ) (3,612 ) (196,305 ) Financing activities Dividends paid to parent (118,825 ) — (3,612 ) 3,612 (118,825 ) Repayments of long-term debt (4,947 ) — — — (4,947 ) Payments on finance leases (8,110 ) (2,671 ) (49 ) — (10,830 ) Other — (2,247 ) (1,588 ) — (3,835 ) Net cash used for financing activities (131,882 ) (4,918 ) (5,249 ) 3,612 (138,437 ) Effect of exchange rate changes on cash and cash equivalents — — (5,296 ) — (5,296 ) Increase (decrease) in cash and cash equivalents (23,103 ) (3,457 ) 83,032 — 56,472 Cash and cash equivalents: Beginning of year 197,965 10,886 217,365 — 426,216 End of year $ 174,862 $ 7,429 $ 300,397 $ — $ 482,688 * * * * *

Adoption of ASC Topic 842 - L_2

Adoption of ASC Topic 842 - Lease Accounting (Tables)	9 Months Ended
	Sep. 30, 2019
Leases [Abstract]
Schedule of Operating and Finance Right-of-Use Assets and Lease Liabilities	The following table represents the operating and finance right-of-use assets and lease liabilities as of September 30, 2019 As of Leases Classification September 30, 2019 Assets (1) Operating lease assets Operating lease assets $ 1,384,019 Finance lease assets Theatre properties and equipment, net of accumulated depreciation and amortization (2) 103,059 Total lease assets $ 1,487,078 Liabilities (1) Current Operating Current portion of operating lease obligations $ 215,015 Finance Current portion of finance lease obligations 15,501 Noncurrent Operating Operating lease obligations, less current portion 1,230,152 Finance Finance lease obligations, less current portion 126,344 Total lease liabilities $ 1,587,012 (1) The operating lease right-of-use assets and liabilities recorded on the Company’s condensed consolidated balance sheet generally do not include renewal options that have not yet been exercised. The Company does not consider a lease renewal as reasonably certain until immediately before the necessary notification is provided to the landlord. (2) Finance lease assets are net of accumulated amortization of $57,506 as of September 30, 2019.
Schedule of Aggregate Lease Costs by Lease Classification	The following table represents the Company’s aggregate lease costs, by lease classification, for the three and nine months ended September 30, 2019. Three Months Ended Nine Months Ended Lease Cost Classification September 30, 2019 September 30, 2019 Operating lease costs Equipment (1) Utilities and other $ 1,569 $ 5,173 Real Estate (2)(3) Facility lease expense 88,149 262,783 Total operating lease costs $ 89,718 $ 267,956 Finance lease costs Amortization of leased assets Depreciation and amortization $ 3,703 $ 11,182 Interest on lease liabilities Interest expense 1,922 5,927 Total finance lease costs $ 5,625 $ 17,109 (1) Includes approximately $452 and $1,808 of short-term lease payments for the three and nine months ended September 30, 2019, respectively. (2) Includes approximately $18,591 and $54,209 of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenues or attendance and variable common area maintenance costs for the three and nine months ended September 30, 2019 (3) Approximately $400 and $1,184 of lease payments are included in general and administrative expenses primarily related to office leases for the three and nine months ended September 30, 2019, respectively.
Schedule of Maturity of Lease Liabilities by Lease Classification	The following table represents the maturity of lease liabilities, by lease classification, as of September 30, 2019. Operating Finance Years Ending Leases Leases Total 2019 $ 70,137 $ 5,588 $ 75,725 2020 276,114 22,373 298,487 2021 258,827 18,661 277,488 2022 229,272 17,925 247,197 2023 198,799 17,236 216,035 After 2023 704,440 101,110 805,550 Total lease payments $ 1,737,589 $ 182,893 $ 1,920,482 Less: Interest 292,422 41,048 333,470 Present value of lease liabilities $ 1,445,167 $ 141,845 $ 1,587,012
Estimated Future Minimum Lease Payments Under Operating Leases	The following table represents future minimum lease payments under noncancelable operating and capital leases at December 31, 2018 as presented in the Company’s Annual Report on Form 10-K filed March 4, 2019: Operating Capital Years Ending Leases Leases 2019 $ 253,323 $ 42,434 2020 242,336 41,502 2021 230,396 34,589 2022 204,628 32,462 2023 176,802 28,534 Thereafter 677,091 166,375 Total $ 1,784,576 345,896 Amounts representing interest payments (86,364 ) Present value of future minimum payments 259,532 Current portion of finance and capital lease obligations (27,065 ) Capital lease obligations, less current portion $ 232,467
Estimated Future Minimum Lease Payments Under Capital Leases	The following table represents future minimum lease payments under noncancelable operating and capital leases at December 31, 2018 as presented in the Company’s Annual Report on Form 10-K filed March 4, 2019: Operating Capital Years Ending Leases Leases 2019 $ 253,323 $ 42,434 2020 242,336 41,502 2021 230,396 34,589 2022 204,628 32,462 2023 176,802 28,534 Thereafter 677,091 166,375 Total $ 1,784,576 345,896 Amounts representing interest payments (86,364 ) Present value of future minimum payments 259,532 Current portion of finance and capital lease obligations (27,065 ) Capital lease obligations, less current portion $ 232,467
Schedule of Weighted-Average Remaining Lease Term and Discount Rate	The following table represents the weighted-average remaining lease term and discount rate, disaggregated by lease classification, as of September 30, 2019. As of Lease Term and Discount Rate September 30, 2019 Weighted-average remaining lease term (years) (1) Operating leases - equipment 4.1 Operating leases - real estate 7.9 Finance leases - equipment 5.9 Finance leases - real estate 10.6 Weighted-average discount rate (2) Operating leases - equipment 4.3 % Operating leases - real estate 4.8 % Finance leases - equipment 5.5 % Finance leases - real estate 5.2 % (1) The lease assets and liabilities recorded on the Company’s condensed consolidated balance sheet generally do not include renewal options that have not yet been executed. The Company does not consider a lease renewal exercise as reasonably certain until immediately before the necessary notification is provided to the landlord. (2) The discount rate for each lease represents the incremental borrowing rate at which the Company would borrow, on a collateralized basis, over a similar term and at an amount equal to the lease payments in a similar economic environment.
Schedule of Minimum Cash Lease Payments	The following table represents the minimum cash lease payments included in the measurement of lease liabilities and the non-cash addition of right-of-use assets for the nine months ended September 30, 2019. Nine Months Ended Other Information September 30, 2019 Cash paid for amounts included in the measurement of lease liabilities Cash outflows for operating leases $ 211,940 Cash outflows for finance leases - operating activities $ 5,756 Cash outflows for finance leases - financing activities $ 10,830 Non-cash amount of leased assets obtained in exchange for: Operating lease liabilities - real estate $ 53,526 Operating lease liabilities - equipment $ 668 Finance lease liabilities $ —

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Sep. 30, 2019
Revenue From Contract With Customer [Abstract]
Summary of Revenues Disaggregated Based on Type of Good Or Service By Reportable Operating Segment and On Timing of Revenue Recognition	The following table presents revenues for the three and nine months ended September 30, 2019 and 2018, disaggregated based on major type of good or service and by reportable operating segment. Three Months Ended Nine Months Ended September 30, 2019 September 30, 2019 U.S. International U.S. International Operating Operating Operating Operating Major Goods/Services Segment (1) Segment Consolidated Segment (1) Segment Consolidated Admissions revenues $ 351,122 $ 103,307 $ 454,429 $ 1,066,884 $ 304,157 $ 1,371,041 Concession revenues 230,415 59,062 289,477 704,727 181,356 886,083 Screen advertising, screen rental and promotional revenues 21,114 16,448 37,562 63,996 49,587 113,583 Other revenues 30,394 9,955 40,349 95,180 28,409 123,589 Total revenues $ 633,045 $ 188,772 $ 821,817 $ 1,930,787 $ 563,509 $ 2,494,296 Three Months Ended Nine Months Ended September 30, 2018 September 30, 2018 U.S. International U.S. International Operating Operating Operating Operating Major Goods/Services Segment (1) Segment Consolidated Segment (1) Segment Consolidated Admissions revenues $ 333,274 $ 94,342 $ 427,616 $ 1,091,489 $ 297,621 $ 1,389,110 Concession revenues 207,960 56,205 264,165 661,328 169,915 831,243 Screen advertising and promotional revenues 19,010 13,420 32,430 58,240 43,135 101,375 Other revenues 22,031 7,993 30,024 76,635 24,896 101,531 Total revenues $ 582,275 $ 171,960 $ 754,235 $ 1,887,692 $ 535,567 $ 2,423,259 (1) U.S. segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 16 for additional information on intercompany eliminations. The following table presents revenues for the three and nine months ended September 30, 2019 and 2018, disaggregated based on timing of revenue recognition. Three Months Ended Nine Months Ended September 30, 2019 September 30, 2019 U.S. International U.S. International Operating Operating Operating Operating Segment (1) Segment Consolidated Segment (1) Segment Consolidated Goods and services transferred at a point in time $ 610,063 $ 169,171 $ 779,234 $ 1,860,828 $ 504,702 $ 2,365,530 Goods and services transferred over time 22,982 19,601 42,583 69,959 58,807 128,766 Total $ 633,045 $ 188,772 $ 821,817 $ 1,930,787 $ 563,509 $ 2,494,296 Three Months Ended Nine Months Ended September 30, 2018 September 30, 2018 U.S. International U.S. International Operating Operating Operating Operating Segment (1) Segment Consolidated Segment (1) Segment Consolidated Goods and services transferred at a point in time $ 561,849 $ 155,291 $ 717,140 $ 1,824,138 $ 482,790 $ 2,306,928 Goods and services transferred over time 20,426 16,669 37,095 63,554 52,777 116,331 Total $ 582,275 $ 171,960 $ 754,235 $ 1,887,692 $ 535,567 $ 2,423,259 (1) U.S. segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 16 for additional information on intercompany eliminations.
Changes in Advances and Deferred Revenues	The following table presents changes in the Company’s advances and deferred revenues for the nine months ended September 30, 2019. NCM screen advertising advances (1) Other Deferred Revenues (2) Total Balance at January 1, 2019 $ 287,349 $ 106,075 $ 393,424 Amounts recognized as accounts receivable — 10,186 10,186 Cash received from customers in advance — 138,927 138,927 Common units received from NCM (see Note 7) 1,552 — 1,552 Revenue recognized during period (11,916 ) (141,684 ) (153,600 ) Foreign currency translation adjustments — (1,321 ) (1,321 ) Balance at September 30, 2019 $ 276,985 $ 112,183 $ 389,168 (1) See Note 7 for the maturity of balance as of September 30, 2019 (2) Includes liabilities associated with outstanding gift cards and SuperSavers, points or rebates outstanding under the Company’s loyalty and membership programs and revenues not yet recognized for screen advertising, screen rental and other promotional activities. Classified as accounts payable and accrued expenses or other long-term liabilities on the condensed consolidated balance sheet.
Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized	The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of September 30, 2019 and when the Company expects to recognize this revenue. Twelve Months Ended September 30, Remaining Performance Obligations 2020 2021 2022 2023 2024 Thereafter Total Deferred revenue 102,449 9,488 200 46 — — 112,183

Long Term Debt Activity (Tables

Long Term Debt Activity (Tables)	9 Months Ended
	Sep. 30, 2019
Debt Disclosure [Abstract]
Summary of Company's Interest Rate Swap Agreements Designated as Cash Flow Hedges	Below is a summary of the Company’s interest rate swap agreements designated as cash flow hedges as of September 30, 2019: Estimated Fair Value at Notional September 30, Amount Effective Date Pay Rate Receive Rate Expiration Date 2019 (1) $ 137,500 December 31, 2018 2.75% 1-Month LIBOR December 31, 2022 $ 5,778 $ 175,000 December 31, 2018 2.75% 1-Month LIBOR December 31, 2022 7,346 $ 137,500 December 31, 2018 2.77% 1-Month LIBOR December 31, 2022 5,864 Total $ 18,988 (1) Approximately $3,746 of the total is included in accounts payable and accrued expenses and $15,242 is included in other long-term liabilities on the condensed consolidated balance sheet as of September 30, 2019.

Equity (Tables)

Equity (Tables)	9 Months Ended
	Sep. 30, 2019
Equity [Abstract]
Summary of Changes in Stockholder's Equity	Below is a summary of changes in stockholder’s equity attributable to Cinemark USA, Inc., noncontrolling interests and total equity for the three and nine months ended September 30, 2019 and 2018: Class A Common Stock Class B Common Stock Treasury Stock Additional Paid-In-Capital Retained Earnings Accumulated Other Total Cinemark USA, Inc. Stockholder's Equity Noncontrolling Interests Total Equity Balance at January 1, 2019 $ — $ 49,543 $ (24,233 ) $ 1,277,921 $ 480,580 $ (319,007 ) $ 1,464,804 $ 12,379 $ 1,477,183 Cumulative effect of change in accounting principle, net of taxes of $6,054 (see Note 3) — — — — 16,985 — 16,985 — 16,985 Share based awards compensation expense — — — 2,743 — — 2,743 — 2,743 Dividends paid to parent — — — — (39,575 ) — (39,575 ) — (39,575 ) Dividends paid to noncontrolling interests — — — — — — — (1,000 ) (1,000 ) Net income — — — — 33,177 — 33,177 465 33,642 Other comprehensive loss in equity method investees — — — — — (71 ) (71 ) — (71 ) Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements — — — — — (3,311 ) (3,311 ) (3,311 ) Foreign currency translation adjustments — — — — — 755 755 — 755 Balance at March 31, 2019 $ — $ 49,543 $ (24,233 ) $ 1,280,664 $ 491,167 $ (321,634 ) $ 1,475,507 $ 11,844 $ 1,487,351 Share based awards compensation expense — — — 3,447 — — 3,447 — 3,447 Dividends paid to parent — — — — (39,600 ) — (39,600 ) — (39,600 ) Dividends paid to noncontrolling interests — — — — — — — (294 ) (294 ) Net income — — — — 101,544 — 101,544 890 102,434 Other comprehensive loss in equity method investees — — — — — (22 ) (22 ) — (22 ) Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements — — — — — (5,902 ) (5,902 ) (5,902 ) Foreign currency translation adjustments — — — — — 4,925 4,925 — 4,925 Balance at June 30, 2019 $ — $ 49,543 $ (24,233 ) $ 1,284,111 $ 553,111 $ (322,633 ) $ 1,539,899 $ 12,440 $ 1,552,339 Share based awards compensation expense — — — 3,609 — — 3,609 — 3,609 Dividends paid to parent — — — — (39,650 ) — (39,650 ) — (39,650 ) Dividends paid to noncontrolling interests — — — — — — — (294 ) (294 ) Net income — — — — 31,796 — 31,796 602 32,398 Other comprehensive loss in equity method investees — — — — — (49 ) (49 ) — (49 ) Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements — — — — — (1,291 ) (1,291 ) — (1,291 ) Foreign currency translation adjustments — — — — — (25,408 ) (25,408 ) — (25,408 ) Balance at September 30, 2019 $ — $ 49,543 $ (24,233 ) $ 1,287,720 $ 545,257 $ (349,381 ) $ 1,508,906 $ 12,748 $ 1,521,654 Class A Common Stock Class B Common Stock Treasury Stock Additional Paid-In-Capital Retained Earnings Accumulated Other Total Cinemark USA, Inc. Stockholder's Equity Noncontrolling Interests Total Equity Balance at January 1, 2018 $ — $ 49,543 $ (24,233 ) $ 1,264,505 $ 373,069 $ (253,282 ) $ 1,409,602 $ 11,893 $ 1,421,495 Cumulative effect of change in accounting principle, net of taxes of $13,079 — — — — 40,526 — 40,526 — 40,526 Share based awards compensation expense — — — 3,199 — — 3,199 — 3,199 Dividends paid to parent — — — — (37,150 ) — (37,150 ) — (37,150 ) Net income — — — — 62,515 — 62,515 156 62,671 Other comprehensive loss in equity method investees — — — — — 136 136 — 136 Foreign currency translation adjustments — — — — — 204 204 — 204 Balance at March 31, 2018 $ — $ 49,543 $ (24,233 ) $ 1,267,704 $ 438,960 $ (252,942 ) $ 1,479,032 $ 12,049 $ 1,491,081 Share based awards compensation expense — — — 3,223 — — 3,223 — 3,223 Dividends paid to parent — — — — (37,200 ) — (37,200 ) — (37,200 ) Net income — — — — 82,693 — 82,693 329 83,022 Other comprehensive loss in equity method investees — — — — — (116 ) (116 ) — (116 ) Foreign currency translation adjustments — — — — — (56,248 ) (56,248 ) — (56,248 ) Balance at June 30, 2018 $ — $ 49,543 $ (24,233 ) $ 1,270,927 $ 484,453 $ (309,306 ) $ 1,471,384 $ 12,378 $ 1,483,762 Share based awards compensation expense — — — 3,254 — — 3,254 3,254 Dividends paid to parent — — — — (37,200 ) — (37,200 ) (37,200 ) Net income — — — — 50,643 — 50,643 393 51,036 Other comprehensive loss in equity method investees — — — — — (63 ) (63 ) (63 ) Foreign currency translation adjustments — — — — — (10,797 ) (10,797 ) (10,797 ) Balance at September 30, 2018 $ — $ 49,543 $ (24,233 ) $ 1,274,181 $ 497,896 $ (320,166 ) $ 1,477,221 $ 12,771 $ 1,489,992

National CineMedia (Tables)

National CineMedia (Tables)	9 Months Ended
	Sep. 30, 2019
Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized	The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of September 30, 2019 and when the Company expects to recognize this revenue. Twelve Months Ended September 30, Remaining Performance Obligations 2020 2021 2022 2023 2024 Thereafter Total Deferred revenue 102,449 9,488 200 46 — — 112,183
NCM Screen Advertising Advances
Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized	The recognition of revenue related to the deferred revenue or NCM screen advertising advances will continue to be recorded on a straight-line basis over the new term of the amended ESA or February 2041. Twelve Months Ended September 30, Remaining Maturity 2020 2021 2022 2023 2024 Thereafter Total NCM screen advertising advances 15,912 15,917 15,917 15,917 15,917 197,405 276,985
NCM
Summary of Activity With Equity Investee Included in the Company's Condensed Consolidated Financial Statements	Below is a summary of activity with NCM included in the Company’s condensed consolidated financial statements: Investment in NCM NCM Screen Advertising Advances Distributions from NCM Equity in Earnings Other Revenue Interest Expense - NCM (2) Cash Received Balance as of January 1, 2019 $ 275,592 $ (287,349 ) Receipt of common units due to annual common unit adjustment ("CUA") 1,552 (1,552 ) — — — — — Revenues earned under ESA (1) (2) — — — — (22,151 ) 13,392 8,759 Revenues earned under amendment to ESA (2)(3) — — — — (1,482 ) 788 694 Receipt of excess cash distributions (16,126 ) — (8,009 ) — — — 24,135 Receipt of cash under tax receivable agreement (2,324 ) — (1,159 ) — — — 3,483 Equity in earnings 14,062 — — (14,062 ) — — — Amortization of deferred revenue — 11,916 — — (11,916 ) — — Balance as of and for the nine months ended September 30, 2019 $ 272,756 $ (276,985 ) $ (9,168 ) $ (14,062 ) $ (35,549 ) $ 14,180 $ 37,071 (1) Amount includes the per patron and per digital screen theatre access fees due to the Company prior to the first amendment to the Amended and Restated ESA, net of amounts paid to NCM for on-screen advertising time provided to the Company’s beverage concessionaire of approximately $8,808. (2) Reflects impact of significant financing component related to amounts received in advance under the ESA and CUA agreements. See also Notes 3 and 4. (3) Reflects screen rental revenues earned after the amendment to the ESA.
Summary Financial Information	NCM Financial Information Below is summary financial information for NCM for the periods indicated (financial information as of and for the three months ended September 27, 2019 is not yet available). Three Six Months ended Three Nine Months Ended June 27, 2019 June 27, 2019 September 27, 2018 September 27, 2018 Gross revenues $ 110,200 $ 187,100 $ 110,100 $ 304,000 Operating income $ 37,700 $ 48,600 $ 42,300 $ 93,500 Net income $ 23,500 $ 20,600 $ 28,500 $ 50,500 As of As of June 27, 2019 December 27, 2018 Current assets $ 141,100 $ 172,700 Noncurrent assets $ 732,900 $ 726,800 Current liabilities $ 88,400 $ 115,200 Noncurrent liabilities $ 939,300 $ 924,900 Members deficit $ (153,700 ) $ (140,600 )

Other Investments (Tables)

Other Investments (Tables)	9 Months Ended
	Sep. 30, 2019
Summary of Activity for Each of Company's Other Investments	Below is a summary of activity for each of the Company’s other investments for the nine months ended September 30, 2019: DCIP AC JV, LLC DCDC FE Concepts Other Total Balance at January 1, 2019 $ 125,252 $ 5,266 $ 2,255 $ 19,918 $ 4,075 $ 156,766 Cash distributions received (7,912 ) (1,800 ) — — — (9,712 ) Equity in income 17,024 2,185 777 (66 ) — 19,920 Equity in other comprehensive loss (142 ) — — — — (142 ) Other — — — — (799 ) (799 ) Balance at September 30, 2019 $ 134,222 $ 5,651 $ 3,032 $ 19,852 $ 3,276 $ 166,033
Digital Cinema Implementation Partners
Summary Financial Information	Below is summary financial information for DCIP for the periods indicated: Three Months Ended Nine Months Ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Gross revenues $ 40,200 $ 43,403 $ 125,869 $ 126,957 Operating income $ 22,617 $ 25,816 $ 73,396 $ 74,310 Net income $ 22,362 $ 24,311 $ 69,323 $ 68,014 As of September 30, 2019 December 31, 2018 Current assets $ 64,019 $ 57,907 Noncurrent assets $ 603,209 $ 684,545 Current liabilities $ 66,942 $ 67,408 Noncurrent liabilities $ 11,985 $ 125,596 Members' equity $ 588,301 $ 549,448
Transactions with DCIP	The Company had the following transactions with DCIP, reflected in utilities and other costs on the condensed consolidated statements of income, during the three and nine months ended September 30, 2019 and 2018: Three Nine Months Ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Equipment lease payments $ 1,105 $ 1,229 $ 3,357 $ 3,689 Warranty reimbursements from DCIP $ (2,953 ) $ (2,791 ) $ (8,842 ) $ (7,909 ) Management service fees $ 128 $ 180 $ 438 $ 558

Share Based Awards (Tables)

Share Based Awards (Tables)	9 Months Ended
	Sep. 30, 2019
Summary of Restricted Stock Activity	Below is a summary of restricted stock activity for the nine months ended September 30, 2019: Shares of Weighted Average Restricted Grant Date Stock Fair Value Outstanding at January 1, 2019 704,353 $ 38.68 Granted 308,250 $ 37.42 Vested (198,711 ) $ 41.38 Forfeited (19,351 ) $ 37.41 Outstanding at September 30, 2019 794,541 $ 37.55 Unvested restricted stock at September 30, 2019 794,541 $ 37.55
Summary of Restricted Stock Unit Award Activity	Below is a table summarizing the potential number of shares that could vest under restricted stock unit awards granted during the nine months ended September 30, 2019 Number of Shares Value at Vesting Grant at IRR of at least 6% 136,285 $ 5,011 at IRR of at least 8% 204,427 $ 7,517 at IRR of at least 14% 306,651 $ 11,276
Restricted Stock
Summary of Restricted Stock Award Activity	Nine Months Ended September 30, 2019 2018 Compensation expense recognized by the Company during the period $ 6,769 $ 4,342 Additional compensation expense recognized by Cinemark Holdings, Inc. during the period $ 687 $ 2,924 Fair value of restricted shares held by Company employees that vested during the period $ 6,650 $ 7,013 Fair value of restricted shares held by Cinemark Holdings, Inc.’s directors that vested during the period $ 980 $ 802 Income tax benefit recognized upon vesting of restricted stock awards held by Company employees $ 1,228 $ 1,550 Additional income tax benefit recognized upon vesting of restricted stock awards held by Cinemark Holdings, Inc.'s directors $ 245 $ 201
Restricted Stock Units (RSUs)
Summary of Restricted Stock Unit Award Activity	Nine Months Ended September 30, 2019 2018 Number of restricted stock unit awards that vested during the period 88,074 127,084 Fair value of restricted stock unit awards that vested during the period $ 3,550 $ 4,846 Accumulated dividends paid upon vesting of restricted stock unit awards $ 375 $ 526 Compensation expense recognized during the period $ 3,030 $ 3,098 Income tax benefit recognized upon vesting of restricted stock unit awards $ 175 $ 740

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2019
Goodwill And Intangible Assets Disclosure [Abstract]
Summary of Goodwill	The Company’s goodwill was as follows: U.S. Operating Segment International Operating Segment Total Balance at January 1, 2019 (1) $ 1,174,041 $ 102,283 $ 1,276,324 Theatres acquired in the US and Brazil (2) 8,812 869 9,681 Foreign currency translation adjustments — (4,651 ) (4,651 ) Balance at September 30, 2019 (1) $ 1,182,853 $ 98,501 $ 1,281,354 (1) Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment. (2) Amount represents final purchase price allocation for two theatres acquired in the U.S. during 2019 and the final purchase price allocation adjustment for theatres acquired in Brazil during 2018.
Intangible Assets	Intangible assets consisted of the following: Balance at January 1, 2019 Impact of Adoption of ASC Topic 842 (1) Amortization Other (2) Balance at September 30, 2019 Intangible assets with finite lives: Gross carrying amount $ 105,256 $ (18,024 ) $ — $ (2,501 ) $ 84,731 Accumulated amortization (74,603 ) 13,597 (3,730 ) 2,130 (62,606 ) Total net intangible assets with finite lives $ 30,653 $ (4,427 ) $ (3,730 ) $ (371 ) $ 22,125 Intangible assets with indefinite lives: Tradename and other 300,257 ― ― 289 300,546 Total intangible assets — net $ 330,910 $ (4,427 ) $ (3,730 ) $ (82 ) $ 322,671 (1) See Note 3 for further discussion of the impact of adoption of ASC Topic 842. (2) Amount represents the write-off of fully amortized intangible assets related to non-compete agreements, the acquisition of tradeable liquor licenses, fair values allocated to intangible assets acquired as part of acquisitions of two theatres in the U.S. and foreign currency translation adjustments.
Estimated Aggregate Future Amortization Expense for Intangible Assets	Estimated aggregate future amortization expense for intangible assets is as follows: For the three months ended December 31, 2019 $ 1,254 For the twelve months ended December 31, 2020 4,986 For the twelve months ended December 31, 2021 3,150 For the twelve months ended December 31, 2022 3,116 For the twelve months ended December 31, 2023 3,083 Thereafter 6,536 Total $ 22,125

Impairment of Long-Lived Asse_2

Impairment of Long-Lived Assets (Tables)	9 Months Ended
	Sep. 30, 2019
Impairment Or Disposal Of Tangible Assets Disclosure [Abstract]
Long-Lived Asset Impairment Charges	Below is a summary of impairment charges for the periods presented: Three Months Ended Nine Months Ended September 30, September 30, 2019 2018 2019 2018 U.S. theatre properties and equipment $ 24,502 $ 1,553 $ 26,754 $ 3,331 U.S. operating lease right-of-use assets 2,157 — 10,204 — International theatre properties and equipment 645 88 6,796 1,689 International operating lease right-of-use assets — — 1,628 — Total $ 27,304 $ 1,641 $ 45,382 $ 5,020

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2019
Fair Value Disclosures [Abstract]
Summary of Liabilities Measured at Fair Value on Recurring Basis	Below is a summary of liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of September 30, 2019: Carry Fair Value Description Value Level 1 Level 2 Level 3 Interest rate swap liabilities (1) $ (18,988 ) $ — $ — $ (18,988 ) (1) See further discussion of interest rate swaps at Note 5. Below is a summary of liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of December 31, 2018: Carry Fair Value Description Value Level 1 Level 2 Level 3 Interest rate swap liabilities (1) $ (5,093 ) $ — $ — $ (5,093 ) (1)
Reconciliation of Beginning and Ending Balance for Liabilities Measured at Fair Value	Below is a reconciliation of the beginning and ending balance for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3): Liabilities (1) 2019 Beginning balance - January 1 $ 5,093 Total loss included in accumulated other comprehensive loss 15,036 Settlements included in interest expense (1,141 ) Ending balance - September 30 $ 18,988

Foreign Currency Translation (T

Foreign Currency Translation (Tables)	9 Months Ended
	Sep. 30, 2019
Fair Value Disclosures [Abstract]
Summary of Impact of Translating Financial Statements of Company's International Subsidiaries	Below is a summary of the impact of translating the September 30, 2019 financial statements of the Company’s international subsidiaries: Other Comprehensive Loss for Exchange Rate as of Nine Months Ended Country September 30, 2019 December 31, 2018 September 30, 2019 September 30, 2018 Brazil 4.16 3.88 $ (14,492 ) $ (42,588 ) Argentina (1) 57.41 37.68 — (18,272 ) Chile 727.65 694.74 (4,017 ) (4,822 ) Colombia 3,462.00 3,249.75 (1,507 ) 70 Peru 3.40 3.39 (203 ) (891 ) All other 491 (338 ) $ (19,728 ) $ (66,841 ) (1)

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information (Tables)	9 Months Ended
	Sep. 30, 2019
Supplemental Cash Flow Elements [Abstract]
Supplemental Information to Condensed Consolidated Statements of Cash Flows	The following is provided as supplemental information to the condensed consolidated statements of cash flows: Nine Months Ended September 30, 2019 2018 Cash paid for interest $ 56,326 $ 62,773 Cash paid for income taxes, net of refunds received $ 69,498 $ 42,631 Noncash investing and financing activities: Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (1) $ (13,642 ) $ 7,050 Theatre properties acquired under capital lease $ — $ 4,035 Interest expense - NCM (see Note 7) $ (14,180 ) $ (14,875 ) Investment in NCM – receipt of common units (see Note 7) $ 1,552 $ 5,012 (1) Additions to theatre properties and equipment included in accounts payable as of September 30, 2019 and December 31, 2018 were $23,362 and $37,004, respectively.

Segments (Tables)

Segments (Tables)	9 Months Ended
	Sep. 30, 2019
Segment Reporting [Abstract]
Selected Financial Information by Reportable Operating Segment	Below is a breakdown of selected financial information by reportable operating segment: Three Months Ended Nine Months Ended September 30, September 30, 2019 2018 2019 2018 Revenues U.S. $ 636,628 $ 585,536 $ 1,941,545 $ 1,897,664 International 188,772 171,960 563,509 535,567 Eliminations (3,583 ) (3,261 ) (10,758 ) (9,972 ) Total revenues $ 821,817 $ 754,235 $ 2,494,296 $ 2,423,259 Adjusted EBITDA U.S. $ 132,705 $ 132,974 $ 454,665 $ 478,164 International 37,411 35,740 113,346 106,518 Total Adjusted EBITDA $ 170,116 $ 168,714 $ 568,011 $ 584,682 Capital expenditures U.S. $ 50,679 $ 65,458 $ 148,609 $ 195,104 International 20,664 17,915 37,903 50,858 Total capital expenditures $ 71,343 $ 83,373 $ 186,512 $ 245,962
Reconciliation of Net Income to Adjusted EBITDA	The following table sets forth a reconciliation of net income to Adjusted EBITDA: Three Months Ended Nine Months Ended September 30, September 30, 2019 2018 2019 2018 Net income $ 32,398 $ 51,036 $ 168,474 $ 196,729 Add (deduct): Income taxes 14,193 16,301 64,615 60,056 Interest expense (1) (2) 24,967 27,144 75,037 82,725 Other income, net (3) (9,964 ) (8,803 ) (25,059 ) (15,233 ) Loss on debt amendments and refinancing — — — 1,484 Distributions from DCIP (4) 2,694 — 7,912 5,201 Other cash distributions from equity investees (5) 5,804 4,786 20,251 15,840 Depreciation and amortization (2) 67,760 64,971 196,795 193,656 Impairment of long-lived assets 27,304 1,641 45,382 5,020 Loss on disposal of assets and other 2,453 7,826 8,057 28,666 Non-cash rent expense (6) (1,102 ) — (3,252 ) — Deferred lease expenses (2) — (20 ) — (952 ) Amortization of long-term prepaid rents (2) — 578 — 1,814 Share based awards compensation expense 3,609 3,254 9,799 9,676 Adjusted EBITDA (2) $ 170,116 $ 168,714 $ 568,011 $ 584,682 (1) Includes amortization of debt issue costs. (2) Amounts for the three and nine months ended September 30, 2019 were impacted by the adoption of ASC Topic 842 and the resulting change in the classification of certain of the Company’s leases. (3) Includes interest income, foreign currency exchange loss, equity in income of affiliates and interest expense - NCM and excludes distributions from NCM. (4) See discussion of cash distributions from DCIP, which were recorded as a reduction of the Company’s investment in DCIP, at Note 8. (5) Includes cash distributions received from equity investees, other than those from DCIP noted above, that were recorded as a reduction of the respective investment balances (see Notes 7 and 8). These distributions are reported entirely within the U.S. operating segment. (6) The adoption of ASC Topic 842 impacted how the Company amortizes lease related assets and liabilities such as deferred lease expenses, favorable and unfavorable lease intangible assets, long-term prepaid rents and deferred lease incentives. Beginning January 1, 2019, these items are amortized to facility lease expense for theatre operating leases and utilities and other for equipment operating leases. See Note 3 for discussion of the impact of ASC Topic 842.
Selected Financial Information by Geographic Area	Below is a breakdown of selected financial information by geographic area: Three Months Ended Nine Months Ended September 30, September 30, Revenues 2019 2018 2019 2018 U.S. $ 636,628 $ 585,536 $ 1,941,545 $ 1,897,664 Brazil 79,776 65,152 240,263 218,265 Other international countries 108,996 106,808 323,246 317,302 Eliminations (3,583 ) (3,261 ) (10,758 ) (9,972 ) Total $ 821,817 $ 754,235 $ 2,494,296 $ 2,423,259 As of As of Theatre Properties and Equipment-net (1) September 30, 2019 December 31, 2018 U.S. $ 1,408,052 $ 1,479,603 Brazil 111,297 140,570 Other international countries 163,052 212,960 Total $ 1,682,401 $ 1,833,133 (1) See Note 3 for discussion of impact of ASC Topic 842 on capital lease assets.

Condensed Consolidating Finan_2

Condensed Consolidating Financial Information of Subsidiary Guarantors (Tables)	9 Months Ended
	Sep. 30, 2019
Statement Of Financial Position [Abstract]
Condensed Consolidating Balance Sheet Information	CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2018 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Assets Current assets Cash and cash equivalents $ 197,965 $ 10,886 $ 217,365 $ — $ 426,216 Other current assets 60,829 19,997 67,149 (15,178 ) 132,797 Accounts receivable from parent or subsidiaries — 284,893 — (265,363 ) 19,530 Total current assets 258,794 315,776 284,514 (280,541 ) 578,543 Theatre properties and equipment - net 664,759 789,536 378,838 - 1,833,133 Investment in subsidiaries 1,806,255 57,845 - (1,864,100 ) — Other assets 1,500,366 155,011 546,834 (112,536 ) 2,089,675 Total assets $ 4,230,174 $ 1,318,168 $ 1,210,186 $ (2,257,177 ) $ 4,501,351 Liabilities and equity Current liabilities Current portion of long-term debt $ 6,595 $ — $ 1,389 $ — $ 7,984 Current portion of capital lease obligations 11,918 9,406 5,741 — 27,065 Accounts payable and accrued expenses 297,302 58,544 96,780 (13,622 ) 439,004 Accounts payable to parent or subsidiaries 40,421 — 224,942 (265,363 ) — Total current liabilities 356,236 67,950 328,852 (278,985 ) 474,053 Long-term liabilities Long-term debt, less current portion 1,872,627 — 7,955 (107,955 ) 1,772,627 Capital lease obligations, less current portion 123,329 59,539 49,599 — 232,467 Other long-term liabilities and deferrals 413,177 60,137 77,844 (6,137 ) 545,021 Total long-term liabilities 2,409,133 119,676 135,398 (114,092 ) 2,550,115 Commitments and contingencies Equity Cinemark USA, Inc.'s stockholder's equity: Common stock 49,543 457,368 10,238 (467,606 ) 49,543 Other stockholder's equity 1,415,262 673,174 723,319 (1,396,494 ) 1,415,261 Total Cinemark USA, Inc. stockholder's equity 1,464,805 1,130,542 733,557 (1,864,100 ) 1,464,804 Noncontrolling interests — — 12,379 — 12,379 Total equity 1,464,805 1,130,542 745,936 (1,864,100 ) 1,477,183 Total liabilities and equity $ 4,230,174 $ 1,318,168 $ 1,210,186 $ (2,257,177 ) $ 4,501,351 CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION SEPTEMBER 30, 2019 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Assets Current assets Cash and cash equivalents $ 174,862 $ 7,429 $ 300,397 $ — $ 482,688 Other current assets 91,856 20,556 66,894 (67,315 ) 111,991 Accounts receivable from parent or subsidiaries — 393,807 — (369,995 ) 23,812 Total current assets 266,718 421,792 367,291 (437,310 ) 618,491 Theatre properties and equipment - net 634,359 749,560 298,482 — 1,682,401 Operating lease right-of-use assets 704,578 486,473 192,968 — 1,384,019 Investment in subsidiaries 1,928,328 20,255 — (1,948,583 ) — Other assets 1,494,644 157,449 549,007 (110,685 ) 2,090,415 Total assets $ 5,028,627 $ 1,835,529 $ 1,407,748 $ (2,496,578 ) $ 5,775,326 Liabilities and equity Current liabilities Current portion of long-term debt $ 6,595 $ — $ 1,389 $ — $ 7,984 Current portion of operating lease obligations 99,173 86,302 29,540 — 215,015 Current portion of finance lease obligations 11,227 4,206 68 — 15,501 Accounts payable and accrued expenses 329,163 45,120 92,166 (65,760 ) 400,689 Accounts payable to parent or subsidiaries 116,745 — 253,250 (369,995 ) — Total current liabilities 562,903 135,628 376,413 (435,755 ) 639,189 Long-term liabilities Long-term debt, less current portion 1,871,663 — 4,455 (104,455 ) 1,771,663 Operating lease obligations, less current portion 635,326 434,533 160,293 — 1,230,152 Finance lease obligations, less current portion 75,841 50,115 388 — 126,344 Other long-term liabilities and deferrals 373,988 43,064 77,057 (7,785 ) 486,324 Total long-term liabilities 2,956,818 527,712 242,193 (112,240 ) 3,614,483 Commitments and contingencies Equity Cinemark USA, Inc.'s stockholder's equity: Common stock 49,543 457,368 10,238 (467,606 ) 49,543 Other stockholder's equity 1,459,363 714,821 766,156 (1,480,977 ) 1,459,363 Total Cinemark USA, Inc. stockholder's equity 1,508,906 1,172,189 776,394 (1,948,583 ) 1,508,906 Noncontrolling interests — — 12,748 — 12,748 Total equity 1,508,906 1,172,189 789,142 (1,948,583 ) 1,521,654 Total liabilities and equity $ 5,028,627 $ 1,835,529 $ 1,407,748 $ (2,496,578 ) $ 5,775,326
Condensed Consolidating Statement of Income Information	CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION THREE MONTHS ENDED SEPTEMBER 30, 2018 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Revenues $ 264,247 $ 314,542 $ 181,866 $ (6,420 ) $ 754,235 Cost of operations Theatre operating expenses 205,693 224,592 134,895 (6,420 ) 558,760 General and administrative expenses 2,344 23,451 11,950 — 37,745 Depreciation and amortization 22,678 24,969 17,324 — 64,971 Impairment of long-lived assets 745 519 377 — 1,641 Loss on disposal of assets and other 2,711 4,856 259 — 7,826 Total cost of operations 234,171 278,387 164,805 (6,420 ) 670,943 Operating income 30,076 36,155 17,061 — 83,292 Other income (expense) Interest expense (24,469 ) (1,684 ) (1,333 ) 342 (27,144 ) Distributions from NCM — — 2,386 — 2,386 Interest expense - NCM (4,983 ) — — — (4,983 ) Equity in income of affiliates 50,262 4,187 10,661 (50,952 ) 14,158 Other income (expense) 1,088 1 (1,119 ) (342 ) (372 ) Total other income (expense) 21,898 2,504 10,595 (50,952 ) (15,955 ) Income before income taxes 51,974 38,659 27,656 (50,952 ) 67,337 Income taxes 1,331 7,671 7,299 — 16,301 Net income 50,643 30,988 20,357 (50,952 ) 51,036 Less: Net income attributable to noncontrolling interests — — 393 — 393 Net income attributable to Cinemark USA, Inc. $ 50,643 $ 30,988 $ 19,964 $ (50,952 ) $ 50,643 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION THREE MONTHS ENDED SEPTEMBER Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Revenues $ 295,148 $ 342,221 $ 200,093 $ (15,645 ) $ 821,817 Cost of operations Theatre operating expenses 238,834 247,512 150,366 (15,645 ) 621,067 General and administrative expenses 2,985 28,570 12,558 — 44,113 Depreciation and amortization 22,909 25,875 18,976 — 67,760 Impairment of long-lived assets 2,494 24,165 645 — 27,304 Loss on disposal of assets and other 1,221 783 449 — 2,453 Total cost of operations 268,443 326,905 182,994 (15,645 ) 762,697 Operating income 26,705 15,316 17,099 — 59,120 Other income (expense) Interest expense (24,482 ) (603 ) (200 ) 318 (24,967 ) Distributions from NCM — — 2,474 — 2,474 Interest expense - NCM (4,666 ) — — — (4,666 ) Equity in income (loss) of affiliates 32,606 1,825 9,832 (29,124 ) 15,139 Other income (expense) 1,173 3,020 (1,378 ) (3,324 ) (509 ) Total other income (expense) 4,631 4,242 10,728 (32,130 ) (12,529 ) Income before income taxes 31,336 19,558 27,827 (32,130 ) 46,591 Income taxes (460 ) 4,745 9,908 — 14,193 Net income 31,796 14,813 17,919 (32,130 ) 32,398 Less: Net income attributable to noncontrolling interests — — 602 — 602 Net income attributable to Cinemark USA, Inc. $ 31,796 $ 14,813 $ 17,317 $ (32,130 ) $ 31,796 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION NINE MONTHS ENDED SEPTEMBER 30, 2018 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Revenues $ 879,552 $ 1,018,666 $ 566,087 $ (41,046 ) $ 2,423,259 Cost of operations Theatre operating expenses 680,182 699,065 422,354 (41,046 ) 1,760,555 General and administrative expenses 9,104 73,401 39,264 — 121,769 Depreciation and amortization 66,333 73,299 54,024 — 193,656 Impairment of long-lived assets 1,946 519 2,555 — 5,020 Loss on disposal of assets and other 7,479 20,265 922 — 28,666 Total cost of operations 765,044 866,549 519,119 (41,046 ) 2,109,666 Operating income 114,508 152,117 46,968 — 313,593 Other income (expense) Interest expense (72,853 ) (5,045 ) (5,862 ) 1,035 (82,725 ) Loss on debt amendments (1,484 ) — — — (1,484 ) Distributions from NCM — — 12,168 — 12,168 Interest expense - NCM (14,875 ) — — — (14,875 ) Equity in income of affiliates 179,170 11,150 24,580 (185,692 ) 29,208 Other income (expense) 3,292 (6 ) (1,351 ) (1,035 ) 900 Total other income (expense) 93,250 6,099 29,535 (185,692 ) (56,808 ) Income before income taxes 207,758 158,216 76,503 (185,692 ) 256,785 Income taxes 11,907 34,611 13,538 — 60,056 Net income 195,851 123,605 62,965 (185,692 ) 196,729 Less: Net income attributable to noncontrolling interests — — 878 — 878 Net income attributable to Cinemark USA, Inc. $ 195,851 $ 123,605 $ 62,087 $ (185,692 ) $ 195,851 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION NINE MONTHS ENDED SEPTEMBER Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Revenues $ 905,445 $ 1,034,084 $ 597,646 $ (42,879 ) $ 2,494,296 Cost of operations Theatre operating expenses 707,057 733,408 447,523 (42,879 ) 1,845,109 General and administrative expenses 8,992 78,623 37,439 — 125,054 Depreciation and amortization 68,813 76,858 51,124 — 196,795 Impairment of long-lived assets 3,659 33,299 8,424 — 45,382 Loss on disposal of assets and other 3,560 2,859 1,638 — 8,057 Total cost of operations 792,081 925,047 546,148 (42,879 ) 2,220,397 Operating income 113,364 109,037 51,498 — 273,899 Other income (expense) Interest expense (73,523 ) (1,846 ) (669 ) 1,001 (75,037 ) Distributions from NCM — — 9,168 — 9,168 Interest expense - NCM (14,180 ) — — — (14,180 ) Equity in income (loss) of affiliates 144,279 (9,940 ) 25,741 (126,098 ) 33,982 Other income (expense) 3,297 6 2,955 (1,001 ) 5,257 Total other income (expense) 59,873 (11,780 ) 37,195 (126,098 ) (40,810 ) Income before income taxes 173,237 97,257 88,693 (126,098 ) 233,089 Income taxes 6,720 31,285 26,610 — 64,615 Net income 166,517 65,972 62,083 (126,098 ) 168,474 Less: Net income attributable to noncontrolling interests — — 1,957 — 1,957 Net income attributable to Cinemark USA, Inc. $ 166,517 $ 65,972 $ 60,126 $ (126,098 ) $ 166,517
Condensed Consolidating Statement of Comprehensive Income Information	CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION THREE MONTHS ENDED SEPTEMBER Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Net income $ 50,643 $ 30,988 $ 20,357 $ (50,952 ) $ 51,036 Other comprehensive loss, net of tax Other comprehensive loss of equity method investments (63 ) — (63 ) 63 (63 ) Foreign currency translation adjustments (10,797 ) — (10,797 ) 10,797 (10,797 ) Total other comprehensive loss, net of tax (10,860 ) — (10,860 ) 10,860 (10,860 ) Total comprehensive income, net of tax $ 39,783 $ 30,988 $ 9,497 $ (40,092 ) $ 40,176 Comprehensive income attributable to noncontrolling interests — — (393 ) — (393 ) Comprehensive income attributable to Cinemark USA, Inc. $ 39,783 $ 30,988 $ 9,104 $ (40,092 ) $ 39,783 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS) INFORMATION THREE MONTHS ENDED SEPTEMBER Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Net income $ 31,796 $ 14,813 $ 17,919 $ (32,130 ) $ 32,398 Other comprehensive loss, net of tax Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $417, net of settlements (1,291 ) — — — (1,291 ) Other comprehensive loss of equity method investments (49 ) — (49 ) 49 (49 ) Foreign currency translation adjustments (25,408 ) — (25,408 ) 25,408 (25,408 ) Total other comprehensive loss, net of tax (26,748 ) — (25,457 ) 25,457 (26,748 ) Total comprehensive income (loss), net of tax $ 5,048 $ 14,813 $ (7,538 ) $ (6,673 ) $ 5,650 Comprehensive income attributable to noncontrolling interests — — (602 ) — (602 ) Comprehensive income (loss) attributable to Cinemark USA, Inc. $ 5,048 $ 14,813 $ (8,140 ) $ (6,673 ) $ 5,048 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS) INFORMATION NINE MONTHS ENDED SEPTEMBER Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Net income $ 195,851 $ 123,605 $ 62,965 $ (185,692 ) $ 196,729 Other comprehensive loss, net of tax Other comprehensive loss of equity method investments (43 ) — (43 ) 43 (43 ) Foreign currency translation adjustments (66,841 ) — (66,841 ) 66,841 (66,841 ) Total other comprehensive loss, net of tax (66,884 ) — (66,884 ) 66,884 (66,884 ) Total comprehensive income (loss), net of tax $ 128,967 $ 123,605 $ (3,919 ) $ (118,808 ) $ 129,845 Comprehensive income attributable to noncontrolling interests — — (878 ) — (878 ) Comprehensive income (loss) attributable to Cinemark USA, Inc. $ 128,967 $ 123,605 $ (4,797 ) $ (118,808 ) $ 128,967 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION NINE MONTHS ENDED SEPTEMBER Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Net income $ 166,517 $ 65,972 $ 62,083 $ (126,098 ) $ 168,474 Other comprehensive loss, net of tax Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $3,391, net of settlements (10,504 ) — — — (10,504 ) Other comprehensive loss of equity method investments (142 ) — (142 ) 142 (142 ) Foreign currency translation adjustments (19,728 ) — (19,728 ) 19,728 (19,728 ) Total other comprehensive loss, net of tax (30,374 ) — (19,870 ) 19,870 (30,374 ) Total comprehensive income, net of tax $ 136,143 $ 65,972 $ 42,213 $ (106,228 ) $ 138,100 Comprehensive income attributable to noncontrolling interests — — (1,957 ) — (1,957 ) Comprehensive income attributable to Cinemark USA, Inc. $ 136,143 $ 65,972 $ 40,256 $ (106,228 ) $ 136,143
Condensed Consolidating Statement of Cash Flows Information	CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION NINE MONTHS ENDED SEPTEMBER Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Operating activities Net income $ 195,851 $ 123,605 $ 62,965 $ (185,692 ) $ 196,729 Adjustments to reconcile net income to cash provided by (used for) operating activities (90,311 ) 91,492 41,392 185,692 228,265 Changes in assets and liabilities 201,287 (243,336 ) (33,326 ) — (75,375 ) Net cash provided by (used for) operating activities 306,827 (28,239 ) 71,031 — 349,619 Investing activities Additions to theatre properties and equipment (70,519 ) (118,468 ) (56,975 ) — (245,962 ) Acquisition of theatres in international markets, net of cash acquired — — (11,289 ) — (11,289 ) Proceeds from sale of theatre properties and equipment and other 1,244 1,740 573 — 3,557 Proceeds from intercompany note repayment 1,867 — — (1,867 ) — Acquisition of NCM common units (78,393 ) — — — (78,393 ) Investment in joint ventures and other — (19,896 ) (546 ) — (20,442 ) Net cash used for investing activities (145,801 ) (136,624 ) (68,237 ) (1,867 ) (352,529 ) Financing activities Dividends paid to parent (111,550 ) — — — (111,550 ) Repayments of long-term debt (4,946 ) — — — (4,946 ) Payment of debt issue costs (5,103 ) — — — (5,103 ) Repayment of intercompany note — — (1,867 ) 1,867 — Payments on capital leases (8,605 ) (6,669 ) (3,504 ) — (18,778 ) Other (704 ) (2,905 ) — — (3,609 ) Net cash used for financing activities (130,908 ) (9,574 ) (5,371 ) 1,867 (143,986 ) Effect of exchange rate changes on cash and cash equivalents — — (8,732 ) — (8,732 ) Increase (decrease) in cash and cash equivalents 30,118 (174,437 ) (11,309 ) — (155,628 ) Cash and cash equivalents: Beginning of year 130,590 180,623 211,202 — 522,415 End of year $ 160,708 $ 6,186 $ 199,893 $ — $ 366,787 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION NINE MONTHS ENDED SEPTEMBER Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated Operating activities Net income $ 166,517 $ 65,972 $ 62,083 $ (126,098 ) $ 168,474 Adjustments to reconcile net income to cash provided by operating activities (71,652 ) 130,125 52,857 126,098 237,428 Changes in assets and liabilities 87,748 (113,891 ) 16,751 — (9,392 ) Net cash provided by operating activities 182,613 82,206 131,691 — 396,510 Investing activities Additions to theatre properties and equipment (64,264 ) (83,757 ) (38,491 ) — (186,512 ) Acquisition of theatres in U.S. and international markets, net of cash acquired (10,170 ) — — — (10,170 ) Proceeds from sale of theatre properties and equipment and other — — 377 — 377 Dividends received from subsidiary 600 3,012 — (3,612 ) — Net cash used for investing activities (73,834 ) (80,745 ) (38,114 ) (3,612 ) (196,305 ) Financing activities Dividends paid to parent (118,825 ) — (3,612 ) 3,612 (118,825 ) Repayments of long-term debt (4,947 ) — — — (4,947 ) Payments on finance leases (8,110 ) (2,671 ) (49 ) — (10,830 ) Other — (2,247 ) (1,588 ) — (3,835 ) Net cash used for financing activities (131,882 ) (4,918 ) (5,249 ) 3,612 (138,437 ) Effect of exchange rate changes on cash and cash equivalents — — (5,296 ) — (5,296 ) Increase (decrease) in cash and cash equivalents (23,103 ) (3,457 ) 83,032 — 56,472 Cash and cash equivalents: Beginning of year 197,965 10,886 217,365 — 426,216 End of year $ 174,862 $ 7,429 $ 300,397 $ — $ 482,688 * * * * *

The Company and Basis of Pres_2

The Company and Basis of Presentation - Additional Information (Detail)	Sep. 30, 2019
Minimum
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Equity method investment, ownership percentage	20.00%
Maximum
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Equity method investment, ownership percentage	50.00%
Cost method investment, ownership Percentage	20.00%

Adoption of ASC Topic 842 - L_3

Adoption of ASC Topic 842 - Lease Accounting - Additional Information (Detail) - USD ($) $ in Thousands		9 Months Ended
		Sep. 30, 2019	Jan. 01, 2019
Lease [Line Items]
Operating lease right-of-use assets	[1]	$ 1,384,019
Operating lease liabilities		1,445,167
Finance lease assets	[1],[2]	103,059
Finance lease liabilities		141,845
Theatres
Lease [Line Items]
Noncancelable lease payments payable under operating lease, lease not yet commenced		$ 258,453
Minimum | Real Estate
Lease [Line Items]
Noncancelable operating and finance leases, term		10 years
Minimum | Equipment
Lease [Line Items]
Noncancelable operating leases, term		5 years
Maximum | Real Estate
Lease [Line Items]
Noncancelable operating and finance leases, term		25 years
Maximum | Equipment
Lease [Line Items]
Noncancelable operating leases, term		12 years
ASC Topic 842
Lease [Line Items]
Deferred rent liabilities			$ (39,235)
Lease intangibles			(5,780)
Deferred lease incentive liabilities			(12,960)
Long-term prepaid rents			7,707
Operating lease right-of-use assets			1,491,245
Operating lease liabilities			1,545,210
Finance lease assets			57,440
Finance lease liabilities			57,440
ASC Topic 842 | Adjustment
Lease [Line Items]
Operating lease right-of-use assets			110,442
Operating lease liabilities			$ 126,376
[1]	The operating lease right-of-use assets and liabilities recorded on the Company’s condensed consolidated balance sheet generally do not include renewal options that have not yet been exercised.  The Company does not consider a lease renewal as reasonably certain until immediately before the necessary notification is provided to the landlord.
[2]	Finance lease assets are net of accumulated amortization of $57,506 as of September 30, 2019.

Schedule of Operating and Finan

Schedule of Operating and Finance Right-of-Use Assets and Lease Liabilities (Detail) $ in Thousands	Sep. 30, 2019USD ($)
Assets
Operating lease assets	$ 1,384,019	[1]
Finance lease assets	$ 103,059	[1],[2]
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	us-gaap:PropertyPlantAndEquipmentNet
Total lease assets	$ 1,487,078	[1]
Liabilities, Current
Operating	215,015	[1]
Finance	15,501	[1]
Liabilities, Noncurrent
Operating	1,230,152	[1]
Finance	126,344	[1]
Total lease liabilities	$ 1,587,012	[1]
[1]	The operating lease right-of-use assets and liabilities recorded on the Company’s condensed consolidated balance sheet generally do not include renewal options that have not yet been exercised.  The Company does not consider a lease renewal as reasonably certain until immediately before the necessary notification is provided to the landlord.
[2]	Finance lease assets are net of accumulated amortization of $57,506 as of September 30, 2019.

Schedule of Operating and Fin_2

Schedule of Operating and Finance Right-of-Use Assets and Lease Liabilities (Parenthetical) (Detail) $ in Thousands	Sep. 30, 2019USD ($)
Leases [Abstract]
Finance lease assets, accumulated amortization	$ 57,506

Schedule of Aggregate Lease Cos

Schedule of Aggregate Lease Costs by Lease Classification (Detail) - USD ($) $ in Thousands		3 Months Ended	9 Months Ended
		Sep. 30, 2019	Sep. 30, 2019
Operating lease costs
Total operating lease costs		$ 89,718	$ 267,956
Finance lease costs
Total finance lease costs		5,625	17,109
Depreciation and Amortization
Finance lease costs
Amortization of leased assets		3,703	11,182
Interest Expense
Finance lease costs
Interest on lease liabilities		1,922	5,927
Equipment | Utilities and Other
Operating lease costs
Total operating lease costs	[1]	1,569	5,173
Real Estate | Facility Lease Expense
Operating lease costs
Total operating lease costs	[2],[3]	$ 88,149	$ 262,783
[1]	Includes approximately $452 and $1,808 of short-term lease payments for the three and nine months ended September 30, 2019, respectively.
[2]	Approximately $400 and $1,184 of lease payments are included in general and administrative expenses primarily related to office leases for the three and nine months ended September 30, 2019, respectively.
[3]	Includes approximately $18,591 and $54,209 of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenues or attendance and variable common area maintenance costs for the three and nine months ended September 30, 2019

Schedule of Aggregate Lease C_2

Schedule of Aggregate Lease Costs by Lease Classification (Parenthetical) (Detail) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2019
Lease Cost [Line Items]
Lease payments		$ 211,940
Equipment | Utilities and Other
Lease Cost [Line Items]
Short term lease payments	$ 452	1,808
Real Estate | Facility Lease Expense
Lease Cost [Line Items]
Variable lease payments	18,591	54,209
Lease payments	$ 400	$ 1,184

Schedule of Maturity of Lease L

Schedule of Maturity of Lease Liabilities by Lease Classification (Detail) $ in Thousands	Sep. 30, 2019USD ($)
Leases [Abstract]
Operating Leases, 2019	$ 70,137
Operating Leases, 2020	276,114
Operating Leases, 2021	258,827
Operating Leases, 2022	229,272
Operating Leases, 2023	198,799
Operating Leases, After 2023	704,440
Operating Leases, Total lease payments	1,737,589
Operating Leases, Less: Interest	292,422
Operating Leases, Present value of lease liabilities	1,445,167
Finance Leases, 2019	5,588
Finance Leases, 2020	22,373
Finance Leases, 2021	18,661
Finance Leases, 2022	17,925
Finance Leases, 2023	17,236
Finance Leases, After 2023	101,110
Finance Leases, Total lease payments	182,893
Finance Leases, Less: Interest	41,048
Finance Leases, Present value of lease liabilities	141,845
Total Leases, 2019	75,725
Total Leases, 2020	298,487
Total Leases, 2021	277,488
Total Leases, 2022	247,197
Total Leases, 2023	216,035
Total Leases, After 2023	805,550
Total Leases, Total lease payments	1,920,482
Total Leases, Less: Interest	333,470
Total Leases, Present value of lease liabilities	$ 1,587,012

Future Minimum Lease Payments U

Future Minimum Lease Payments Under Noncancelable Operating and Capital Leases (Detail) $ in Thousands	Dec. 31, 2018USD ($)
Leases [Abstract]
Future minimum operating lease payments, current	$ 253,323
Future minimum operating lease payments, in two years	242,336
Future minimum operating lease payments, in three years	230,396
Future minimum operating lease payments, in four years	204,628
Future minimum operating lease payments, in five years	176,802
Future minimum operating lease payments, thereafter	677,091
Future minimum operating lease payments, total	1,784,576
Future minimum capital leases payments, current	42,434
Future minimum capital leases payments, in two years	41,502
Future minimum capital leases payments, in three years	34,589
Future minimum capital leases payments, in four years	32,462
Future minimum capital leases payments, in five years	28,534
Future minimum capital leases payments, thereafter	166,375
Future minimum capital leases payments, total	345,896
Amounts representing interest payments	(86,364)
Present value of future minimum payments	259,532
Current portion of finance and capital lease obligations	(27,065)
Capital lease obligations, less current portion	$ 232,467

Schedule of Weighted-Average Re

Schedule of Weighted-Average Remaining Lease Term and Discount Rate (Detail)	Sep. 30, 2019
Equipment
Lease [Line Items]
Weighted-average remaining lease term - Operating leases	4 years 1 month 6 days	[1]
Weighted-average remaining lease term - Finance leases	5 years 10 months 24 days	[1]
Weighted-average discount rate - Operating leases	4.30%	[2]
Weighted-average discount rate - Finance leases	5.50%	[2]
Real Estate
Lease [Line Items]
Weighted-average remaining lease term - Operating leases	7 years 10 months 24 days	[1]
Weighted-average remaining lease term - Finance leases	10 years 7 months 6 days	[1]
Weighted-average discount rate - Operating leases	4.80%	[2]
Weighted-average discount rate - Finance leases	5.20%	[2]
[1]	The lease assets and liabilities recorded on the Company’s condensed consolidated balance sheet generally do not include renewal options that have not yet been executed.  The Company does not consider a lease renewal exercise as reasonably certain until immediately before the necessary notification is provided to the landlord.
[2]	The discount rate for each lease represents the incremental borrowing rate at which the Company would borrow, on a collateralized basis, over a similar term and at an amount equal to the lease payments in a similar economic environment.

Schedule of Minimum Cash Lease

Schedule of Minimum Cash Lease Payments (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2019USD ($)
Cash paid for amounts included in the measurement of lease liabilities
Cash outflows for operating leases	$ 211,940
Cash outflows for finance leases - operating activities	5,756
Cash outflows for finance leases - financing activities	10,830
Real Estate
Non-cash amount of leased assets obtained in exchange for:
Operating lease liabilities - real estate	53,526
Equipment
Non-cash amount of leased assets obtained in exchange for:
Operating lease liabilities - real estate	$ 668

Revenue Recognition - Additiona

Revenue Recognition - Additional Information (Detail)	Sep. 30, 2019USD ($)
Revenue From Contract With Customer [Abstract]
Receivables related to contracts with customers	$ 29,719,000
Assets related to costs to obtain or fulfill contract with customers	$ 0

Summary of Revenues Disaggregat

Summary of Revenues Disaggregated Based on Major Type of Good or Service and by Reportable Operating Segment (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Disaggregation of Revenue [Line Items]
Total revenues		$ 821,817	$ 754,235	$ 2,494,296	$ 2,423,259
Admissions Revenues
Disaggregation of Revenue [Line Items]
Total revenues		454,429	427,616	1,371,041	1,389,110
Concession Revenues
Disaggregation of Revenue [Line Items]
Total revenues		289,477	264,165	886,083	831,243
Other Revenues
Disaggregation of Revenue [Line Items]
Total revenues		40,349	30,024	123,589	101,531
Screen Advertising, Screen Rental and Promotional Revenues
Disaggregation of Revenue [Line Items]
Total revenues		37,562		113,583
Screen Advertising and Promotional Revenues
Disaggregation of Revenue [Line Items]
Total revenues			32,430		101,375
U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	633,045	582,275	1,930,787	1,887,692
U.S. Operating Segment | Admissions Revenues
Disaggregation of Revenue [Line Items]
Total revenues	[1]	351,122	333,274	1,066,884	1,091,489
U.S. Operating Segment | Concession Revenues
Disaggregation of Revenue [Line Items]
Total revenues	[1]	230,415	207,960	704,727	661,328
U.S. Operating Segment | Other Revenues
Disaggregation of Revenue [Line Items]
Total revenues	[1]	30,394	22,031	95,180	76,635
U.S. Operating Segment | Screen Advertising, Screen Rental and Promotional Revenues
Disaggregation of Revenue [Line Items]
Total revenues	[1]	21,114		63,996
U.S. Operating Segment | Screen Advertising and Promotional Revenues
Disaggregation of Revenue [Line Items]
Total revenues	[1]		19,010		58,240
International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		188,772	171,960	563,509	535,567
International Operating Segment | Admissions Revenues
Disaggregation of Revenue [Line Items]
Total revenues		103,307	94,342	304,157	297,621
International Operating Segment | Concession Revenues
Disaggregation of Revenue [Line Items]
Total revenues		59,062	56,205	181,356	169,915
International Operating Segment | Other Revenues
Disaggregation of Revenue [Line Items]
Total revenues		9,955	7,993	28,409	24,896
International Operating Segment | Screen Advertising, Screen Rental and Promotional Revenues
Disaggregation of Revenue [Line Items]
Total revenues		$ 16,448		$ 49,587
International Operating Segment | Screen Advertising and Promotional Revenues
Disaggregation of Revenue [Line Items]
Total revenues			$ 13,420		$ 43,135
[1]	U.S. segment revenues include eliminations of intercompany transactions with the international operating segment.  See Note 16 for additional information on intercompany eliminations.

Summary of Revenues Disaggreg_2

Summary of Revenues Disaggregated Based on Timing of Revenue Recognition (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Disaggregation of Revenue [Line Items]
Total revenues		$ 821,817	$ 754,235	$ 2,494,296	$ 2,423,259
U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	633,045	582,275	1,930,787	1,887,692
International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		188,772	171,960	563,509	535,567
Goods and Services Transferred at a Point in Time
Disaggregation of Revenue [Line Items]
Total revenues		779,234	717,140	2,365,530	2,306,928
Goods and Services Transferred at a Point in Time | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	610,063	561,849	1,860,828	1,824,138
Goods and Services Transferred at a Point in Time | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		169,171	155,291	504,702	482,790
Goods and Services Transferred Over Time
Disaggregation of Revenue [Line Items]
Total revenues		42,583	37,095	128,766	116,331
Goods and Services Transferred Over Time | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	22,982	20,426	69,959	63,554
Goods and Services Transferred Over Time | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		$ 19,601	$ 16,669	$ 58,807	$ 52,777
[1]	U.S. segment revenues include eliminations of intercompany transactions with the international operating segment.  See Note 16 for additional information on intercompany eliminations.

Changes in Advances and Deferre

Changes in Advances and Deferred Revenues (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2019USD ($)
Change in Contract with Customer Liability [Line Items]
Balance at January 1, 2019	$ 393,424
Amounts recognized as accounts receivable	10,186
Cash received from customers in advance	138,927
Common units received from NCM (see Note 7)	1,552
Revenue recognized during period	(153,600)
Foreign currency translation adjustments	(1,321)
Balance at September 30, 2019	389,168
NCM Screen Advertising Advances
Change in Contract with Customer Liability [Line Items]
Balance at January 1, 2019	287,349
Common units received from NCM (see Note 7)	(1,552)
Revenue recognized during period	(11,916)
Balance at September 30, 2019	276,985
NCM Screen Advertising Advances | NCM
Change in Contract with Customer Liability [Line Items]
Common units received from NCM (see Note 7)	1,552
Other Deferred Revenues
Change in Contract with Customer Liability [Line Items]
Balance at January 1, 2019	106,075	[1]
Amounts recognized as accounts receivable	10,186	[1]
Cash received from customers in advance	138,927	[1]
Revenue recognized during period	(141,684)	[1]
Foreign currency translation adjustments	(1,321)	[1]
Balance at September 30, 2019	$ 112,183	[1]
[1]	Includes liabilities associated with outstanding gift cards and SuperSavers, points or rebates outstanding under the Company’s loyalty and membership programs and revenues not yet recognized for screen advertising, screen rental and other promotional activities. Classified as accounts payable and accrued expenses or other long-term liabilities on the condensed consolidated balance sheet.

Aggregate Amount of Transaction

Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized (Detail) - Deferred Revenue $ in Thousands	Sep. 30, 2019USD ($)
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 112,183
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2019-10-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 102,449
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2020-10-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 9,488
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2021-10-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 200
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-10-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 46
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-10-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-10-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period

Aggregate Amount of Transacti_2

Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized (Detail 1) $ in Thousands	Sep. 30, 2019USD ($)
Deferred Revenue
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 112,183

Long Term Debt Activity - Addit

Long Term Debt Activity - Additional Information (Detail) $ in Thousands	Mar. 29, 2018USD ($)	Sep. 30, 2019USD ($)Agreement	Sep. 30, 2018USD ($)	Dec. 31, 2018USD ($)
Debt Instrument [Line Items]
Incurred debt issue costs			$ 5,103
Carrying value of long-term debt		$ 1,804,364		$ 1,809,311
Fair value of long-term debt		$ 1,825,063		$ 1,774,066
Number of interest rate swap agreements | Agreement		3
Amended Senior Secured Credit Facility
Debt Instrument [Line Items]
Debt instrument, reduction in interest rate	0.25%
Quarterly principal payments due	$ 1,649
Last quarterly payment date	Dec. 31, 2024
Final principal payment	$ 613,351
Incurred debt issue costs			4,962
Wrote-off of unamortized debt issuance costs			780
Debt amendment, legal and other fees			$ 704
Amended Senior Secured Credit Facility | Term Loan Credit facility
Debt Instrument [Line Items]
Final principal payment due date	Mar. 29, 2025

Long Term Debt Activity - Summa

Long Term Debt Activity - Summary of Company's Interest Rate Swap Agreements Designated as Cash Flow Hedges (Detail) - Designated as Hedging Instrument - Cash Flow Hedging $ in Thousands	9 Months Ended
	Sep. 30, 2019USD ($)
Debt Instrument [Line Items]
Estimated Fair Value	$ 18,988	[1]
Interest Rate Swap Agreement 1
Debt Instrument [Line Items]
Notional Amount	$ 137,500
Effective Date	Dec. 31, 2018
Pay Rate	2.75%
Receive Rate	1-Month LIBOR
Expiration Date	Dec. 31, 2022
Estimated Fair Value	$ 5,778	[1]
Interest Rate Swap Agreement 2
Debt Instrument [Line Items]
Notional Amount	$ 175,000
Effective Date	Dec. 31, 2018
Pay Rate	2.75%
Receive Rate	1-Month LIBOR
Expiration Date	Dec. 31, 2022
Estimated Fair Value	$ 7,346	[1]
Interest Rate Swap Agreement 3
Debt Instrument [Line Items]
Notional Amount	$ 137,500
Effective Date	Dec. 31, 2018
Pay Rate	2.77%
Receive Rate	1-Month LIBOR
Expiration Date	Dec. 31, 2022
Estimated Fair Value	$ 5,864	[1]
[1]	Approximately $3,746 of the total is included in accounts payable and accrued expenses and $15,242 is included in other long-term liabilities on the condensed consolidated balance sheet as of September 30, 2019.

Long Term Debt Activity - Sum_2

Long Term Debt Activity - Summary of Company's Interest Rate Swap Agreements Designated as Cash Flow Hedges (Parenthetical) (Detail) - Designated as Hedging Instrument - Cash Flow Hedging $ in Thousands	Sep. 30, 2019USD ($)
Debt Instrument [Line Items]
Estimated Fair Value	$ 18,988	[1]
Accounts Payable and Accrued Expenses
Debt Instrument [Line Items]
Estimated Fair Value	3,746
Other Long-Term Liabilities
Debt Instrument [Line Items]
Estimated Fair Value	$ 15,242
[1]	Approximately $3,746 of the total is included in accounts payable and accrued expenses and $15,242 is included in other long-term liabilities on the condensed consolidated balance sheet as of September 30, 2019.

Summary of Changes in Stockhold

Summary of Changes in Stockholders Equity (Detail) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018
Shareholders Equity [Line Items]
Total Equity, Beginning Balance	$ 1,552,339	$ 1,487,351	$ 1,477,183	$ 1,483,762	$ 1,491,081	$ 1,421,495	$ 1,477,183	$ 1,421,495
Cumulative effect of change in accounting principle, net of taxes			16,985			40,526
Share based awards compensation expense	3,609	3,447	2,743	3,254	3,223	3,199
Dividends paid to parent	(39,650)	(39,600)	(39,575)	(37,200)	(37,200)	(37,150)
Dividends paid to noncontrolling interests	(294)	(294)	(1,000)
Net income	32,398	102,434	33,642	51,036	83,022	62,671	168,474	196,729
Other comprehensive loss in equity method investees	(49)	(22)	(71)	(63)	(116)	136	(142)	(43)
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements	(1,291)	(5,902)	(3,311)	0			(10,504)	0
Foreign currency translation adjustments	(25,408)	4,925	755	(10,797)	(56,248)	204
Total Equity, Ending Balance	1,521,654	1,552,339	1,487,351	1,489,992	1,483,762	1,491,081	1,521,654	1,489,992
Class B common stock
Shareholders Equity [Line Items]
Total Equity, Beginning Balance	49,543	49,543	49,543	49,543	49,543	49,543	49,543	49,543
Total Equity, Ending Balance	49,543	49,543	49,543	49,543	49,543	49,543	49,543	49,543
Treasury Stock
Shareholders Equity [Line Items]
Total Equity, Beginning Balance	(24,233)	(24,233)	(24,233)	(24,233)	(24,233)	(24,233)	(24,233)	(24,233)
Total Equity, Ending Balance	(24,233)	(24,233)	(24,233)	(24,233)	(24,233)	(24,233)	(24,233)	(24,233)
Additional Paid-In-Capital
Shareholders Equity [Line Items]
Total Equity, Beginning Balance	1,284,111	1,280,664	1,277,921	1,270,927	1,267,704	1,264,505	1,277,921	1,264,505
Share based awards compensation expense	3,609	3,447	2,743	3,254	3,223	3,199
Total Equity, Ending Balance	1,287,720	1,284,111	1,280,664	1,274,181	1,270,927	1,267,704	1,287,720	1,274,181
Retained Earnings
Shareholders Equity [Line Items]
Total Equity, Beginning Balance	553,111	491,167	480,580	484,453	438,960	373,069	480,580	373,069
Cumulative effect of change in accounting principle, net of taxes			16,985			40,526
Dividends paid to parent	(39,650)	(39,600)	(39,575)	(37,200)	(37,200)	(37,150)
Net income	31,796	101,544	33,177	50,643	82,693	62,515
Total Equity, Ending Balance	545,257	553,111	491,167	497,896	484,453	438,960	545,257	497,896
Accumulated Other
Shareholders Equity [Line Items]
Total Equity, Beginning Balance	(322,633)	(321,634)	(319,007)	(309,306)	(252,942)	(253,282)	(319,007)	(253,282)
Other comprehensive loss in equity method investees	(49)	(22)	(71)	(63)	(116)	136
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements	(1,291)	(5,902)	(3,311)
Foreign currency translation adjustments	(25,408)	4,925	755	(10,797)	(56,248)	204
Total Equity, Ending Balance	(349,381)	(322,633)	(321,634)	(320,166)	(309,306)	(252,942)	(349,381)	(320,166)
Total Cinemark USA, Inc.'s Stockholder's Equity
Shareholders Equity [Line Items]
Total Equity, Beginning Balance	1,539,899	1,475,507	1,464,804	1,471,384	1,479,032	1,409,602	1,464,804	1,409,602
Cumulative effect of change in accounting principle, net of taxes			16,985			40,526
Share based awards compensation expense	3,609	3,447	2,743	3,254	3,223	3,199
Dividends paid to parent	(39,650)	(39,600)	(39,575)	(37,200)	(37,200)	(37,150)
Net income	31,796	101,544	33,177	50,643	82,693	62,515
Other comprehensive loss in equity method investees	(49)	(22)	(71)	(63)	(116)	136
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements	(1,291)	(5,902)	(3,311)
Foreign currency translation adjustments	(25,408)	4,925	755	(10,797)	(56,248)	204
Total Equity, Ending Balance	1,508,906	1,539,899	1,475,507	1,477,221	1,471,384	1,479,032	1,508,906	1,477,221
Noncontrolling Interests
Shareholders Equity [Line Items]
Total Equity, Beginning Balance	12,440	11,844	12,379	12,378	12,049	11,893	12,379	11,893
Dividends paid to noncontrolling interests	(294)	(294)	(1,000)
Net income	602	890	465	393	329	156
Total Equity, Ending Balance	$ 12,748	$ 12,440	$ 11,844	$ 12,771	$ 12,378	$ 12,049	$ 12,748	$ 12,771

Summary of Changes in Stockho_2

Summary of Changes in Stockholders Equity (Parenthetical) (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Equity [Abstract]
Cumulative effect of change in accounting principle, taxes	$ 6,054	$ 13,079

Summary of Activity with NCM In

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Schedule Of Equity Method Investments [Line Items]
Receipt of common units due to annual common unit adjustment ("CUA")				$ 1,552
Equity in earnings		$ 15,139	$ 14,158	33,982	$ 29,208
NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance				275,592
Beginning Balance				(287,349)
Equity in earnings		9,050	$ 6,830	14,062	$ 11,341
Ending Balance		272,756		272,756
Ending Balance		(276,985)		(276,985)
Investment In NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance				275,592
Receipt of common units due to annual common unit adjustment ("CUA")				1,552
Receipt of excess cash distributions				(16,126)
Receipt of cash under tax receivable agreement				(2,324)
Equity in earnings				14,062
Ending Balance		272,756		272,756
NCM Screen Advertising Advances
Schedule Of Equity Method Investments [Line Items]
Beginning Balance				(287,349)
Receipt of common units due to annual common unit adjustment ("CUA")				(1,552)
Ending Balance		(276,985)		(276,985)
NCM Screen Advertising Advances | NCM
Schedule Of Equity Method Investments [Line Items]
Receipt of common units due to annual common unit adjustment ("CUA")				1,552
Amortization of deferred revenue				11,916
Distributions from NCM
Schedule Of Equity Method Investments [Line Items]
Receipt of excess cash distributions				(8,009)
Receipt of cash under tax receivable agreement				(1,159)
Ending Balance		(9,168)		(9,168)
Equity in Earnings
Schedule Of Equity Method Investments [Line Items]
Ending Balance		(14,062)		(14,062)
Equity in Earnings | NCM
Schedule Of Equity Method Investments [Line Items]
Equity in earnings				(14,062)
Other Revenue
Schedule Of Equity Method Investments [Line Items]
Revenues earned under ESA	[1],[2]			(22,151)
Revenues earned under amendment to ESA	[2],[3]			(1,482)
Total Revenues		(35,549)		(35,549)
Other Revenue | NCM
Schedule Of Equity Method Investments [Line Items]
Amortization of deferred revenue				(11,916)
Interest Expense - NCM
Schedule Of Equity Method Investments [Line Items]
Revenues earned under ESA	[1],[2]			13,392
Revenues earned under amendment to ESA	[2],[3]			788
Ending Balance	[2]	14,180		14,180
Cash Received (Paid)
Schedule Of Equity Method Investments [Line Items]
Revenues earned under ESA	[1],[2]			8,759
Revenues earned under amendment to ESA	[2],[3]			694
Receipt of excess cash distributions				24,135
Receipt of cash under tax receivable agreement				3,483
Ending Balance		$ 37,071		$ 37,071
[1]	Amount includes the per patron and per digital screen theatre access fees due to the Company prior to the first amendment to the Amended and Restated ESA, net of amounts paid to NCM for on-screen advertising time provided to the Company’s beverage concessionaire of approximately $8,808.
[2]	Reflects impact of significant financing component related to amounts received in advance under the ESA and CUA agreements.  See also Notes 3 and 4.
[3]	Reflects screen rental revenues earned after the amendment to the ESA.

Summary of Activity with NCM _2

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Parenthetical) (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2019USD ($)
Equity Method Investments And Joint Ventures [Abstract]
Company's beverage concessionaire advertising costs	$ 8,808

National CineMedia - Additional

National CineMedia - Additional Information (Detail) $ / shares in Units, $ in Thousands	Mar. 29, 2019USD ($)shares	Sep. 30, 2019USD ($)$ / sharesshares	Sep. 30, 2018USD ($)	Sep. 30, 2019USD ($)$ / sharesshares	Sep. 30, 2018USD ($)
Schedule Of Equity Method Investments [Line Items]
Equity in earnings		$ 15,139	$ 14,158	$ 33,982	$ 29,208
Number of additional common units of NCM received under common unit adjustment agreement | shares	219,056
Value of common units received from NCM	$ 1,552			$ 1,552	5,012
Number of common units of NCM owned by Company | shares		39,737,700		39,737,700
Interest in common units of NCM owned by Company		25.00%		25.00%
Investment In NCM
Schedule Of Equity Method Investments [Line Items]
Equity in earnings				$ 14,062
Common unit convertible into share of NCMI common stock, conversion ratio	1
Estimated fair value of investment using NCM's stock price		$ 325,849		$ 325,849
NCMI common stock price | $ / shares		$ 8.20		$ 8.20
NCM
Schedule Of Equity Method Investments [Line Items]
Remaining performance obligations		$ 174,000		$ 174,000
Deferred revenue amortization year and month				2037-02
Equity in earnings		9,050	6,830	$ 14,062	11,341
Deferred revenue or NCM screen advertising advances extended term				2041-02
Recognized incremental screen advertising revenue and offsetting interest expense		$ 4,666	$ 4,983	$ 14,180	$ 14,875
NCM | Minimum
Schedule Of Equity Method Investments [Line Items]
Percentage of incremental borrowing rates				4.40%
NCM | Maximum
Schedule Of Equity Method Investments [Line Items]
Percentage of incremental borrowing rates				8.00%

Summary of Recognition of Reven

Summary of Recognition of Revenue Related to Deferred Revenue (Detail) - NCM Screen Advertising Advances $ in Thousands	Sep. 30, 2019USD ($)
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue remaining performance obligation, amount	$ 276,985
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2019-10-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue remaining performance obligation, amount	$ 15,912
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2020-10-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue remaining performance obligation, amount	$ 15,917
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2021-10-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue remaining performance obligation, amount	$ 15,917
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-10-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue remaining performance obligation, amount	$ 15,917
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-10-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue remaining performance obligation, amount	$ 15,917
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-10-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period
Revenue remaining performance obligation, amount	$ 197,405

Summary of Recognition of Rev_2

Summary of Recognition of Revenue Related to Deferred Revenue (Detail 1) $ in Thousands	Sep. 30, 2019USD ($)
NCM Screen Advertising Advances
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue remaining performance obligation, amount	$ 276,985

Summary Financial Information f

Summary Financial Information for National CineMedia (Detail) - NCM - USD ($) $ in Thousands	3 Months Ended		6 Months Ended	9 Months Ended
	Jun. 27, 2019	Sep. 27, 2018	Jun. 27, 2019	Sep. 27, 2018	Dec. 27, 2018
Schedule Of Equity Method Investments [Line Items]
Gross revenues	$ 110,200	$ 110,100	$ 187,100	$ 304,000
Operating income	37,700	42,300	48,600	93,500
Net income	23,500	$ 28,500	20,600	$ 50,500
Current assets	141,100		141,100		$ 172,700
Noncurrent assets	732,900		732,900		726,800
Current liabilities	88,400		88,400		115,200
Noncurrent liabilities	939,300		939,300		924,900
Members deficit	$ (153,700)		$ (153,700)		$ (140,600)

Summary of Activity for Each of

Summary of Activity for Each of Company's Other Investments (Detail) - USD ($) $ in Thousands		3 Months Ended						9 Months Ended
		Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				$ 156,766				$ 156,766
Cash distributions received								(28,163)	$ (21,041)
Equity in income		$ 15,139			$ 14,158			33,982	29,208
Other comprehensive loss in equity method investments		(49)	$ (22)	(71)	$ (63)	$ (116)	$ 136	(142)	(43)
Investments, ending balance		166,033						166,033
Digital Cinema Implementation Partners
Schedule Of Equity Method Investments [Line Items]
Cash distributions received	[1]	(2,694)						(7,912)	$ (5,201)
Other Affiliates
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				156,766				156,766
Cash distributions received								(9,712)
Equity in income								19,920
Other comprehensive loss in equity method investments								(142)
Other								(799)
Investments, ending balance		166,033						166,033
Other Affiliates | Digital Cinema Implementation Partners
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				125,252				125,252
Cash distributions received								(7,912)
Equity in income								17,024
Other comprehensive loss in equity method investments								(142)
Other								0
Investments, ending balance		134,222						134,222
Other Affiliates | AC JV, LLC
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				5,266				5,266
Cash distributions received								(1,800)
Equity in income								2,185
Other comprehensive loss in equity method investments								0
Other								0
Investments, ending balance		5,651						5,651
Other Affiliates | Digital Cinema Distribution Coalition
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				2,255				2,255
Cash distributions received								0
Equity in income								777
Other comprehensive loss in equity method investments								0
Other								0
Investments, ending balance		3,032						3,032
Other Affiliates | FE Concepts, LLC
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				19,918				19,918
Cash distributions received								0
Equity in income								(66)
Other comprehensive loss in equity method investments								0
Other								0
Investments, ending balance		19,852						19,852
Other Affiliates | Other Investments
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				$ 4,075				4,075
Cash distributions received								0
Equity in income								0
Other comprehensive loss in equity method investments								0
Other								(799)
Investments, ending balance		$ 3,276						$ 3,276
[1]	See discussion of cash distributions from DCIP, which were recorded as a reduction of the Company’s investment in DCIP, at Note 8.

Other Investments - Additional

Other Investments - Additional Information (Detail) $ in Thousands	Apr. 30, 2018USD ($)	Sep. 30, 2019USD ($)StudioProjectionSystem	Sep. 30, 2018USD ($)
Maximum
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest		50.00%
Minimum
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest		20.00%
Digital Cinema Implementation Partners
Schedule Of Equity Method Investments [Line Items]
Number of major motion picture studio, long-term digital cinema deployment agreements | Studio		6
Description of digital cinema deployment agreements		The DCDAs end on the earlier to occur of (i) the tenth anniversary of the "mean deployment date" for all digital projection systems scheduled to be deployed over a period of up to five years, or (ii) the date DCIP achieves "cost recoupment", each as defined in the DCDAs.
Percentage of voting interest		33.00%
Economic interest in Digital Cinema Implementation Partners		24.30%
Number of equipment being leased under master equipment lease agreement | ProjectionSystem		3,866
Digital Cinema Implementation Partners | Maximum
Schedule Of Equity Method Investments [Line Items]
Deployment period of digital cinema deployment agreements		5 years
AC JV, LLC | Film rentals and advertising
Schedule Of Equity Method Investments [Line Items]
Event fees		$ 10,332	$ 8,516
NCM
Schedule Of Equity Method Investments [Line Items]
Remaining outstanding balance of note payable		$ 1,389
Cash contributions			78,393
Digital Cinema Distribution Coalition
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest		14.60%
Payments for content delivery services		$ 703	$ 657
CNMK Texas Properties, LLC
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest	50.00%
Cash contributions	$ 20,000
CNMK Texas Properties, LLC | AWSR Investments, LLC
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest	50.00%
Cash contributions	$ 20,000

Summary Financial Information_2

Summary Financial Information for DCIP (Detail) - Other Affiliates - Digital Cinema Implementation Partners - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Schedule Of Equity Method Investments [Line Items]
Gross revenues	$ 40,200	$ 43,403	$ 125,869	$ 126,957
Operating income	22,617	25,816	73,396	74,310
Net income	22,362	$ 24,311	69,323	$ 68,014
Current assets	64,019		64,019		$ 57,907
Noncurrent assets	603,209		603,209		684,545
Current liabilities	66,942		66,942		67,408
Noncurrent liabilities	11,985		11,985		125,596
Members' equity	$ 588,301		$ 588,301		$ 549,448

Transactions with DCIP (Detail)

Transactions with DCIP (Detail) - Digital Cinema Implementation Partners - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Schedule Of Equity Method Investments [Line Items]
Equipment lease payments	$ 1,105	$ 1,229	$ 3,357	$ 3,689
Warranty reimbursements from DCIP	(2,953)	(2,791)	(8,842)	(7,909)
Management service fees	$ 128	$ 180	$ 438	$ 558

Share Based Awards - Additional

Share Based Awards - Additional Information (Detail) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2019USD ($)shares$ / shares
Restricted Stock
Stockholders Equity Note [Line Items]
Number of restricted shares | shares	308,250
Market value of common stock on the dates of grant | $ / shares	$ 37.42
Restricted Stock | Minimum
Stockholders Equity Note [Line Items]
Forfeiture rate for restricted stock awards	0.00%
Award vesting period for restricted stock	1 year
Restricted Stock | Maximum
Stockholders Equity Note [Line Items]
Forfeiture rate for restricted stock awards	10.00%
Award vesting period for restricted stock	4 years
Restricted Stock | Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Number of restricted shares | shares	308,250
Restricted Stock | Cinemark Holdings, Inc. | Minimum
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant | $ / shares	$ 36.70
Restricted Stock | Cinemark Holdings, Inc. | Maximum
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant | $ / shares	$ 41.61
Unvested Restricted Stock Awards
Stockholders Equity Note [Line Items]
Unrecognized compensation expense | $	$ 17,998
Remaining Compensation Expense recognition period (in years)	2 years
Unvested Restricted Stock Awards | Cinemark USA, Inc.
Stockholders Equity Note [Line Items]
Unrecognized compensation expense | $	$ 17,350
Unvested Restricted Stock Awards | Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Unrecognized compensation expense | $	$ 648
Restricted Stock Units (RSUs)
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant | $ / shares	$ 36.77
Unrecognized compensation expense | $	$ 11,128
Remaining Compensation Expense recognition period (in years)	2 years
Share-based compensation arrangement by share-based payment award, description	The financial performance factors are based on an implied equity value concept that determines an internal rate of return (“IRR”) during the two fiscal year periods ending December 31, 2020 based on a formula utilizing a multiple of Adjusted EBITDA subject to certain adjustments as specified by the Compensation Committee prior to the grant date
Internal rate of return, performance period	2 years
Percentage of IRR, which is the threshold	6.00%
Percentage of IRR, which is the target	8.00%
Percentage of IRR, which is the maximum	14.00%
Percentage of IRR expected	11.00%
Share-based compensation arrangement by share-based payment award, vesting condition	All restricted stock units granted during 2019 will vest subject to an additional two-year service requirement and will be paid in the form of common stock of Cinemark Holdings, Inc. if the participant continues to provide services through the fourth anniversary of the grant date
Expected forfeiture rate	5.00%
Achieved Percentage of IRR	9.30%
Number of hypothetical shares of common stock at maximum IRR level | shares	554,529
Percentage of IRR, which is the threshold, before modification	7.00%
Percentage of IRR, which is the target before modification	9.50%
Percentage of IRR, which is the maximum before modification	13.00%
Restricted Stock Units (RSUs) | Stock Grants 2016
Stockholders Equity Note [Line Items]
Achieved Percentage of IRR	7.20%
Restricted Stock Units (RSUs) | Stock Grants 2017 and 2018
Stockholders Equity Note [Line Items]
Impact of modification of awards | $	$ 132
Restricted Stock Units (RSUs) | Stock Grants 2017
Stockholders Equity Note [Line Items]
Impact of final performance measure | $	$ 563
Restricted Stock Units (RSUs) | Maximum | Threshold IRR
Stockholders Equity Note [Line Items]
Vesting percentage of restricted stock units | shares	102,217
Restricted Stock Units (RSUs) | Maximum | Targeted IRR
Stockholders Equity Note [Line Items]
Vesting percentage of restricted stock units | shares	204,434
Restricted Stock Units (RSUs) | Maximum | Maximum IRR
Stockholders Equity Note [Line Items]
Vesting percentage of restricted stock units	100.00%
Restricted Stock Units (RSUs) | Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Number of hypothetical shares of common stock | shares	306,651

Summary of Restricted Stock Act

Summary of Restricted Stock Activity (Detail) - Restricted Stock	9 Months Ended
	Sep. 30, 2019$ / sharesshares
Shares of Restricted Stock
Shares of Restricted Stock, Beginning balance | shares	704,353
Shares of Restricted Stock, Granted | shares	308,250
Shares of Restricted Stock, Vested | shares	(198,711)
Shares of Restricted Stock, Forfeited | shares	(19,351)
Shares of Restricted Stock, Ending balance | shares	794,541
Shares of Restricted Stock, Unvested restricted stock | shares	794,541
Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value Outstanding, Beginning | $ / shares	$ 38.68
Weighted Average Grant Date Fair Value, Granted | $ / shares	37.42
Weighted Average Grant Date Fair Value, Vested | $ / shares	41.38
Weighted Average Grant Date Fair Value, Forfeited | $ / shares	37.41
Weighted Average Grant Date Fair Value Outstanding, Ending | $ / shares	37.55
Weighted Average Grant Date Fair Value, Unvested restricted stock | $ / shares	$ 37.55

Summary of Restricted Stock Awa

Summary of Restricted Stock Award Activity (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized by the Company during the period	$ 6,769	$ 4,342
Number of restricted stock unit awards that vested during the period	198,711
Restricted Stock | Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of share based awards that vested during the period	$ 6,650	7,013
Income tax benefit recognized upon vesting of restricted stock awards	1,228	1,550
Restricted Stock | Cinemark Holdings, Inc.
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized by the Company during the period	687	2,924
Restricted Stock | Cinemark Holdings, Inc. | Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of share based awards that vested during the period	980	802
Income tax benefit recognized upon vesting of restricted stock awards	245	201
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized by the Company during the period	3,030	3,098
Fair value of share based awards that vested during the period	3,550	4,846
Income tax benefit recognized upon vesting of restricted stock awards	$ 175	$ 740
Number of restricted stock unit awards that vested during the period	88,074	127,084
Accumulated dividends paid upon vesting of restricted stock unit awards	$ 375	$ 526

Summary of Potential Number of

Summary of Potential Number of Shares Vesting under Restricted Stock Unit Awards (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2019USD ($)shares
Disclosure Of Restricted Stock Unit [Abstract]
Number of shares vesting at IRR of at least 6% | shares	136,285
Number of shares vesting at IRR of at least 8% | shares	204,427
Number of shares vesting at IRR of at least 14% | shares	306,651
Value at grant at IRR of at least 6% | $	$ 5,011
Value at grant at IRR of at least 8% | $	7,517
Value at grant at IRR of at least 14% | $	$ 11,276

Summary of Goodwill (Detail)

Summary of Goodwill (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2019USD ($)
Goodwill [Line Items]
Beginning Balance	$ 1,276,324	[1]
Theatres acquired in the US and Brazil	9,681	[2]
Foreign currency translation adjustments	(4,651)
Ending Balance	1,281,354	[1]
U.S. Operating Segment
Goodwill [Line Items]
Beginning Balance	1,174,041	[1]
Theatres acquired in the US and Brazil	8,812	[2]
Ending Balance	1,182,853	[1]
International Operating Segment
Goodwill [Line Items]
Beginning Balance	102,283	[1]
Theatres acquired in the US and Brazil	869	[2]
Foreign currency translation adjustments	(4,651)
Ending Balance	$ 98,501	[1]
[1]	Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.
[2]	Amount represents final purchase price allocation for two theatres acquired in the U.S. during 2019 and the final purchase price allocation adjustment for theatres acquired in Brazil during 2018.

Summary of Goodwill (Parentheti

Summary of Goodwill (Parenthetical) (Detail) $ in Thousands	Sep. 30, 2019USD ($)Theatre
U.S. Operating Segment
Goodwill [Line Items]
Accumulated impairment losses	$ 214,031
Number of theatres acquired | Theatre	2
International Operating Segment
Goodwill [Line Items]
Accumulated impairment losses	$ 27,622

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2019CommunityCountry
U.S. Operating Segment
Goodwill [Line Items]
Number of reporting unit | Community	19
International Operating Segment
Goodwill [Line Items]
Number of reporting unit | Country	7

Intangible Assets (Detail)

Intangible Assets (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2019USD ($)
Intangible Assets [Line Items]
Intangible assets with finite lives, Beginning balance	$ 105,256
Other, Gross carrying amount	(2,501)	[1]
Intangible assets with finite lives, Ending balance	84,731
Intangible assets with finite lives, Accumulated amortization, Beginning balance	(74,603)
Accumulated amortization	(3,730)
Other Accumulated Amortization of Intangible Assets	2,130	[1]
Intangible assets with finite lives, Accumulated amortization, Ending balance	(62,606)
Net intangible assets with finite lives, Beginning balance	30,653
Amortization, intangible assets	(3,730)
Other, Finite lived intangible assets	(371)	[1]
Net intangible assets with finite lives, Ending balance	22,125
Indefinite-lived Intangible Assets, Tradename and Other, Beginning Balance	300,257
Other, Tradename and Other	289	[1]
Indefinite-lived Intangible Assets, Tradename and Other, Ending Balance	300,546
Total intangible assets - net, Beginning balance	330,910
Other, Total intangible assets - net	(82)	[1]
Total intangible assets - net, Ending balance	322,671
ASC Topic 842
Intangible Assets [Line Items]
Impact of Adoption, Gross carrying amount	(18,024)	[2]
Impact of Adoption, Accumulated amortization	13,597	[2]
Impact of Adoption, Finite lived intangible assets	(4,427)	[2]
Impact of Adoption, Trade and other	0	[2]
Impact of Adoption, Total intangible assets - net	$ (4,427)	[2]
[1]	Amount represents the write-off of fully amortized intangible assets related to non-compete agreements, the acquisition of tradeable liquor licenses, fair values allocated to intangible assets acquired as part of acquisitions of two theatres in the U.S. and foreign currency translation adjustments.
[2]	See Note 3 for further discussion of the impact of adoption of ASC Topic 842.

Estimated Aggregate Future Amor

Estimated Aggregate Future Amortization Expense for Intangible Assets (Detail) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Finite Lived Intangible Assets Net [Abstract]
For the three months ended December 31, 2019	$ 1,254
For the twelve months ended December 31, 2020	4,986
For the twelve months ended December 31, 2021	3,150
For the twelve months ended December 31, 2022	3,116
For the twelve months ended December 31, 2023	3,083
Thereafter	6,536
Total	$ 22,125	$ 30,653

Impairment of Long-Lived Asse_3

Impairment of Long-Lived Assets - Additional Information (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2019USD ($)	Sep. 30, 2018
Impairment Or Disposal Of Tangible Assets Disclosure [Abstract]
Estimated aggregate fair value of long-lived assets impaired during current period	$ 27,383
Multiple of cash flows used to estimate fair value of long-lived asset	6.5	6.5

Long-Lived Asset Impairment Cha

Long-Lived Asset Impairment Charges (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Impaired Long-Lived Assets Held and Used [Line Items]
Impairment of long-lived assets	$ 27,304	$ 1,641	$ 45,382	$ 5,020
U.S. Operating Segment
Impaired Long-Lived Assets Held and Used [Line Items]
Theatre properties and equipment	24,502	1,553	26,754	3,331
Operating lease right-of-use assets	2,157		10,204
International Operating Segment
Impaired Long-Lived Assets Held and Used [Line Items]
Theatre properties and equipment	$ 645	$ 88	6,796	$ 1,689
Operating lease right-of-use assets			$ 1,628

Summary of Liabilities Measured

Summary of Liabilities Measured at Fair Value on a Recurring Basis (Detail) - Fair Value Measurements, Recurring - USD ($) $ in Thousands		Sep. 30, 2019	Dec. 31, 2018
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Interest rate swap liabilities	[1]	$ (18,988)	$ (5,093)
Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Interest rate swap liabilities	[1]	$ (18,988)	$ (5,093)
[1]	See further discussion of interest rate swaps at Note 5.

Reconciliation of Beginning and

Reconciliation of Beginning and Ending Balance for Liabilities Measured at Fair Value on Recurring Basis Unobservable Inputs (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2019USD ($)	[1]
Fair Value Disclosures [Abstract]
Beginning balances - Liabilities	$ 5,093
Total loss included in accumulated other comprehensive loss	15,036
Settlements included in interest expense	(1,141)
Ending balances - Liabilities	$ 18,988
[1]	Represents interest rate swap liabilities.  See further discussion of interest rate swaps at Note 5.

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2019USD ($)
Fair Value Disclosures [Abstract]
Fair value of assets transfers in or out, level 1 to level 2	$ 0
Fair value of assets transfers in or out, level 2 to level 1	0
Fair value, asset transfers into Level 3	0
Fair value, asset transfers out of Level 3	$ 0

Foreign Currency Translation -

Foreign Currency Translation - Additional Information (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Foreign Currency [Abstract]
Accumulated other comprehensive income (loss)	$ 349,381	$ 319,007
Cumulative foreign currency adjustments	$ 335,028	$ 315,300
Cumulative inflation rate	100.00%
Cumulative inflation period	3 years

Summary of Impact of Translatin

Summary of Impact of Translating Financial Statements of Company's International Subsidiaries (Detail) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)	Dec. 31, 2018
Foreign Currency Translation [Line Items]
Other comprehensive Loss		$ (25,408)	$ (10,797)	$ (19,728)	$ (66,841)
Brazil
Foreign Currency Translation [Line Items]
Exchange Rate		4.16		4.16		3.88
Other comprehensive Loss				$ (14,492)	(42,588)
Argentina
Foreign Currency Translation [Line Items]
Exchange Rate	[1]	57.41		57.41		37.68
Other comprehensive Loss	[1]				(18,272)
Chile
Foreign Currency Translation [Line Items]
Exchange Rate		727.65		727.65		694.74
Other comprehensive Loss				$ (4,017)	(4,822)
Colombia
Foreign Currency Translation [Line Items]
Exchange Rate		3,462		3,462		3,249.75
Other comprehensive Loss				$ (1,507)	70
Peru
Foreign Currency Translation [Line Items]
Exchange Rate		3.40		3.40		3.39
Other comprehensive Loss				$ (203)	(891)
Other foreign countries
Foreign Currency Translation [Line Items]
Other comprehensive Loss				491	(338)
International Subsidiaries | Cinemark USA, Inc. Stockholder's Equity
Foreign Currency Translation [Line Items]
Other comprehensive Loss				$ (19,728)	$ (66,841)
[1]	Beginning July 1, 2018, Argentina was deemed highly inflationary.  The impact of translating Argentina financial results to U.S. dollars, which was not significant, has been recorded in foreign currency exchange loss on the Company’s condensed consolidated statement of income.

Supplemental Information to Con

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail) - USD ($) $ in Thousands		Mar. 29, 2019	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Schedule Of Cash Flow Supplemental [Line Items]
Cash paid for interest					$ 56,326	$ 62,773
Cash paid for income taxes, net of refunds received					69,498	42,631
Noncash investing and financing activities:
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment	[1]				(13,642)	7,050
Theatre properties acquired under capital lease						4,035
Investment in NCM – receipt of common units (see Note 7)		$ 1,552			1,552	5,012
NCM
Noncash investing and financing activities:
Interest expense - NCM (see Note 7)			$ (4,666)	$ (4,983)	$ (14,180)	$ (14,875)
[1]	Additions to theatre properties and equipment included in accounts payable as of September 30, 2019 and December 31, 2018 were $23,362 and $37,004, respectively.

Supplemental Information to C_2

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Parenthetical) (Detail) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Supplemental Cash Flow Elements [Abstract]
Additions to theatre properties and equipment included in accounts payable	$ 23,362	$ 37,004

Selected Financial Information

Selected Financial Information by Reportable Operating Segment (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Segment Reporting Information [Line Items]
Revenues		$ 821,817	$ 754,235	$ 2,494,296	$ 2,423,259
Adjusted EBITDA	[1]	170,116	168,714	568,011	584,682
Capital expenditures		71,343	83,373	186,512	245,962
U.S. Operating Segment
Segment Reporting Information [Line Items]
Revenues	[2]	633,045	582,275	1,930,787	1,887,692
International Operating Segment
Segment Reporting Information [Line Items]
Revenues		188,772	171,960	563,509	535,567
Operating Segments | U.S. Operating Segment
Segment Reporting Information [Line Items]
Revenues		636,628	585,536	1,941,545	1,897,664
Adjusted EBITDA		132,705	132,974	454,665	478,164
Capital expenditures		50,679	65,458	148,609	195,104
Operating Segments | International Operating Segment
Segment Reporting Information [Line Items]
Revenues		188,772	171,960	563,509	535,567
Adjusted EBITDA		37,411	35,740	113,346	106,518
Capital expenditures		20,664	17,915	37,903	50,858
Eliminations
Segment Reporting Information [Line Items]
Revenues		$ (3,583)	$ (3,261)	$ (10,758)	$ (9,972)
[1]	Amounts for the three and nine months ended September 30, 2019 were impacted by the adoption of ASC Topic 842 and the resulting change in the classification of certain of the Company’s leases
[2]	U.S. segment revenues include eliminations of intercompany transactions with the international operating segment.  See Note 16 for additional information on intercompany eliminations.

Reconciliation of Net Income to

Reconciliation of Net Income to Adjusted EBITDA (Detail) - USD ($) $ in Thousands		3 Months Ended						9 Months Ended
		Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018
Segment Reporting Information [Line Items]
Net income		$ 32,398	$ 102,434	$ 33,642	$ 51,036	$ 83,022	$ 62,671	$ 168,474	$ 196,729
Add (deduct):
Income taxes		14,193			16,301			64,615	60,056
Interest expense	[1],[2]	24,967			27,144			75,037	82,725
Other income, net	[3]	(9,964)			(8,803)			(25,059)	(15,233)
Loss on debt amendments and refinancing									1,484
Other cash distributions from equity investees								28,163	21,041
Depreciation and amortization	[1]	67,760			64,971			196,795	193,656
Impairment of long-lived assets		27,304			1,641			45,382	5,020
Loss on disposal of assets and other		2,453			7,826			8,057	28,666
Non-cash rent expense	[4]	(1,102)						(3,252)
Deferred lease expenses	[1]				(20)				(952)
Amortization of long-term prepaid rents	[1]				578				1,814
Share based awards compensation expense		3,609			3,254			9,799	9,676
Adjusted EBITDA	[1]	170,116			168,714			568,011	584,682
Digital Cinema Implementation Partners
Add (deduct):
Other cash distributions from equity investees	[5]	2,694						7,912	5,201
Other Investees
Add (deduct):
Other cash distributions from equity investees	[6]	$ 5,804			$ 4,786			$ 20,251	$ 15,840
[1]	Amounts for the three and nine months ended September 30, 2019 were impacted by the adoption of ASC Topic 842 and the resulting change in the classification of certain of the Company’s leases
[2]	Includes amortization of debt issue costs.
[3]	Includes interest income, foreign currency exchange loss, equity in income of affiliates and interest expense - NCM and excludes distributions from NCM.
[4]	The adoption of ASC Topic 842 impacted how the Company amortizes lease related assets and liabilities such as deferred lease expenses, favorable and unfavorable lease intangible assets, long-term prepaid rents and deferred lease incentives.  Beginning January 1, 2019, these items are amortized to facility lease expense for theatre operating leases and utilities and other for equipment operating leases.  See Note 3 for discussion of the impact of ASC Topic 842
[5]	See discussion of cash distributions from DCIP, which were recorded as a reduction of the Company’s investment in DCIP, at Note 8.
[6]	Includes cash distributions received from equity investees, other than those from DCIP noted above, that were recorded as a reduction of the respective investment balances (see Notes 7 and 8).  These distributions are reported entirely within the U.S. operating segment.

Selected Financial Informatio_2

Selected Financial Information by Geographic Area (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues		$ 821,817	$ 754,235	$ 2,494,296	$ 2,423,259
Theatre Properties and Equipment - net	[1]	1,682,401		1,682,401		$ 1,833,133
Reportable Geographical Components | U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues		636,628	585,536	1,941,545	1,897,664
Theatre Properties and Equipment - net	[1]	1,408,052		1,408,052		1,479,603
Reportable Geographical Components | Brazil
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues		79,776	65,152	240,263	218,265
Theatre Properties and Equipment - net	[1]	111,297		111,297		140,570
Reportable Geographical Components | Other international countries
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues		108,996	106,808	323,246	317,302
Theatre Properties and Equipment - net	[1]	163,052		163,052		$ 212,960
Eliminations
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues		$ (3,583)	$ (3,261)	$ (10,758)	$ (9,972)
[1]	See Note 3 for discussion of impact of ASC Topic 842 on capital lease assets.

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2019USD ($)TheatreFacilityLease	Sep. 30, 2018USD ($)	Dec. 31, 2018USD ($)
Related Party Transaction [Line Items]
Net receivable from Cinemark Holdings, Inc.	$ 23,812,000		$ 19,530,000
Cash dividends paid to Cinemark Holdings, Inc.	$ 118,825,000	$ 111,550,000
FE Concepts LLC
Related Party Transaction [Line Items]
Equity method investment, ownership percentage	50.00%
Laredo Theatre, Ltd
Related Party Transaction [Line Items]
Company's interest in Laredo	75.00%
Lone Star Theatre's interest in Laredo	25.00%
Ownership interest held by David Roberts	100.00%
Percentage of common stock held by Chairman of the Board of Directors	8.00%
Percentage of management fees based on theatre revenues	5.00%
Maximum amount of theater revenue used to calculate management fees	$ 50,000,000
Percentage of management fees based on theatre revenues in excess	3.00%
Minimum amount of theater revenue used to calculate management fees	$ 50,000,000
Management fee revenues	539,000	488,000
Copper Beech Capital LLC
Related Party Transaction [Line Items]
Amount paid for the use of aircraft	$ 111,000	51,000
Syufy Enterprises, LP
Related Party Transaction [Line Items]
Number of theatres leased | Theatre	14
Number of parking facilities leased | Facility	1
Total number of leases | Lease	15
Number of leases with minimum annual rent | Lease	14
Number of leases without minimum annual rent | Lease	1
Total rent paid to Syufy	$ 20,006,000	19,465,000
Related party transaction expense	36,000
Cinemark Holdings, Inc.
Related Party Transaction [Line Items]
Net receivable from Cinemark Holdings, Inc.	23,812,000		$ 19,530,000
Cash dividends paid to Cinemark Holdings, Inc.	$ 118,825,000	$ 111,550,000

Condensed Consolidating Finan_3

Condensed Consolidating Financial Information of Subsidiary Guarantors - Additional Information (Detail) $ in Thousands	Sep. 30, 2019USD ($)
5.125% Senior Notes Due 2022
Condensed Consolidating Financial Information [Line Items]
Outstanding aggregate principal amount of Senior Notes	$ 400,000
Interest rate	5.125%
4.875% Senior Notes Due 2023
Condensed Consolidating Financial Information [Line Items]
Outstanding aggregate principal amount of Senior Notes	$ 755,000
Interest rate	4.875%

Condensed Consolidating Balance

Condensed Consolidating Balance Sheet Information (Detail) - USD ($) $ in Thousands		Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017
Current assets
Cash and cash equivalents		$ 482,688			$ 426,216
Other current assets		111,991			132,797
Accounts receivable from parent or subsidiaries		23,812			19,530
Total current assets		618,491			578,543
Theatre properties and equipment - net	[1]	1,682,401			1,833,133
Operating lease right-of-use assets	[2]	1,384,019
Investment in subsidiaries		0			0
Other assets		2,090,415			2,089,675
Total assets		5,775,326			4,501,351
Current liabilities
Current portion of long-term debt		7,984			7,984
Current portion of capital lease obligations					27,065
Current portion of operating lease obligations	[2]	215,015
Current portion of finance lease obligations	[2]	15,501
Accounts payable and accrued expenses		400,689			439,004
Accounts payable to parent or subsidiaries		0			0
Total current liabilities		639,189			474,053
Long-term liabilities
Long-term debt, less current portion		1,771,663			1,772,627
Capital lease obligations, less current portion					232,467
Operating lease obligations, less current portion	[2]	1,230,152
Finance lease obligations, less current portion	[2]	126,344
Other long-term liabilities and deferrals		486,324			545,021
Total long-term liabilities		3,614,483			2,550,115
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543			49,543
Other stockholder's equity		1,459,363			1,415,261
Total Cinemark USA, Inc.'s stockholder's equity		1,508,906			1,464,804
Noncontrolling interests		12,748			12,379
Total equity		1,521,654	$ 1,552,339	$ 1,487,351	1,477,183	$ 1,489,992	$ 1,483,762	$ 1,491,081	$ 1,421,495
Total liabilities and equity		5,775,326			4,501,351
Eliminations
Current assets
Cash and cash equivalents		0			0
Other current assets		(67,315)			(15,178)
Accounts receivable from parent or subsidiaries		(369,995)			(265,363)
Total current assets		(437,310)			(280,541)
Theatre properties and equipment - net		0			0
Operating lease right-of-use assets		0
Investment in subsidiaries		(1,948,583)			(1,864,100)
Other assets		(110,685)			(112,536)
Total assets		(2,496,578)			(2,257,177)
Current liabilities
Current portion of long-term debt		0			0
Current portion of capital lease obligations					0
Current portion of operating lease obligations		0
Current portion of finance lease obligations		0
Accounts payable and accrued expenses		(65,760)			(13,622)
Accounts payable to parent or subsidiaries		(369,995)			(265,363)
Total current liabilities		(435,755)			(278,985)
Long-term liabilities
Long-term debt, less current portion		(104,455)			(107,955)
Capital lease obligations, less current portion					0
Operating lease obligations, less current portion		0
Finance lease obligations, less current portion		0
Other long-term liabilities and deferrals		(7,785)			(6,137)
Total long-term liabilities		(112,240)			(114,092)
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock		(467,606)			(467,606)
Other stockholder's equity		(1,480,977)			(1,396,494)
Total Cinemark USA, Inc.'s stockholder's equity		(1,948,583)			(1,864,100)
Noncontrolling interests		0			0
Total equity		(1,948,583)			(1,864,100)
Total liabilities and equity		(2,496,578)			(2,257,177)
Cinemark USA, Inc.
Current assets
Cash and cash equivalents		174,862			197,965
Other current assets		91,856			60,829
Accounts receivable from parent or subsidiaries		0			0
Total current assets		266,718			258,794
Theatre properties and equipment - net		634,359			664,759
Operating lease right-of-use assets		704,578
Investment in subsidiaries		1,928,328			1,806,255
Other assets		1,494,644			1,500,366
Total assets		5,028,627			4,230,174
Current liabilities
Current portion of long-term debt		6,595			6,595
Current portion of capital lease obligations					11,918
Current portion of operating lease obligations		99,173
Current portion of finance lease obligations		11,227
Accounts payable and accrued expenses		329,163			297,302
Accounts payable to parent or subsidiaries		116,745			40,421
Total current liabilities		562,903			356,236
Long-term liabilities
Long-term debt, less current portion		1,871,663			1,872,627
Capital lease obligations, less current portion					123,329
Operating lease obligations, less current portion		635,326
Finance lease obligations, less current portion		75,841
Other long-term liabilities and deferrals		373,988			413,177
Total long-term liabilities		2,956,818			2,409,133
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543			49,543
Other stockholder's equity		1,459,363			1,415,262
Total Cinemark USA, Inc.'s stockholder's equity		1,508,906			1,464,805
Noncontrolling interests		0			0
Total equity		1,508,906			1,464,805
Total liabilities and equity		5,028,627			4,230,174
Subsidiary Guarantors
Current assets
Cash and cash equivalents		7,429			10,886
Other current assets		20,556			19,997
Accounts receivable from parent or subsidiaries		393,807			284,893
Total current assets		421,792			315,776
Theatre properties and equipment - net		749,560			789,536
Operating lease right-of-use assets		486,473
Investment in subsidiaries		20,255			57,845
Other assets		157,449			155,011
Total assets		1,835,529			1,318,168
Current liabilities
Current portion of long-term debt		0			0
Current portion of capital lease obligations					9,406
Current portion of operating lease obligations		86,302
Current portion of finance lease obligations		4,206
Accounts payable and accrued expenses		45,120			58,544
Accounts payable to parent or subsidiaries		0			0
Total current liabilities		135,628			67,950
Long-term liabilities
Long-term debt, less current portion		0			0
Capital lease obligations, less current portion					59,539
Operating lease obligations, less current portion		434,533
Finance lease obligations, less current portion		50,115
Other long-term liabilities and deferrals		43,064			60,137
Total long-term liabilities		527,712			119,676
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock		457,368			457,368
Other stockholder's equity		714,821			673,174
Total Cinemark USA, Inc.'s stockholder's equity		1,172,189			1,130,542
Noncontrolling interests		0			0
Total equity		1,172,189			1,130,542
Total liabilities and equity		1,835,529			1,318,168
Subsidiary Non-Guarantors
Current assets
Cash and cash equivalents		300,397			217,365
Other current assets		66,894			67,149
Accounts receivable from parent or subsidiaries		0			0
Total current assets		367,291			284,514
Theatre properties and equipment - net		298,482			378,838
Operating lease right-of-use assets		192,968
Investment in subsidiaries		0			0
Other assets		549,007			546,834
Total assets		1,407,748			1,210,186
Current liabilities
Current portion of long-term debt		1,389			1,389
Current portion of capital lease obligations					5,741
Current portion of operating lease obligations		29,540
Current portion of finance lease obligations		68
Accounts payable and accrued expenses		92,166			96,780
Accounts payable to parent or subsidiaries		253,250			224,942
Total current liabilities		376,413			328,852
Long-term liabilities
Long-term debt, less current portion		4,455			7,955
Capital lease obligations, less current portion					49,599
Operating lease obligations, less current portion		160,293
Finance lease obligations, less current portion		388
Other long-term liabilities and deferrals		77,057			77,844
Total long-term liabilities		242,193			135,398
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock		10,238			10,238
Other stockholder's equity		766,156			723,319
Total Cinemark USA, Inc.'s stockholder's equity		776,394			733,557
Noncontrolling interests		12,748			12,379
Total equity		789,142			745,936
Total liabilities and equity		$ 1,407,748			$ 1,210,186
[1]	See Note 3 for discussion of impact of ASC Topic 842 on capital lease assets.
[2]	The operating lease right-of-use assets and liabilities recorded on the Company’s condensed consolidated balance sheet generally do not include renewal options that have not yet been exercised.  The Company does not consider a lease renewal as reasonably certain until immediately before the necessary notification is provided to the landlord.

Condensed Consolidating Stateme

Condensed Consolidating Statement of Income Information (Detail) - USD ($) $ in Thousands		3 Months Ended						9 Months Ended
		Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018
Condensed Financial Statements, Captions [Line Items]
Revenues		$ 821,817			$ 754,235			$ 2,494,296	$ 2,423,259
Cost of operations
Theatre operating expenses		621,067			558,760			1,845,109	1,760,555
General and administrative expenses		44,113			37,745			125,054	121,769
Depreciation and amortization	[1]	67,760			64,971			196,795	193,656
Impairment of long-lived assets		27,304			1,641			45,382	5,020
Loss on disposal of assets and other		2,453			7,826			8,057	28,666
Total cost of operations		762,697			670,943			2,220,397	2,109,666
Operating income		59,120			83,292			273,899	313,593
Other income (expense)
Interest expense	[1],[2]	(24,967)			(27,144)			(75,037)	(82,725)
Loss on debt amendments									(1,484)
Equity in income of affiliates		15,139			14,158			33,982	29,208
Other income (expense)		(509)			(372)			5,257	900
Total other expense		(12,529)			(15,955)			(40,810)	(56,808)
Income before income taxes		46,591			67,337			233,089	256,785
Income taxes		14,193			16,301			64,615	60,056
Net income		32,398	$ 102,434	$ 33,642	51,036	$ 83,022	$ 62,671	168,474	196,729
Less: Net income attributable to noncontrolling interests		602			393			1,957	878
Net income attributable to Cinemark USA, Inc.		31,796			50,643			166,517	195,851
Eliminations
Condensed Financial Statements, Captions [Line Items]
Revenues		(15,645)			(6,420)			(42,879)	(41,046)
Cost of operations
Theatre operating expenses		(15,645)			(6,420)			(42,879)	(41,046)
General and administrative expenses		0			0			0	0
Depreciation and amortization		0			0			0	0
Impairment of long-lived assets		0			0			0	0
Loss on disposal of assets and other		0			0			0	0
Total cost of operations		(15,645)			(6,420)			(42,879)	(41,046)
Operating income		0			0			0	0
Other income (expense)
Interest expense		318			342			1,001	1,035
Loss on debt amendments									0
Equity in income of affiliates		(29,124)			(50,952)			(126,098)	(185,692)
Other income (expense)		(3,324)			(342)			(1,001)	(1,035)
Total other expense		(32,130)			(50,952)			(126,098)	(185,692)
Income before income taxes		(32,130)			(50,952)			(126,098)	(185,692)
Income taxes		0			0			0	0
Net income		(32,130)			(50,952)			(126,098)	(185,692)
Less: Net income attributable to noncontrolling interests		0			0			0	0
Net income attributable to Cinemark USA, Inc.		(32,130)			(50,952)			(126,098)	(185,692)
Cinemark USA, Inc.
Condensed Financial Statements, Captions [Line Items]
Revenues		295,148			264,247			905,445	879,552
Cost of operations
Theatre operating expenses		238,834			205,693			707,057	680,182
General and administrative expenses		2,985			2,344			8,992	9,104
Depreciation and amortization		22,909			22,678			68,813	66,333
Impairment of long-lived assets		2,494			745			3,659	1,946
Loss on disposal of assets and other		1,221			2,711			3,560	7,479
Total cost of operations		268,443			234,171			792,081	765,044
Operating income		26,705			30,076			113,364	114,508
Other income (expense)
Interest expense		(24,482)			(24,469)			(73,523)	(72,853)
Loss on debt amendments									(1,484)
Equity in income of affiliates		32,606			50,262			144,279	179,170
Other income (expense)		1,173			1,088			3,297	3,292
Total other expense		4,631			21,898			59,873	93,250
Income before income taxes		31,336			51,974			173,237	207,758
Income taxes		(460)			1,331			6,720	11,907
Net income		31,796			50,643			166,517	195,851
Less: Net income attributable to noncontrolling interests		0			0			0	0
Net income attributable to Cinemark USA, Inc.		31,796			50,643			166,517	195,851
Subsidiary Guarantors
Condensed Financial Statements, Captions [Line Items]
Revenues		342,221			314,542			1,034,084	1,018,666
Cost of operations
Theatre operating expenses		247,512			224,592			733,408	699,065
General and administrative expenses		28,570			23,451			78,623	73,401
Depreciation and amortization		25,875			24,969			76,858	73,299
Impairment of long-lived assets		24,165			519			33,299	519
Loss on disposal of assets and other		783			4,856			2,859	20,265
Total cost of operations		326,905			278,387			925,047	866,549
Operating income		15,316			36,155			109,037	152,117
Other income (expense)
Interest expense		(603)			(1,684)			(1,846)	(5,045)
Loss on debt amendments									0
Equity in income of affiliates		1,825			4,187			(9,940)	11,150
Other income (expense)		3,020			1			6	(6)
Total other expense		4,242			2,504			(11,780)	6,099
Income before income taxes		19,558			38,659			97,257	158,216
Income taxes		4,745			7,671			31,285	34,611
Net income		14,813			30,988			65,972	123,605
Less: Net income attributable to noncontrolling interests		0			0			0	0
Net income attributable to Cinemark USA, Inc.		14,813			30,988			65,972	123,605
Subsidiary Non-Guarantors
Condensed Financial Statements, Captions [Line Items]
Revenues		200,093			181,866			597,646	566,087
Cost of operations
Theatre operating expenses		150,366			134,895			447,523	422,354
General and administrative expenses		12,558			11,950			37,439	39,264
Depreciation and amortization		18,976			17,324			51,124	54,024
Impairment of long-lived assets		645			377			8,424	2,555
Loss on disposal of assets and other		449			259			1,638	922
Total cost of operations		182,994			164,805			546,148	519,119
Operating income		17,099			17,061			51,498	46,968
Other income (expense)
Interest expense		(200)			(1,333)			(669)	(5,862)
Loss on debt amendments									0
Equity in income of affiliates		9,832			10,661			25,741	24,580
Other income (expense)		(1,378)			(1,119)			2,955	(1,351)
Total other expense		10,728			10,595			37,195	29,535
Income before income taxes		27,827			27,656			88,693	76,503
Income taxes		9,908			7,299			26,610	13,538
Net income		17,919			20,357			62,083	62,965
Less: Net income attributable to noncontrolling interests		602			393			1,957	878
Net income attributable to Cinemark USA, Inc.		17,317			19,964			60,126	62,087
NCM
Other income (expense)
Distributions from NCM		2,474			2,386			9,168	12,168
Interest expense - NCM		(4,666)			(4,983)			(14,180)	(14,875)
Equity in income of affiliates		9,050			6,830			14,062	11,341
NCM | Eliminations
Other income (expense)
Distributions from NCM		0			0			0	0
Interest expense - NCM		0			0			0	0
NCM | Cinemark USA, Inc.
Other income (expense)
Distributions from NCM		0			0			0	0
Interest expense - NCM		(4,666)			(4,983)			(14,180)	(14,875)
NCM | Subsidiary Guarantors
Other income (expense)
Distributions from NCM		0			0			0	0
Interest expense - NCM		0			0			0	0
NCM | Subsidiary Non-Guarantors
Other income (expense)
Distributions from NCM		2,474			2,386			9,168	12,168
Interest expense - NCM		$ 0			$ 0			$ 0	$ 0
[1]	Amounts for the three and nine months ended September 30, 2019 were impacted by the adoption of ASC Topic 842 and the resulting change in the classification of certain of the Company’s leases
[2]	Includes amortization of debt issue costs.

Condensed Consolidating State_2

Condensed Consolidating Statement of Comprehensive Income (Loss) Information (Detail) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018
Condensed Statement Of Income Captions [Line Items]
Net income	$ 32,398	$ 102,434	$ 33,642	$ 51,036	$ 83,022	$ 62,671	$ 168,474	$ 196,729
Other comprehensive loss, net of tax
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements	(1,291)	(5,902)	(3,311)	0			(10,504)	0
Other comprehensive loss in equity method investments	(49)	$ (22)	$ (71)	(63)	$ (116)	$ 136	(142)	(43)
Foreign currency translation adjustments	(25,408)			(10,797)			(19,728)	(66,841)
Total other comprehensive loss, net of tax	(26,748)			(10,860)			(30,374)	(66,884)
Total comprehensive income, net of tax	5,650			40,176			138,100	129,845
Comprehensive income attributable to noncontrolling interests	(602)			(393)			(1,957)	(878)
Comprehensive income attributable to Cinemark USA, Inc.	5,048			39,783			136,143	128,967
Eliminations
Condensed Statement Of Income Captions [Line Items]
Net income	(32,130)			(50,952)			(126,098)	(185,692)
Other comprehensive loss, net of tax
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements	0						0
Other comprehensive loss in equity method investments	49			63			142	43
Foreign currency translation adjustments	25,408			10,797			19,728	66,841
Total other comprehensive loss, net of tax	25,457			10,860			19,870	66,884
Total comprehensive income, net of tax	(6,673)			(40,092)			(106,228)	(118,808)
Comprehensive income attributable to noncontrolling interests	0			0			0	0
Comprehensive income attributable to Cinemark USA, Inc.	(6,673)			(40,092)			(106,228)	(118,808)
Cinemark USA, Inc.
Condensed Statement Of Income Captions [Line Items]
Net income	31,796			50,643			166,517	195,851
Other comprehensive loss, net of tax
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements	(1,291)						(10,504)
Other comprehensive loss in equity method investments	(49)			(63)			(142)	(43)
Foreign currency translation adjustments	(25,408)			(10,797)			(19,728)	(66,841)
Total other comprehensive loss, net of tax	(26,748)			(10,860)			(30,374)	(66,884)
Total comprehensive income, net of tax	5,048			39,783			136,143	128,967
Comprehensive income attributable to noncontrolling interests	0			0			0	0
Comprehensive income attributable to Cinemark USA, Inc.	5,048			39,783			136,143	128,967
Subsidiary Guarantors
Condensed Statement Of Income Captions [Line Items]
Net income	14,813			30,988			65,972	123,605
Other comprehensive loss, net of tax
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements	0						0
Other comprehensive loss in equity method investments	0			0			0	0
Foreign currency translation adjustments	0			0			0	0
Total other comprehensive loss, net of tax	0			0			0	0
Total comprehensive income, net of tax	14,813			30,988			65,972	123,605
Comprehensive income attributable to noncontrolling interests	0			0			0	0
Comprehensive income attributable to Cinemark USA, Inc.	14,813			30,988			65,972	123,605
Subsidiary Non-Guarantors
Condensed Statement Of Income Captions [Line Items]
Net income	17,919			20,357			62,083	62,965
Other comprehensive loss, net of tax
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements	0						0
Other comprehensive loss in equity method investments	(49)			(63)			(142)	(43)
Foreign currency translation adjustments	(25,408)			(10,797)			(19,728)	(66,841)
Total other comprehensive loss, net of tax	(25,457)			(10,860)			(19,870)	(66,884)
Total comprehensive income, net of tax	(7,538)			9,497			42,213	(3,919)
Comprehensive income attributable to noncontrolling interests	(602)			(393)			(1,957)	(878)
Comprehensive income attributable to Cinemark USA, Inc.	$ (8,140)			$ 9,104			$ 40,256	$ (4,797)

Condensed Consolidating State_3

Condensed Consolidating Statement of Comprehensive Income (Loss) Information (Parenthetical) (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Condensed Financial Information Of Subsidiaries Disclosure [Abstract]
Unrealized loss due to fair value adjustments on interest rate swap agreements, taxes	$ 417	$ 0	$ 3,391	$ 0

Condensed Consolidating State_4

Condensed Consolidating Statement of Cash Flows Information (Detail) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018
Operating activities
Net income	$ 32,398	$ 102,434	$ 33,642	$ 51,036	$ 83,022	$ 62,671	$ 168,474	$ 196,729
Adjustments to reconcile net income to cash provided by (used for) operating activities							237,428	228,265
Changes in assets and liabilities							(9,392)	(75,375)
Net cash provided by operating activities							396,510	349,619
Investing activities
Additions to theatre properties and equipment	(71,343)			(83,373)			(186,512)	(245,962)
Acquisition of theatres in U.S. and international markets, net of cash acquired							(10,170)	(11,289)
Proceeds from sale of theatre properties and equipment and other							377	3,557
Dividends received from subsidiary							0
Proceeds from intercompany note repayment								0
Investment in joint ventures and other								(20,442)
Net cash used for investing activities							(196,305)	(352,529)
Financing activities
Dividends paid to parent							(118,825)	(111,550)
Repayments of long-term debt							(4,947)	(4,946)
Payment of debt issue costs								(5,103)
Repayment of intercompany note								0
Payments on finance and capital leases							(10,830)	(18,778)
Other							(3,835)	(3,609)
Net cash used for financing activities							(138,437)	(143,986)
Effect of exchange rate changes on cash and cash equivalents							(5,296)	(8,732)
Increase (decrease) in cash and cash equivalents							56,472	(155,628)
Cash and cash equivalents:
Beginning of period			426,216			522,415	426,216	522,415
End of period	482,688			366,787			482,688	366,787
Eliminations
Operating activities
Net income	(32,130)			(50,952)			(126,098)	(185,692)
Adjustments to reconcile net income to cash provided by (used for) operating activities							126,098	185,692
Changes in assets and liabilities							0	0
Net cash provided by operating activities							0	0
Investing activities
Additions to theatre properties and equipment							0	0
Acquisition of theatres in U.S. and international markets, net of cash acquired							0	0
Proceeds from sale of theatre properties and equipment and other							0	0
Dividends received from subsidiary							(3,612)
Proceeds from intercompany note repayment								(1,867)
Investment in joint ventures and other								0
Net cash used for investing activities							(3,612)	(1,867)
Financing activities
Dividends paid to parent							3,612	0
Repayments of long-term debt							0	0
Payment of debt issue costs								0
Repayment of intercompany note								1,867
Payments on finance and capital leases							0	0
Other							0	0
Net cash used for financing activities							3,612	1,867
Effect of exchange rate changes on cash and cash equivalents							0	0
Increase (decrease) in cash and cash equivalents							0	0
Cash and cash equivalents:
Beginning of period			0			0	0	0
End of period	0			0			0	0
NCM
Investing activities
Acquisition of NCM common units								(78,393)
NCM | Eliminations
Investing activities
Acquisition of NCM common units								0
Cinemark USA, Inc.
Operating activities
Net income	31,796			50,643			166,517	195,851
Adjustments to reconcile net income to cash provided by (used for) operating activities							(71,652)	(90,311)
Changes in assets and liabilities							87,748	201,287
Net cash provided by operating activities							182,613	306,827
Investing activities
Additions to theatre properties and equipment							(64,264)	(70,519)
Acquisition of theatres in U.S. and international markets, net of cash acquired							(10,170)	0
Proceeds from sale of theatre properties and equipment and other							0	1,244
Dividends received from subsidiary							600
Proceeds from intercompany note repayment								1,867
Investment in joint ventures and other								0
Net cash used for investing activities							(73,834)	(145,801)
Financing activities
Dividends paid to parent							(118,825)	(111,550)
Repayments of long-term debt							(4,947)	(4,946)
Payment of debt issue costs								(5,103)
Repayment of intercompany note								0
Payments on finance and capital leases							(8,110)	(8,605)
Other							0	(704)
Net cash used for financing activities							(131,882)	(130,908)
Effect of exchange rate changes on cash and cash equivalents							0	0
Increase (decrease) in cash and cash equivalents							(23,103)	30,118
Cash and cash equivalents:
Beginning of period			197,965			130,590	197,965	130,590
End of period	174,862			160,708			174,862	160,708
Cinemark USA, Inc. | NCM
Investing activities
Acquisition of NCM common units								(78,393)
Subsidiary Guarantors
Operating activities
Net income	14,813			30,988			65,972	123,605
Adjustments to reconcile net income to cash provided by (used for) operating activities							130,125	91,492
Changes in assets and liabilities							(113,891)	(243,336)
Net cash provided by operating activities							82,206	(28,239)
Investing activities
Additions to theatre properties and equipment							(83,757)	(118,468)
Acquisition of theatres in U.S. and international markets, net of cash acquired							0	0
Proceeds from sale of theatre properties and equipment and other							0	1,740
Dividends received from subsidiary							3,012
Proceeds from intercompany note repayment								0
Investment in joint ventures and other								(19,896)
Net cash used for investing activities							(80,745)	(136,624)
Financing activities
Dividends paid to parent							0	0
Repayments of long-term debt							0	0
Payment of debt issue costs								0
Repayment of intercompany note								0
Payments on finance and capital leases							(2,671)	(6,669)
Other							(2,247)	(2,905)
Net cash used for financing activities							(4,918)	(9,574)
Effect of exchange rate changes on cash and cash equivalents							0	0
Increase (decrease) in cash and cash equivalents							(3,457)	(174,437)
Cash and cash equivalents:
Beginning of period			10,886			180,623	10,886	180,623
End of period	7,429			6,186			7,429	6,186
Subsidiary Guarantors | NCM
Investing activities
Acquisition of NCM common units								0
Subsidiary Non-Guarantors
Operating activities
Net income	17,919			20,357			62,083	62,965
Adjustments to reconcile net income to cash provided by (used for) operating activities							52,857	41,392
Changes in assets and liabilities							16,751	(33,326)
Net cash provided by operating activities							131,691	71,031
Investing activities
Additions to theatre properties and equipment							(38,491)	(56,975)
Acquisition of theatres in U.S. and international markets, net of cash acquired							0	(11,289)
Proceeds from sale of theatre properties and equipment and other							377	573
Dividends received from subsidiary							0
Proceeds from intercompany note repayment								0
Investment in joint ventures and other								(546)
Net cash used for investing activities							(38,114)	(68,237)
Financing activities
Dividends paid to parent							(3,612)	0
Repayments of long-term debt							0	0
Payment of debt issue costs								0
Repayment of intercompany note								(1,867)
Payments on finance and capital leases							(49)	(3,504)
Other							(1,588)	0
Net cash used for financing activities							(5,249)	(5,371)
Effect of exchange rate changes on cash and cash equivalents							(5,296)	(8,732)
Increase (decrease) in cash and cash equivalents							83,032	(11,309)
Cash and cash equivalents:
Beginning of period			$ 217,365			$ 211,202	217,365	211,202
End of period	$ 300,397			$ 199,893			$ 300,397	199,893
Subsidiary Non-Guarantors | NCM
Investing activities
Acquisition of NCM common units								$ 0